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5Introduction to the Portfolio
The portfolio contains the work that I have done across the three years of the 
Doctorate in Clinical Psychology. The portfolio consists of two volumes. Volume 
One is a public document that will be held at the University of Surrey library. 
Volume Two is a private document that contains confidential documents. This will 
be stored securely as an electronic document at the Department of Psychology for 
three years and then destroyed. The purpose of this portfolio is to show the breadth 
of work completed while tracking the developmental progression of the author.
This is Volume One. Volume One consists of three dossiers: the Academic, Clinical 
and Research dossiers. The Academic dossier consists of a literature review, 
professional essay, two reflective accounts and two process account summaries. The 
Clinical dossier consists of an overview of my clinical placements and the 
experiences gained. The Research dossier contains a service related research project, 
a group qualitative research abstract, my major research project and research log.
Volume Two contains four case reports and documents supporting the oral 
presentation that show work undertaken with clients across the clinical placements. 
Volume Two also contains the placement documents, including logbooks, contracts 
and placement evaluation forms. The full process accounts are also included.
Statement of Copyright
All rights reserved. No part of this document may be reproduced or transmitted in 
any form without prior permission of Christina A. Trigeorgis.
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7Factors mediating the relationship between bipolar disorder and 
creativity: A review of recent evidence
Literature Review
Year 1 
December 2010
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Abstract
The link between bipolar disorder and creativity has long fascinated researchers. In 
this review, the potential mechanisms underlying this link were evaluated. A search 
of the relevant literature revealed three potential mediators to the relationship: i) 
temperament, ii) cognitive/affective processes, and iii) genes. The evidence linking 
these factors to both bipolar disorder and creativity suggests each of them is useful 
for explaining how and why the two concepts are associated. The clinical, ethical, 
and diversity implications for these findings are discussed. Future studies are needed 
to assess the relative contribution of each mediator, how the mediators may interact 
to affect the bipolar disorder-creativity relationship, and the effects of treatment and 
medication on the link.
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Background
The age-old connection between creativity and mood disorders was first 
considered by Aristotle, who posited why so many eminent and creative people of 
his time were ‘melancholics’ (Akiskal & Akiskal, 2007). The romantic idea that the 
positive and often desirable concept of creativity co-occurred alongside the 
distressing and disabling experiences associated with bipolar disorder (BPD), has led 
to stereotypes such as ‘the mad genius’ or ‘tortured artist’ being cemented in popular 
cultural and folk psychology. Over time, this idea also interested many researchers, 
with the four most commonly referenced early empirical studies being those by 
Andreasen (1987), Richards, Kinney, Lunde, Benet and Merzel (1988b), Jamison 
(1989), and Ludwig (1994).
Andreasen (1987) used a sample of 30 writers to assess the prevalence of 
mood disorder in them and their families. She then compared this prevalence rate to 
that of a control group of non-writers. In this landmark study, it was found that 80% 
of writers had experienced a mood disorder episode, compared to 30% of the control 
group. Also, it was reported that 43% of writers experienced an episode of mania or 
hypomania as opposed to 10% of non-writers. Another outcome of this study was 
that the immediate relatives of writers also had higher rates of both mood disorders 
and creativity compared to the relatives of the non-writers. These findings were 
important for establishing a link between creativity and BPD, and for pointing 
towards a familial or genetic component for them. However, only a small sample 
was used in the study and it consisted mostly of males, limiting the external validity 
of findings. Also, as the study relied on retrospective data, this increased the risk of 
selection, measurement and investigator bias.
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Following this, Richards and colleagues (1988b) assessed levels of non- 
eminent creativity with the Lifetime Creativity Scale (Richards, Kinney, Benet & 
Mertzel, 1988a). A clinical sample was used of people with mood disorders and their 
immediate relatives. The results of this study indicated that the healthy first-degree 
relatives of patients with BPD and the patients with Cyclothemia, although not the 
patients themselves, had higher levels of creativity than healthy controls. This early 
study was unique in using a standardized scale to measure ‘everyday’ creativity 
rather than relying on eminence. This study also suggested a non-linear relationship 
between creativity and BPD, whereby milder forms of BPD and predisposition to the 
disorder were more closely related to enhanced creativity than were severe forms of 
BPD. The researchers indicated that the milder forms of BPD could serve as an 
advantage by increasing creative achievements, while extreme symptoms would 
impede this.
In another study, Jamison (1989), who herself has been diagnosed with BPD, 
used interviews from a sample of 47 eminent award-winning English artists and 
discovered that 38% of them had received treatment for a mood disorder. It was also 
found that the group of artists more likely to receive treatment was play writers 
(68%), while poets were the only group to be diagnosed with mania, with 17% of 
them seeking treatment. However, as the study had no control group, no conclusions 
can be drawn about whether these artists had higher rates of mood disorder than non­
artists.
Lastly, Ludwig (1994) compared mood disorder rates between 59 creative 
female writers and a control group, and found that 56% of writers while only 14% of 
controls ever had a depressive episode. Additionally, 19% of the sample had 
experienced a manic episode, compared to only 3% of controls. Findings from both
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Jamison’s (1989) and Ludwig’s (1994) studies highlight the higher prevalence of 
depressive and manic episodes in creative populations compared to the general 
population. However, the use of only females in the sample restricts the 
generalisability of Ludwig’s (1994) findings.
The Current Review
Expanding on the association between creativity and BPD reported by these 
early studies, this review will evaluate the recent evidence pertaining to the nature of 
the BPD-creativity association. In particular, we will focus on the potential mediators 
underlying this relationship. Although other recent reviews have also focused on this 
relationship, they focused on reviewing singular mechanisms or narrow aspects of 
the BPD-creativity relationship (McCrea, 2010; Murray & Johnson, 2010; 
Rybakowski, Klonowska, Patrzala & Jaracz, 2008; Srivastava & Ketter, 2010). This 
review alternatively aims to add to the current literature by reviewing multiple 
mechanisms underlying the BPD-creativity link and synthesizing findings to provide 
a more holistic view of the relationship. To do this, the empirical evidence for each 
mechanism will be reviewed and in light of the various methodological challenges 
faced by the studies investigating each mechanism, the relative theoretical and 
clinical contribution of the mechanisms will be considered. Additionally, the 
implications of the BPD-creativity link for clinical and professional practice will be 
discussed.
Definitions
Before reviewing the studies, the concepts of bipolar disorder and creativity 
first need to be described. The clinical definition for BPD specifies the presence of at 
least one depressive or mixed episode and one manic or hypomanie episode 
(American Psychiatric Association, 2000). According to this then, what distinguishes
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BPD from unipolar depression is the presence of manic or hypomanie episodes. 
People experiencing depression and manic episodes are diagnosed with Bipolar Type 
I, while those experiencing depression and hypomanie episodes are diagnosed with 
Bipolar Type II. Numerous and frequent symptoms of both depression and 
hypomania are classified as Cyclothymia.
The estimated prevalence of BPD in the UK and USA is around 1 to 1.5% 
(Weissman et al., 1996). BPD symptoms usually emerge in early adulthood with 
genetic factors and environmental stressors increasing the likelihood of its 
occurrence. Common symptoms of a depressive episode are low affect, diminished 
pleasure, changes in appetite and sleep, low self-esteem, decreased concentration, 
negative thinking and suicidal ideation (American Psychiatric Association, 2000). 
Manic episodes on the other hand are characterized extreme energy, productivity, 
creativity, increased goal directed behaviour, grandiosity, impulsivity, racing 
thoughts, psychomotor agitation, irritability and distractibility. A diagnosis of a 
hypomanie episode is given when these symptoms are less extreme and cause less 
functional impairment. Due to the range of symptoms and severity that people 
experience, bipolar disorders are considered to lie on a continuum with normal 
experiences (see Figure 1 : Akiskal & Akiskal, 2007).
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Figure 1. Bipolar disorder conceptualised as a spectrum, including temperament (Akiskal & 
Akiskal, 2007).
The second concept, creativity, involves temperament, genetic and 
environmental components and can be defined as the generation of novel ideas 
considered to be socially useful (Feist as cited in Murray & Johnson, 2010; 
Rybakowski, Klonowska, Patrzala, & Jaracz, 2008; Srivastava & Ketter, 2010). 
Creativity can be seen as both an attribute and a process (Murray & Johnson, 2010). 
As an attribute, eminent and non-eminent (or ‘everyday’) creativity is linked to 
occupations such as artists, writers, poets, philosophers, as well as scientists. As a 
process, creativity is mostly influenced by cognitive and affective factors.
Method 
Search Strategy
To locate the relevant literature, the databases MedLine, Psychlnfo, 
PsychArticles, PsychBooks, E-Joumals, and the Psychology and Behavioural 
Sciences Collection were selected. The search terms used were (bipolar disorder) and 
(creativ*). The inclusion criteria specified publishing date from 2005 and an adult 
age group. The rationale for using these criteria was to locate the most recent 
findings and to focus on the age group most affected by BPD. A search on Google
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Scholar was also conducted to find any additional papers. Exclusion criteria for the 
search were articles considered to be irrelevant, of low quality, duplicates, or book 
reviews. Articles that could not be accessed were also excluded.
Results
Three main mechanisms were identified in the literature as candidates for 
mediating the relationship between BPD and creativity: i) Temperament; ii)
Cognitive and affective factors; and iii) Familial genes. The recent studies providing 
evidence each will be evaluated next.
Temperament Studies
The notion of temperament ages back to the Ancient Greeks, who considered 
illness and disorders to arise from an imbalance of fluids in ones body. In modem 
psychology, temperament describes the biological and inherited aspects of 
personality expressed as phenotypic traits (Akiskal & Akiskal, 2007). It is considered 
that temperaments act as predispositions to mental disorders such as BPD, with 
extreme forms of normal temperament leading to dysfunctional and diagnosable 
symptoms (Akiskal & Akiskal, 2005).
One paper focusing on temperaments related to BPD was that by Akiskal and 
Akiskal (2005). In this study, the researchers used evolutionary theory to argue that 
temperaments are inherited because they provide evolutionary advantages. From this 
they hypothesised that people with a predisposition to BPD and their first-degree 
relatives would have inherited some benefit from their BP temperaments. To test 
this, they correlated traits within the Affective Temperament Evaluation of Memphis, 
Pisa, Paris and San Diego (TEMPS-A: Akiskal, Akiskal, Haykal, Manning &
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Connor, 2005) and between the TEMPS and the Temperament and Character 
Inventory (TCI: Cloninger et al. as cited in Akiskal & Akiskal, 2005). Factor analysis 
was used and five temperaments related to BPD were extracted. These were the 
Dythymic, Cyclothymic, Hyperthymic, Irritable, and Generalised anxious 
temperaments. Of these, the Cyclothymic temperament, previously associated with 
creativity and romance (Akiskal & Akiskal, 1988), also correlated with novelty 
seeking and, paradoxically, harm avoidance in this study (Akiskal & Akiskal, 2005). 
In relation to its function, the Cyclothymic temperament was said to play adaptive 
role in the pursuit of sexual partners and for reproductive success.
The contribution of this study was to identify a temperament involved with 
both BPD and creativity, while also highlighting that milder forms of BPD may be 
advantageous. Looking back at the earlier studies of Andreasen (1987) and Richard 
and colleagues (1988b), an evolutionary temperament theory could be used to 
explain why creativity was higher in the healthy relatives of people with BPD and in 
people with Cyclothymia than in people with full-blown BPD. However, the idea 
that BP temperaments offer an evolutionary advantage is only hypothetical. 
Alternatively, it could be that BP temperaments simply persist because they do not 
impede reproductive success as opposed to because they actively facilitate it.
Another study looking at the mediating role of temperaments was that by 
Nowakowska, Strong, Santosa, Wang and Ketter (2005). These researchers aimed to 
compare temperaments between creative people and people with BPD. To do this, 
they compared 49 euthymie BPD and 25 unipolar major depressive disorder (MDD) 
subjects, 32 creative discipline controls (CC) and 47 healthy controls (HC). The 
measures used to assess temperament were the TEMPS-A (Akiskal et al., 2005), the 
TCI (Cloninger as cited in Nowakowska, Strong, Santosa, Wang & Ketter, 2005),
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and the Revised NEO Personality Inventory (NEO-PI-R: Costa & McCrea as cited in 
Nowakowska et ah, 2005). The results of this study indicated that there were 
temperamental commonalities; such as increased Cyclothemia, Dysthymia,
Irritability, Neuroticism, Harm avoidance and Novelty-seeking, and decreased 
Conscientiousness and Self-directedness; between BPD, MDD and creative controls. 
Only the BPD subjects and creative controls shared an additional temperament of 
Openness to experience.
A strength of this study was that the researchers employed a controlled design 
to show that not only did BPD and CC subjects have similar temperaments but also 
that these were significantly different from the temperaments of people without a 
mood disorder. However, the study also had various limitations that the researchers 
alluded to, such as that their sample consisted of highly educated people, meaning 
that their results may not be generalisable to less educated populations. Furthermore, 
the creative controls were significantly younger than the BPD group so an effect of 
age could have affected findings. Also, the CC group did not consist of a 
homogenous set of students as it represented a range of art specialties that could have 
attracted people with dissimilar temperaments. Additionally, the CC group was made 
up of people with and without a history of mood disorder, while the comparably 
smaller and uneven sizes of the CC and MDD groups may have also confounded 
results. Similarly, the BPD group consisted of a mix of heterogeneously medicated 
and unmedicated subjects. Another limitation was that the BPD spectrum was 
collapsed to include all BPD types, so differences between BPD types were not 
considered. Finally, as the MDD group scored significantly higher on the Beck 
Depression Inventory (BDI: Beck et al. as cited in Nowakowska et al., 2005) than the 
other groups this may have affected their responses on measures assessing
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temperaments such as Openness to experience. Overall, the contribution of this study 
was to provide evidence for the argument that people with BPD and people with 
creativity have similar temperaments, thus offering an account for the high rate of 
co-occurrence reported between BPD and creativity.
In a follow-up study by the same researchers, non-eminent creativity levels 
were compared between the same four groups used above (Santosa et al., 2007). The 
measures used to assess creativity were: the Barron-Welsh Art Scale that is made up 
of Total, Like and Dislike subscales, (BWAS: Barron as cited in Santosa et al.,
2007), the Adjective Check List Personality Scale (ACL-CPS: Gough as cited in 
Santosa et al., 2007), and two Torrance Tests of Creative Thinking, the Figurai and 
Verbal versions (TTCT: Torrance as cited in Santosa et al., 2007). Outcomes of this 
study indicated that the BPD and CC groups, but not the MDD group, had on 
average higher creativity scores than the HC group on the BWAS-Total and BWAS- 
Dislike scales. Such higher BWAS Dislike scores represent a dislike of symmetrical 
and simple images, with higher scores associated with creative and artistic people 
(Simeonova, Chang, Strong & Ketter, 2005). These findings are important as they 
demonstrate that people with BPD and creative people without BPD both have 
similarly higher creativity levels compared to healthy controls. However, as the same 
sample was used, the same limitations mentioned in the previous study also constrict 
results here. Crucially however, the age effect of the CC group is particularly 
relevant here as age correlated with the BWAS measure and so may have inflated 
scores. Notably, although this study did not include a measure for temperaments, it 
was included in this section as it is useful for connecting findings from the previous 
study with those of the next one.
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The next study conducted by the same researcher group (Strong et ah, 2007), 
using the same sample, assessed the relationship between the factors emerging from 
the three temperament measures used by Nowakowska and colleagues (2005) and the 
scores obtained on the four creativity measures used by Santosa and colleagues 
(2007) above. The objective for doing this was to investigate the relationship 
between temperament and creativity amongst the four groups. Five temperament 
factors emerged from this study. Of these the Neuroticism/Cyclothymia/Dysthymia 
factor, was thought to reflect an affective component underlying creativity, while the 
Openness factor found was believed to reflect a cognitive flexibility component. 
Crucially, the Neuroticism/Cyclothymia/Dysthymia factor has been found in the past 
to be significantly related to BWAS-Total and BWAS-Dislike (Barron as cited in 
Strong et al., 2007) scores. In this study, Strong and colleagues also found the 
Neuroticism/Cyclothymia/Dysthymia scores to be higher in the BPD, CC, and MDD 
groups compared to DCs, and the Openness factor scores to be higher in BPD and 
CC groups. In total, these results indicated that the two temperament factors found in 
people with BPD were also correlated with creativity scores. An important 
consideration however is that in addition to the limitations stated earlier, there was a 
significant effect of past mood disorders in the CC group on the 
Neuroticism/Cyclothymia/Dysthymia factor scores, whereby CCs with a history of 
mood disorders had more similar scores with the BPD group.
In a fourth study by this research group (Srivastava et al., 2010), the above 
findings were replicated. Additionally, the cognitive factor of Intuition, as measured 
by the Myers-Briggs Type Inventory-Form M (MBTI: Myers and McCaulley as cited 
in Srivastava et al., 2010), was found to be correlated with creativity and to be higher 
in the BPD and CC groups than the HC group. By including this extra factor, the
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researchers hoped to present an integrative model of the affective 
(Neuroticism/Cyclothymia/Dysthymia) and cognitive (Openness and Intuition) 
temperaments making up creativity. An integration of the findings across the four 
studies reveals that certain temperaments, such as Cyclothemia, Openness to 
experience and Intuitive thinking, found in people with BPD are also related to 
enhanced creativity. Overall, these studies provide strong evidence for the mediating 
role of temperament in the BPD-creativity relationship.
Neurological, Cognitive and Affective Studies
Another group of studies emerging from the literature is those examining the 
role of particular cerebral functions associated with both BPD and creativity.
Flaherty (2005) presented three anatomical structures thought to influence creativity: 
the frontal lobe, temporal lobe, and the mesolimbic system. Of these, the temporal 
and frontal lobes are involved in the cognitive process of generating ideas (expressed 
as verbal creativity in mania), with deficits in the frontal lobe associated with 
decreased idea generation. The temporal lobe is also important for storing specialized 
knowledge, while the frontal lobe is crucial for executive functions such as problem­
solving (Heilman et al. as cited in McCrea, 2008). In fact, it has been found that 
frontal lobe deficits in people with depression may be able to explain the poorer 
decision-making and poorer creative thinking during depressive episodes (Galynker 
as cited in Rybakowski et al., 2008). The third structure, the mesolimbic system, is a 
dopaminergic pathway involved in novelty-seeking, goal-directed behaviour, 
motivation and creative drive, while additionally being related to BPD (Murray & 
Johnson, 2010). It has been suggested that during hypomania, higher activity in these 
three structures facilitate cognitive functioning and creativity, while a dysfunction of
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these occurs during mania (McCrea, 2008), further supporting the idea that milder 
forms of BPD promote greater creative functioning than full-blown mania. Also, 
these studies indicate that similar cerebral functions may underlie both creative
processing and BPD.
Furthermore, positive affect was considered to affect the BPD-creativity 
relationship. By definition, the manic episodes of BPD are related to increased 
positive affect. In a meta-analysis by Davis (2009), however, it was suggested that 
although mood may increase creative thinking, it is not linearly related to more 
creative performance. Rather, the relationship between positive mood and creative 
performance is curvilinear and influenced by affective intensity, in that moderate 
positive mood will increase performance whereas both low and extreme mood will 
not. Again, this could explain why studies found increased creativity in milder forms 
of BPD than in people with mania (Andreasen, 1987; Richards et al., 1988b). 
Genetic Studies
Another explanation proposed in the literature for the relationship between 
creativity and BPD was that they have common genetic components. Simeonova, 
Chang, Strong and Ketter (2005) set out to find the mechanisms by which creativity 
and BPD could be passed on across family generations. To do this, they compared 
BWAS (Barron as cited in Simeonova et al., 2005) creativity scores between 40 
parents and 20 offspring with BPD, 20 bipolar offspring with attention-deficit 
hyperactivity disorder (ADHD) and 18 healthy controls. This study found 
significantly higher creativity in parents with BPD and the bipolar offspring with 
either BPD or ADHD than in healthy children, signifying that a genetic co­
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transmission of creativity in families with or at risk of BPD may account for the link 
between the two concepts.
Various limitations of this study however hinder the conclusions that can be 
drawn concerning the BPD-creativity link (Simeonova et ak, 2005). For instance, the 
BWAS results did not differ significantly between offspring with ADHD and those 
with BPD. The researchers suggested that this could be explained by offspring with 
ADHD having parents with BPD, putting them at risk for BPD. Alternatively it could 
be that the small sample size restricted the study’s statistical power to detect 
creativity differences between the groups. However, neither of these explanations 
can be determined and future studies may benefit from including an ADHD offspring 
group without bipolar parents. Another drawback was that the children with ADHD 
were younger than the others, which may have affected their creativity scores. 
Moreover, since BWAS was the only creativity measure used, the results of this 
study are limited to the particular non-verbal and perceptual aspects of creativity 
captured by this measure. Importantly, the BWAS had not been validated in children, 
so it is unknown whether it was measuring the same thing in children as in adults. 
Replication studies using validated measures are thus needed to confirm results. As a 
whole, this study was useful for showing that creativity is higher in families with a 
genetic predisposition to BPD than in healthy controls. Still, the original aim of the 
researchers to reveal the mechanisms by which this was happening was less 
successful.
Other studies aiming to establish the genetic basis of the BPD-creativity 
relationship have identified specific genes that may be playing a role. In 2006, 
Schmechel, Browndyke and Ohio investigated the link between the alpha-1- 
antitrypsin (AAT) gene and BPD. The AAT gene is involved in immune responses to
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stress, inflammation, iron and lipid metabolism and delaying onset of toxic 
environmental exposure, with carriers being at risk for liver and lung disease. A 
strong relationship between the AAT phenotype and bipolar disorder was found, 
whereby certain polymorphisms of the gene were present in 42% of people with 
BPD compared to 10% of controls. In a follow-up study, Schmechel (2007) extended 
these findings by examining the relationship between AAT polymorphisms, pre­
existing BPD and artistic ability or occupation in 1537 people. In addition to 
replicating his earlier finding, the researcher also found a significant association 
between the AAT gene and creativity, with a 50% overlap of people with BPD and 
creativity having the AAT phenotype. The researcher expanded on this, proposing a 
new behavioural phenotype for AAT called ‘intense creative energy’ (ICE) that 
could incorporate both creativity and BPD. However, this idea warrants further 
investigation, with the relative contribution of AAT and other genetic, behavioural 
and environmental factors to an ICE phenotype remaining to be determined.
Another study identifying a specific genetic vulnerability to BPD was that by 
Rybakowski, Borkowska, Skibinska and Hauser (2006) who found a positive 
association between the val66met polymorphism of the brain-derived neurotrophic 
factor (BDNF) gene and executive functioning in 111 inpatients with mild BPD, but 
not in 129 inpatients with schizophrenia and 92 healthy controls in Poland. Executive 
cognitive functioning, associated with the prefrontal cortex, was assessed using the 
Wisconsin Card Sorting Test (WCST: Grant & Berg as cited in Rybakowski et al., 
2006). This is significant for the BPD-creativity link because the BDNF gene and 
prefrontal lobe activity have also been considered to play a key role in creativity 
(Rybakowski et al., 2008). Thus taken together, these findings propose a connection 
between the val66met BDNF polymorphism, BPD, increased prefrontal cortex
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activity and enhanced creativity. However, a study specifically assessing the 
relationship between the BDNF gene and creativity in people with BPD is needed to 
test this.
Taken as a whole, this section provides evidence for a genetic linkage 
between BPD and creativity, with two genes being isolated as potential candidates 
for relating the two concepts. Such a genetic tie would also provide support for the 
evolutionary argument in favour of creativity being adaptive benefits of BPD 
preventing its genetic elimination (Rybakowski et al., 2006; Schmechel, 2007). On 
the other hand, it could be that the mere genetic complexities and combination of 
genes contributing to BPD is responsible for the evolutionary persistence of the 
disorder (Tremblay, Grosskopf & Yang, 2010). Either way, as mentioned in the 
temperaments section, using an evolutionary claim may be far-fetched and difficult 
to prove.
Thus, further consideration of how genetic mechanisms may interact with 
other factors such as temperament, having an artistic family, and physiological and 
environmental stressors is needed in order to gain a better understanding of the 
complex relationship between BPD and creativity (Rybakowski et al., 2008; 
Schmechel, 2007; Simeonova et al., 2005; Tremblay et al., 2010).
Discussion 
Summary of Findings
In this review, three main mechanisms were identified as potential mediators 
of the relationship between BPD and creativity: temperament, cognitive/affective, 
and genetic mechanisms. Overall, research suggested a strong evidence base in favor 
of temperaments such as Cyclothymia, Neuroticism, Novelty-seeking and Openness
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to experience being common to people with BPD and creative individuals. The 
possible role of cognitive and affective processes in mediating the relationship was 
also supported by several research studies. Finally, an argument was put forth for the 
genetic linkage of BPD and creativity in families, but further research is needed to 
understand how and why this may happen.
It should be noted that although the aim of this review has been to provide a 
holistic view of the mechanisms underlying the BPD-creativity link, it was beyond 
the scope of this paper to review all potential mediators and their related literature so 
some, like intelligence, have been inevitably missed out.
Methodological Challenges
Several challenges to identifying the nature of the relationship between BPD 
and creativity have been noticed in the literature. One fundamental problem is that 
there is no agreed definition or measure of creativity, making it difficult to compare 
and integrate findings across studies (Andreasen, 2008). Also, most studies assessing 
creativity rely upon self-report measures that are open to response bias. Furthermore, 
as the number of people with either BPD or high creativity is relatively low in the 
general population, trying to identify and recruit enough people with both is a 
definite challenge for researchers. This is especially the case as people having 
positive experiences related to BPD may be less likely to come into contact with 
psychologists. As a result, many studies are conducted using small or non-random 
samples, and researchers often collapse the bipolar spectrum to increase participant 
numbers, combining people with mild and severe symptoms.
Implications for Clinical Practice and Services
An important clinical implication of the link between BPD and creativity is 
that it can affect adherence to therapy and medication. This is because clients may
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fear that when the negative symptoms of BPD decrease then the positive aspects of 
the disorder, such as creativity, will subside too. Thus it is imperative for therapists 
to acknowledge and understand the features of the disorder that are valued by clients, 
and to work with clients to alleviate anxieties about engaging with mental health 
services. Furthermore, when high levels of creativity are observed in clients with 
BPD, it would be worthwhile for therapists to utilize this strength in the client’s 
formulation and intervention (Murray & Johnson, 2010). Additionally, creative 
clients may well be encouraged to come up with their own innovative coping 
strategies to facilitate their recovery and treatment outcomes. Therapists should also 
be mindful, however, of risky behaviours associated with creativity, such as novelty- 
seeking and suicide attempts (Andreasen, 2008).
Diversity and Ethical Considerations
Following from the above implications, it is important for therapists to be 
aware of the unique strengths, weaknesses and experiences of clients, with 
consideration given to how differences in beliefs, values, cultures and lifestyles can 
affect perceptions and attitudes towards creativity. Moreover, since empirical 
evidence is used to guide practice, it is imperative to consider issues of race, gender, 
age, culture and socio-economic status before extrapolating research findings. For 
example, as the majority of participants used in the studies reviewed by this paper 
were White, male, middle-aged and highly educated, this limits the extent to which 
results can be extended to different populations. As such, more studies using diverse 
samples are needed to verify findings relating creativity to people with BPD.
Similarly, attention should be given to ethical considerations likely to arise 
when in contact with clients with BPD and creativity. One such consideration arises 
due to the lack of evidence about how treatment interventions, especially
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medications like lithium, are likely to affect creativity (Andreasen, 2008). 
Accordingly, a balance is needed between supporting treatment interventions in the 
best interest of the client while still being transparent about the gaps in our 
knowledge, at the risk of the client disengaging. Additionally, ethical consideration is 
needed on how to best disseminate research findings concerning genetic and 
temperament vulnerabilities to BPD so as to prevent discrimination, familial blame 
and diffusion of responsibility. Furthermore, since creativity is romanticized in 
Western culture, therapists should be wary of the ethical concerns of either idealizing 
clients who are highly creative or stereotyping them as pathological (Murray & 
Johnson, 2010).
Reflecting on Clinical Practice
My interest in finding out more about the relationship underlying bipolar 
disorder and creativity stemmed, similarly to Andreasen and Jamison, from 
observing the substantial number of famous creatives who allegedly have bipolar 
disorder, such as Steven Fry, Jackson Pollock, Nina Simone, Robert Schumann, 
Sophie Anderton, Kurt Cobain, Carrie Fisher, Britney Spears, Eminem, and so forth. 
From this, I became curious about why these two concepts may co-occur in people. 
The main objective in reviewing this topic was to recognize and explore a more 
positive facet of bipolar disorder. By better understanding and utilizing the strengths 
that a client may have this could in turn facilitate the therapeutic relationship and 
recovery process.
Having reviewed the evidence for some of the factors accounting for the 
relationship, I believe I am in a better position to understand both the benefits and 
challenges faced by creative clients with bipolar mood disorder. Also, reflecting on 
the clients with BPD and creativity that I have been in contact with, I now have an
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increased appreciation for the effect that this link has had on their sense of personal 
achievement and identity. In the future I can integrate this knowledge into my 
practice by helping clients to test their misconceptions regarding the need for mania 
to be creative, for example by asking them to keep a record of how changes in mood 
affect their creativity. This is especially essential due to the research findings that 
milder manic symptoms are more related to creativity than extreme ones.
Future Research
Many unexplored gaps still remain in the literature, while many existing 
studies are in need of replication to validate their findings. Future studies should 
assess the relative contribution of the various mediators, as well as ways in which 
people’s genes, environment and temperament interact to increase rates of BPD and 
creativity. To do this for example, studies could compare creativity levels in 
undiagnosed children with a predisposition to BPD, children with BPD and healthy 
children. Additionally, studies should examine how creativity levels differ within 
different types, episodes and intensities of BPD. Importantly, the effects of 
medication on creativity require a lot more investigation. Overall, there is a great 
need for more prospective, controlled, and population- based studies to explore more 
of this complex and intriguing association.
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“The vast majority of applied psychologists and psychotherapists 
are female, as are their clients. However many men experience 
psychological or emotional distress but are not accessing the 
psychological services provided. To what extent are psychological 
services inherently feminised and therefore doomed to exclude men?”
Professional Issues Essay
Year 2 
January 2012
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Introduction
We live in a social world that is significantly affected by social categories such 
as gender, class, race, age, physical condition and sexual orientation. We use these 
concepts to help us understand and define our selves and the world around us. The 
dominant representations of these social categories have become institutionalised 
practices, using differences as organizing principles that produce realities that affect 
the way we think, feel and behave. These concepts are incorporated into our 
everyday lives from a young age and influence, for instance, the ways that we relate 
to others, the occupations we pursue, the ways we experience and express emotion, 
the ways we ask for help and ultimately our physical and mental well-being.
In this essay I ^will explore how one of these social categories, gender, impacts 
mental health professionals, in particular applied psychologists and psychotherapists, 
and their clients. I will begin by looking at whether gender differences exist in 
psychological services in the United Kingdom (UK), for example in who provides 
and who accesses services, and for what. I will then argue that mental health is 
‘gendered’ as are current psychological services, to the extent that gender is a 
determinant of mental health and service utilisation. I will then review various 
theories and research studies to offer possible understandings of how this social 
phenomenon came to prevail. Using a social constructionist perspective it will be 
argued that services are not “inherently feminized” nor are they “doomed” to exclude 
men. Current UK policies that attempt to tackle gender equality in mental health will 
finally be evaluated. I will conclude by reviewing and evaluating some 
recommendations and offering reflections on how gender competence, equity and 
positive change can be promoted in the future.
1 The first person was used to highlight that the essay will reflect my subjective interpretation of the 
title provided and the issues involved.
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It is important to start by defining the concepts sex, gender and femininity so as 
to make clear how I will be using these in my paper. For the purpose of this essay, 
sex is defined as the biologically determined differences between males and females 
that lead to hormonal and anatomical differences, including reproductive differences 
(World Health Organisation (WHO), 1998). This has been differentiated from 
gender, which is described as the “socially defined characteristics that different 
cultures assign to those individuals defined as female and those defined as male” 
(WHO, 1998, p. 10). These gender characteristics refer to culturally ascribed roles 
and ideals of how males and females are expected to be, including ideals of 
‘masculinity’ and ‘femininity’ or ‘maleness’ and ‘femaleness’.
Gender-based differences have sometimes been attributed to, or justified, using 
sex differences. One example is that due to their biological ability to bear children, 
women are often considered to be more caring and nurturing, thus more relating to 
others (WHO, 1998). In turn, characteristics such as being caring are perceived to be 
more ‘feminine’ and this is reinforced by social structures that place the child-caring 
responsibilities predominantly on females. Biological differences alone however 
cannot account for gender differences. Gender differences are determined by a 
complex interaction of biomedical, psychosocial, epidemiological, cultural, 
economic and political factors (Afifi, 2007).
Having made this distinction, it is highlighted that ‘female’ and ‘feminised’ 
cannot be used interchangeably. In relation to the essay title, having more female 
psychologists and clients does not necessarily suggest that psychological services are 
“inherently feminized”. There are structural, social and cultural factors that can 
create such phenomena and these need to be accounted for.
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Current View of the Field of Psychology: Is the Supply ‘Feminised’? 
Psychology and education.
In 2004, the British Psychological Society (BPS) released a report highlighting 
the importance o f 6 Widening access within undergraduate psychology education’ 
(Turpin, 2004). This report was ultimately aimed at tackling the barriers to having 
more diverse clinical training programs and a more diverse workforce. This report 
was influenced by the consultation paper outlined by the Department of Health 
(DoH, 2003a) ‘Delivering Race Equality: A framework for action’, which stated that 
the providers of mental health services should be representative of the diversity of 
the local health communities that it serves so as to better meet their needs.
Similarly, in 2011 a publication of the American Psychological Association 
(APA), published an article titled ‘Men: A growing minority?’ as their January cover 
story (Willyard, 2011). The article reported that women were outnumbering men 
three to one in earning doctoral degrees in psychology. This ‘féminisation’ shift 
began in the 1970s, with the second and third waves of feminism, and by the 1980s 
women were earning more PhDs in psychology than men. This may be because men 
started moving towards other evolving fields, such as technology or business. A 
similar trend had also been noted in other professions, such as education and law, 
and in 2009 women earned more doctoral degrees overall than men for the first time 
in the USA (Cynkar, 2007; Phillips & Phillips, 2010).
These gender differences in higher education have been of increasing interest 
to researchers as they try to understand them. One study found support for the 
hypothesis that the increase in females choosing to study psychology was due to the
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belief that empathy was important for therapeutic outcome, which alongside the 
perception that women have higher levels of empathy, led to the gendered view that 
women would be more able to excel in this care-oriented profession (Harton &
Lyons, 2003). This shows that the feminine characteristics of caring and empathy 
may determine the choice of females to study psychology.
Psychology as a profession.
The gender differences in education continue to be evident in career 
progression within the profession. According to the summary report published by the 
BPS in 2007 as part of the ‘National New Ways of Working’ project, the profile of 
the UK Applied Psychology workforce was predominantly female, young and white. 
This ‘féminisation’ of services had reportedly raised concerns about the future 
diversity of the psychology workforce and led to a recommendation to decrease this 
gender gap by attracting and recruiting more male applied psychologists.
These concerns have likely been raised because it is believed that the 
profession of psychology could be disadvantaged by services being ‘feminised’. One 
such disadvantage could be that, as women on average earn less than men, this shift 
could lead to lower incomes across the profession, which may in turn attract even 
fewer men (Osterag & McNamara, 1991; Willyard, 2011). Additionally, some have 
said that the influx of females to the field has resulted in less occupational prestige 
for psychologists. Others, however, have argued that the profession had provisionally 
lost prestige in the 1980s and 1990s, leading men to exit the profession in the first 
place and women to enter to fill the gaps (Cynkar, 2007). Other concerns have 
included negative changes to work structure, education and training, theory, research
PORTFOLIO
36
and practice as the perspectives and valuable views of men could be lost from the 
profession (Osterag & McNamara, 1991).
On the other hand, these concerns may be inflated. It may be evident that the 
majority of applied psychologists delivering services are female, but men still occupy 
the majority of higher paid positions (BPS, 2007). This means that there is still a 
gender gap with regard to hierarchy; the higher the scale the more male-dominated it 
is. Additionally, males developed many of the main theories, models and 
interventions currently used by applied psychologists, such as Cognitive Behavioural 
Therapy and Psychodynamic psychotherapy. Thus, even though men may be 
outnumbered in the psychology workforce, concerns about the lack of male input and 
influence in the profession may be premature as the majority of those making 
service-related decisions and policies are male.
Furthermore, the shift towards having more females could also bring 
advantages to the field of psychology. For instance, males are thought to be more 
individualistic and females more collectivist. If this stereotype stands, it could mean 
that females can contribute models and theories that were more collectivist, inclusive 
and considerate of wider social and diversity issues (Willyard, 2011).
Current View of the Field of Psychology: Is the Demand ‘Feminised’? 
Men and women’s mental health access.
Beyond gender differences in the applied psychology and psychotherapy 
workforce that prove the mental health services, significant gender differences also 
exist among clients who access those services. A report published in 2009 by the 
NHS Information Centre found that in 2008-2009 19.1% more women were
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accessing NHS mental health services than men. Women were also more likely to 
see a GP or counsellor than men (Mind, 2009).
Gender differences have been widely recognised in the types of difficulties for 
which people seek help. Women have been found to have a higher prevalence of 
affective disorders, such as depression and anxiety, which are considered to be 
internalising disorders. Conversely, men report higher rates of behavioural disorders, 
such as substance use disorders, problem gambling and antisocial behaviours, which 
are considered to be externalising disorders (NHS Information Centre, 2007;
Piccinelli & Homen, 1997; WHO, 2002). Notably, males had higher rates of 
accessing inpatient care and were more likely to be detained under the Mental Health 
Act (Audini & Lelliott, 2002). Also, 83.4% of service users accessing services via 
the criminal justice system were male (Audini & Lelliott, 2002). These gender 
differences have been consistently reported across different age groups.
Men and women’s mental health needs.
The above statistics reflect the extent to which treatment is accessed, not the 
extent to which it is needed. Epidemiological evidence suggests that the gender 
differences in mental health refer to the patterns of the disorders rather than to the 
overall prevalence of mental distress (Piccinelli & Homen, 1997). This is particularly 
evident in the higher rates reported above of male specialist inpatient service use 
compared to primary care use, but also in the significantly higher risk of suicide 
amongst men compared to women despite males having lower self-reported levels of 
mental distress (Office for National statistics, 2009; Piccinelli & Homen, 1997).
This suggests that males represent a group who have unmet needs and are not 
accessing psychological services.
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‘Gendered’ mental health attitudes.
The barriers to accessing psychological services by males and females have 
been investigated by various studies. One predominant factor hypothesised to affect 
access to services has been gendered attitudes towards help seeking. In a 2010 report 
about attitudes towards mental illness (DoH, 2010), women were more likely than 
men to report feeling comfortable with discussing mental health issues with friends 
and family. A similar national report in 2011 (NHS Information Centre, 2011) found 
that women were less negative towards people with mental illness, they had more 
tolerant attitudes and they were more likely to believe that psychotherapy would be 
an effective treatment. Another study investigating the underutilization of 
psychological services by men found that women had more positive attitudes 
towards help-seeking than men, and were more psychologically open to 
acknowledging, recognizing and labeling emotions (Mackenzie, Gekoski & Knox, 
2006).
Additionally, while women were found to seek help if their distress interfered 
with social activities and if healthcare was free, men were more like to seek help if 
they experienced interference with physical activities, if they had a partner, more 
education, were unemployed or lived in a rural area; men’s help-seeking was also 
greatly influenced by self-reported embarrassment (Doherty & Kartalova-O’Doherty, 
2010). Other studies have reported stigma avoidance and mistrust of mental health 
services as psychosocial barriers for males (Ojeda & Bergstresser, 2008). Similar 
gender differences in willingness to use mental health services and perceived stigma 
were also found in early adolescent teens (Chandra & Minkovitz, 2006). This 
suggests that gendered views of mental health develop early on.
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Theoretical Frameworks
In order to understand why mental health is gendered, a deeper investigation of 
how the gender differences in access, need and attitudes developed is required. 
Different theories will be considered to appreciate this multi-faceted issue, without 
the theories being mutually exclusive. I chose to include and prioritise some theories 
over others to maintain the focus of the essay and to make it more relevant to my 
arguments, personal views and clinical experience.
Psychodynamic theories of gender and mental health.
One of the earliest theorists to hypothesise about the connection between 
gender and mental health was Freud. He believed that a distinction between the 
genders began in the phallic developmental stage when children become aware of the 
genital differences between them (Rosenfield & Smith, 2010). Freud theorized that 
this stage presented a crisis for females, as they understood that they were visibly 
inferior to males and developed penis envy. Freud claimed that this crisis affected the 
ego and superego development of females, predisposing them to passivity, 
masochism and vanity. Furthermore, Freud hypothesised that as boys tried to resolve 
the Oedipal complex they went on to identify with their same-sex parent and 
internalised their father’s gender characteristics (Rosenfield & Smith, 2010).
These classical Freudian theories could be used to understand why women tend 
toward internalizing psychopathologies and men tend toward externalizing. 
Nevertheless, feminists and non-feminists alike have criticized the validity of these 
theories. One central criticism was that Freud overemphasised the role of biology on 
gender development. Karen Homey claimed that women’s feelings of inferiority
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originated not in women’s recognition of their castration but in women’s realisation 
of their social subordination (Tong, 2009).
Another psychodynamic theory proposed was Chodorow’s Object-relations 
theory (Chodorow, 1978). This theory posed that females, who are generally more 
involved with parenting, identify more with daughters than sons because they are 
more similar to them. Due to this, sons experience premature disidentification and 
are encouraged to be more independent than daughters. Females then become more 
capable of, and preoccupied with, having social relationships. At the same time, they 
are more vulnerable to developing low self-esteem and depression due to being 
undervalued in society (Rosenfield, Vertefuille & Mcalpine, 2000). Men, on the 
other hand, become more prone to shame, more distant and fearful of dependency 
and rejection and thus less likely to seek support or help (Addis & Cohane, 2005). 
While helpful, this theory was based on traditional family structures and 
underemphasises various sociocultural factors that influence gender development.
Psychosocial and cognitive developmental theories.
Social learning theory has been extensively used to understand gender 
differences in mental health (Addis & Cohane, 2005). This theory highlights the role 
of social agents in the development of gender, particularly the role of parents.
Parents tend to match a child’s early gender identity to the child’s sex type and 
reinforce this gender identity, for example, by buying children gender-appropriate 
clothing and toys. Same-sex parents also model gender norms, which children 
imitate and come to internalise (Addis & Cohane, 2005). The gender roles expected 
of males and females vary as males are socialised to be more independent and 
autonomous, while females more vulnerable and dependent. Gender-role strain and
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gender-role conflict (O’Neil, 1982) may consequently develop when these restrictive 
gendered expectations cannot be met and result in similarly gendered mental health 
difficulties (Addis & Cohane, 2005).
Social learning theory, however, assumes children are passive agents.
Cognitive development theory instead suggests that children also self-socialise for 
self-concept consistency and gender constancy. This means that once children 
understand what gender is, they then want to ensure that they act in accordance with 
it (Martin, Ruble & Szkrybalo, 2002). Early experiences and beliefs are then 
organised into gender schemas, used to interpret the world and guide behavior 
throughout adulthood.
Sociopolitical theories of gender and mental health.
In order to understand other factors, beyond individual and nuclear family 
factors, that shape gender-appropriate beliefs about mental health, a wider 
sociopolitical perspective will be included.
Historically in agricultural societies men and women had similar 
responsibilities, and the household and workplace were not seen as separate. Later on 
with industrialisation in Western societies, a division of home and work life became 
more prominent with women and men taking on different roles (Rosenfield & Smith, 
2010). The public sphere became male-dominated and associated with more 
masculine characteristics such as competitiveness and assertiveness. The domestic 
sphere became associated with feminine characteristics such as caretaking, 
sensitivity and serving the needs of the family. This division of labour led to 
differential power relations between the sexes primarily because males had more 
access to economic and political resources.
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These gendered power dynamics continued even after females began to enter 
the public sphere. As a result, women’s skills have been valued less, they earn less 
income than males for the same work, they have less political control, and they 
experience more discrimination and violence (Rosenfield & Smith, 2010). 
Additionally, employed women are still generally considered to be responsible for 
the childcare and housework, leading to fewer resources and increasing demands 
being placed on women. These gender-specific social demands produce differential 
stressors and risk factors for the sexes, and could explain why females have needed 
psychological services more than men for incidents of anxiety and depression 
(Rosenfield & Smith, 2010). A grounded theory study supported this view, finding 
that adolescent girls had more negative experiences of social processes leaving them 
vulnerable to mental health difficulties (Landstedt, Asplund & Gadin, 2009).
These different adult experiences, combined with childhood socialisation 
processes have led to gendered norms about appropriate ways of expressing 
emotions in response to stress, with women expected to be more emotional and better 
at recognising and labeling emotions (Rosenfield & Smith, 2010). Females may thus 
be more likely to seek help for emotional distress because they do not have to 
challenge traditional gender norms to access psychological services, while men do. 
Studies have shown males to have restrictive emotionality due to negative attitudes 
towards emotion expression, difficulty identifying feelings and difficulty with 
emotional communication (Wong, Pituch & Rochlen, 2006). Male restrictive 
emotionality is consistent with masculine characteristics of wanting to appear more 
autonomous, in control and self-reliant, and may also explain why males are more 
reluctant to seek help.
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Feminist frameworks have also supported a focus on how power dynamics 
have shaped gendered experiences and mental health access. They add, however, that 
having negative help-seeking attitudes may benefit males by preserving the status 
quo of having more power than women and being seen as physically and emotionally 
strong (Addis & Cohane, 2005). Men may also avoid expressing emotionality or 
vulnerability due to ‘fear of femininity’, meaning fear of being associated with 
socially devalued feminine characteristics (O’Neil, 1982). Thus, men are more likely 
to express emotions seen as relating to power, such as anger and pride (Lee & Owen, 
2002). These views were supported by a study that found fear of losing status, 
control, fear of damaging ones identity, fear of incompetence and dependence to be 
barriers to help-seeking for men (Môller-Leimkühler, 2002). At the same time, 
however, feminist theories posit that men may feel more subjectively disempowered 
(Kaufman, 1994) as they have more restricted options by having to keep up with 
prescriptive dominant ideals of masculinity. Additionally, it is important to consider 
the fact that various subgroups of men are less able to conform to the traditional 
‘masculine’ image, for instance due to socio-economic and race factors. Power is 
thus distributed unevenly even between men so not all men have equal objective or 
subjective access to power, leaving some men more disadvantaged and vulnerable to 
mental health problems than others (Addis & Cohane, 2005).
Another theoretical framework that has been considered with regard to gender 
and mental health is the theory of social constructionism. Both social learning and 
social constructionist views emphasise the way in which society shapes gender but 
social constructionist views are different in that they emphasize that individuals are 
active agents that construct different masculine and feminine norms in different 
sociocultural contexts and times (Addis & Cohane, 2005). In this way, gender can be
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seen as dynamic, flexible and constantly changing depending on how men and 
women construct and engage with different competing masculine or feminine ideals 
to “do” gender. This offers a richer framework as it allows for multiple masculinities 
and femininities to co-exist rather than assuming the existence of stable gender roles. 
This perspective also considers the intersection of other social identities, such as 
ethnicity, age, sexuality and social class, and how these interact with gender to 
construct different meanings in different contexts (Addis & Cohane, 2005). This 
could offer different accounts and explanations of how men and women engage with 
mental health services, and allow for reconstructions or de-constructions of these 
accounts to counter the idea that psychological services are “doomed” to exclude 
men. One study, for example, found that changes in the traditionality of female 
gender roles over time, in places where female roles became more similar to male 
roles, subsequently had effects on mental health patterns and narrowed the gap 
between the genders in disorders such as depression and substance abuse (Seedat et 
ah, 2009).
Putting Theory into Practice
When researching for this essay, I noticed that the majority of gender-related 
resources were aimed predominantly at women, suggesting that gender was 
considered to be a woman’s issue. When policies addressed gender-specific mental 
health issues and equality of service provision this would often mean addressing 
women’s mental health. Examples of such policies in the UK were the publications 
o f ‘Into the Mainstream’ (DoH, 2002) and ‘Mainstreaming Gender and Women’s 
Mental Health’ (DoH, 2003b). The aim of the publications was to increase gender- 
awareness and to put gender at the forefront of service planning, commissioning and
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delivering; yet they predominantly focused on women’s needs, neglecting the needs 
of men.
This exclusion of males has recently come to the attention of the independent 
charity, Mind, who in 2009 published, ‘Men and mental health: Get if off your 
chest’. This campaign highlighted the unmet needs of men, particularly of male 
subgroups such as homosexual, black and ethnic minority and unemployed men. In a 
positive step forward, the charity recommended that male-specific services are 
developed, professionals are trained to identify and manage symptoms of male 
distress and that specific policies are developed to target men’s mental health. 
Following this campaign, the report ‘Untold Problems’ was published (Wilkins,
2010). This report reviewed some of the problems faced by men but also identified 
specific challenges in tackling male underutilisation of services. These challenges 
included difficulties identifying men who are struggling to cope, having a lack of 
expertise in how to plan and deliver services that men will use, and difficulties 
engaging men in a dialogue about help-seeking to begin with.
Finally, in 2011 ‘Delivering Male’, commissioned by the National Mental 
Health Development Unit, offered the first mental health guidelines focusing on men 
(Wilkins & Kemple, 2011). When evaluating this document, it appeared that this was 
a step forward in addressing men’s needs, perspectives, experiences and engagement 
with mental health services. The report provided useful recommendations about how 
to achieve change at different levels. For example, it was suggested that social and 
cultural expectations could be tackled early on through education. It was further 
suggested that more importance be given to fatherhood, that more positive male role 
models are desired (for example in the media), that social stigma should be addressed 
through campaigns and that friends, family and employers should support help
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seeking. Outreach programmes and peer support groups could also facilitate 
engagement with psychological service. Importantly, the gender blindness and biases 
of mental health professionals in the detection and treatment of psychological 
distress, especially in primary care services, should additionally to be addressed. 
Psychological service providers should also be wary of using more punitive 
interventions with males presenting with aggression or high risk to avoid further 
excluding males from services.
Research studies have offered further recommendations to help make services 
more inclusive and friendly for males. In relation to help-seeking attitudes, it was 
found that men experiencing more gender-role conflict were more reluctant to seek 
help if they believed the focus of counseling sessions was on emotion rather than 
cognition (Wisch, Mahalik, Hayes & Nutt, 1995). Presenting treatment options that 
are more cognition, problem solving and skills-based could thus improve help- 
seeking attitudes for males who adhere to conventional gender roles. Additionally, 
studies investigating male restrictive emotionality found that men with high 
restrictive emotionality had less favourable perceptions of face-to-face counseling 
but evaluated online counseling similarly as men with lower restrictive emotionality 
(Rochlen, Land & Wong, 2004), suggesting that some men may be more willing to 
engage in online therapy. Moreover findings from studies indicate that providing 
men with information and educating them about psychotherapy could positively 
affect their help-seeking attitudes (Mackenzie et al., 2006; Rochlen et al., 2004).
The research findings used from these various studies, however, may be 
limited by the extent to which they are representative of differences between and 
within gender groups. There is a risk of being essentialist by assuming that all men 
and all women are the same (or different in the same ways). Caution should be used
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when generalizing findings across different identity groups and subgroups, especially 
as many studies recruit mainly white subjects and represent American- or 
Eurocentric views.
Similarly, focusing only on gender identity does not sufficiently take into 
account people with multiple diverse identities that may feel particularly excluded. It 
is important for psychologists and professionals to also consider how these identities 
interact and intersect. One way to do this is to promote multicultural awareness, 
which includes gender diversity (McCarthy & Holliday, 2004). Rather than only 
fostering equality, a multicultural approach tackles issues of equity, choice and social 
justice. This leaves scope for work outside of strictly gender-related issues, including 
rights to basic amenities, and access to mental health services for all. Developing 
multicultural and gender competencies would also help build the therapeutic alliance 
between psychologists and clients. Particularly, multicultural competencies can help 
in identifying the function that gender has on a client’s personality, being more 
flexible in therapy and using strategies that fit the client’s gender culture. To do this, 
psychologists must also challenge, through supervision, their own stereotypes and 
their influence on their work. The benefits for including multicultural and gender 
frameworks have been supported by a study relating therapists’ gender competencies 
to psychotherapy outcomes (Owen, Wong & Rodolfa, 2009).
Critical evaluation and reflection.
Reflecting on my personal and professional experiences, I do not think enough 
emphasis is placed on the effects of gender on psychology as a profession. On the 
clinical training course, for instance, the stark underrepresentation of males is rarefy 
addressed beyond some occasional anecdotal comments. Similarly on my
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placements, the effect of gender roles on client’s presenting problems and emotional 
repertoires is often overlooked.
As a woman myself, it was encouraging to realise that women’s mental health 
has been a priority for the government and psychological services. It was not difficult 
to also appreciate why some males would feel excluded from policies aiming to 
increase gender awareness. I have found myself at various points feeling offended on 
men’s behalf. I am still, however, very conscious of the overarching power 
imbalances between men and women existing in society. The continued need for the 
empowerment of women is evident, particularly in developing countries, as is the 
responsibility of psychologists and service providers to advocate for them. The 
empowerment of women, however, does not have to exclude the voice of men 
particularly if a multicultural approach is used. I believe a patriarchal culture affects 
both men and women in different ways and as applied psychologists we need to be 
more mindful of how individual clients are situated in and constrained by wider 
social structures.
At the same time, I question strategies that attempt to address gender issues 
and male underutilisation of psychological services by exploiting traditional 
masculine stereotypes. For example, my attention was draw to suggestions described 
in ‘Delivering Male’ that involved using masculine ideals of strength and bravery to 
attract males to services, such as encouraging males to “have the courage” or be 
brave enough to seek help (Wilkins & Kemple, 2011, p.56). It is unclear whether 
using these stereotypes may in turn further perpetuate or legitimise the same 
constructions of gender that have oppressed women and excluded men to begin with. 
While using these strategies may be useful in attracting male clients to services in the
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short-term, more radical approaches may be needed long-term to create the change 
needed at the societal level to deconstruct and reconstruct gender ideals.
Conclusion
The theories and studies presented indicate that real differences exist between 
males and females in terms of their experiences, life stressors and mental health 
needs. These gender disparities are due to differential socialisation processes, power 
relations, and gendered sociopolitical and economic structures. Consequently, these 
processes may have led to the ‘féminisation’ of psychology as a profession and the 
exclusion of males. According to social constructionist views, however, the current 
structures are flexible to change, and thus are not doomed to exclude men.
Additionally, the distinction between gender and sex suggests that having more 
women enter the profession does not mean that the psychological services provided 
by these women are “inherently feminised”. If applied psychologists and 
psychotherapists, regardless of sex, are well informed about the different theories 
then this can enrich their understanding and competencies of addressing not only 
gender but also all other social divisions connected to our social and individual 
identity and mental health.
More research is needed however to understand gender differences, as opposed 
to sex differences, in the prevalence and epidemiology of psychological disorders. 
Future research should also focus on identifying factors that promote social change, 
social mobility and the belief that group boundaries are permeable. This knowledge 
could then be used to design psychological services, interventions, legislations, 
education, training and outreach programmes to stimulate gender equity at different 
levels and to promote the awareness of co-existing multiple masculinities and
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femininities. Overall, through the investigation of these issues, it has become 
apparent that the question posed for this essay is very complex and multi-level, 
inviting us to understand and address the social, psychological, cultural, educational 
and economic factors that contribute to this ‘féminisation’ claim. I hope this essay 
has contributed to this understanding.
PORTFOLIO
51
References
Addis, M , & Cohane, G. (2005). Social scientific paradigms of masculinity and their 
implications for research and practice in men's mental health. Journal o f  
Clinical Psychology, (57(6), 633-647.
Afifi, M. (2007). Gender differences in mental health. Singapore Medical Journal, 
49(5), 385-391.
Audini, B., & Lelliott, P. (2002). Age, gender and ethnicity of those detailed under 
part II of the Mental Health Act 1983. The British Journal o f  Psychiatry, 180, 
222-226.
British Psychological Society. (2007). New ways o f  working for applied
psychologists in health and social care: Career pathways and roles.
Leicester, UK: Author.
Chandra, A., & Minkovitz, C. (2006). Stigma starts early: Gender differences in teen 
willingness to use mental health services. Journal o f Adolescent Health,
3 # ) ,  751-758.
Chodorow, N. (1978). The reproduction o f mothering. Berkeley, CA: University of 
California Press.
Cynkar, A. (2007). The changing gender composition of psychology. Monitor on 
Psychology, 38(6), 46.
Department of Health. (2002). Women’s mental health: Into the mainstream.
Retrieved from http://www.nmhdu.org.uk/silo/files/into-the-mainstream.pdf
Department of Health. (2003a). Delivering race equality: A framework for action. 
Retrieved from
http://www.dh.gov.Uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/d
ocuments/digitalasset/dh_4069427.pdf 
Department of Health. (2003b). Mainstreaming gender and women’s mental health: 
Implementation guidance. Retrieved from
http://www.dh.gov.Uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/d
ocuments/digitalasset/dh_4072069.pdf 
Department of Health. (2010). Attitudes to mental illness 2010 research report. 
Retrieved from
http://www.dh.gov.Uk/prod_consum_dh/groups/dh_digitalassets/documents/d
igitalasset/dhl 14902.pdf
PORTFOLIO
52
Doherty, D., & Kartalova-O’Doherty, Y. (2010). Gender and self-reported mental 
health problems: Predictors of help seeking from a general practitioner.
British Journal o f Health Psychology, 75(1), 213-228.
Harton, H., & Lyons, P. (2003). Gender, empathy, and the choice of the psychology 
major. Teaching Psychology, 30(1), 19-24.
Kaufman, M. (1994). Men, feminism, and men’s contradictory experiences of power. 
In H. Brod & M. Kaufman (Eds.), Theorizing masculinities (pp. 142-163). 
Thousand Oaks, CA: Sage.
Landstedt, E., Asplund, K., & Gillander Gâdin, K. (2009). Understanding adolescent 
mental health: The influence of social processes, doing gender and gendered 
power relations. Sociology o f Health and Illness, 37(7), 962-978.
Lee, C., & Owens, R. (2002). The psychology o f  men’s health. Buckingham, UK: 
Open University Press.
Mackenzie, C., Gekoski, W., & Knox, V. (2006). Age, gender, and the
underutilization of mental health services: The influence of help-seeking 
attitudes. Aging and Mental Health, 10(6), 574-582.
McCarthy, 1, & Holliday, E. (2004). Help-seeking and counseling within a 
traditional male gender role: An examination from a multicultural 
perspective. Journal o f Counseling and Development, 82, 25-30.
Mind. (2009). Men and mental health: Get i f  o ff your chest. Retrieved from
http://www.mind.org.uk/assets/0000/0186/men and mental health report.pd
f
NHS Information Centre. (2007). Adult psychiatric morbidity in England, 2007: 
Results o f a household survey. Retrieved from 
http://www.ic.nhs.uk/pubs/psychiatricmorbidity07
NHS Information Centre. (2009). Mental health bulletin: Third report from mental 
health minimum dataset annual returns, 2004-2009. Retrieved from 
http://www.ic.nhs.uk/pubs/mhbmhmds0809
NHS Information Centre. (2011). Attitudes to mental illness 2011 survey report. 
Retrieved from http://www.ic.nhs.uk/pubs/attitudestomil 1
Martin, C., Ruble, D., & Szkrybalo, J. (2002). Cognitive theories of early gender 
development. Psychological Bulletin, 723(6), 903-933.
PORTFOLIO
53
Môller-Leimkühler, A. (2002). Barriers to help seeking by men: A review of
sociocultural and clinical literature with particular reference to depression. 
Journal o f Affective Disorders, 77(1-3), 1-9.
Office for National Statistics. (2009). Suicide rates in the United Kingdom, 2000- 
2009. Newport, UK: Author.
O’Neil, J. (1981). Patterns of gender role conflict and strain: Sexism and fear of 
femininity in men’s lives. Personnel & Guidance Journal, 60(4), 203-210.
Ojeda, V., & Bergstresser, S. (2008). Gender, race-ethnicity, and psychosocial
barriers to mental health care: An examination of perceptions and attitudes 
among adults reporting unmet need. Journal o f Health and Social Behaviour, 
49(3), 317-334.
Osterag, P., & McNamara, J. (1991). Féminisation of psychology: The changing sex 
ratio and its implications for the profession. Psychology o f  Women Quarterly, 
7 J(3), 349-369.
Owen, J., Wong, Y., & Rodolfa, E. (2009). Empirical search for psychotherapists’ 
gender competence in psychotherapy. Psychotherapy Theory, Research, 
Practice, Training, 46(4), 448-458.
Phillips, A., & Phillips, G. (2010). The persistence of traditional gender stereotypes: 
Evidence from the distribution of academic honors at a female-majority 
university. American Journal o f Business Education, 3(10), 45-53.
Piccinelli, M., & Homen, F. (1997). Gender differences in the epidemiology o f  
affective disorders and schizophrenia. Switzerland: World Health 
Organisation.
Rochlen, A., Land, L., & Wong, Y. (2004). Male restrictive emotionality and
evaluations of online versus face-to-face counseling. Psychology o f  Men and 
Masculinity, 5(2), 190-200.
Rosenfield, S., & Smith, D. (2010). Gender and mental health: Do men and women 
have different amounts or types of problems? In T. Scheid & T. Brown 
(Eds.), A handbook for the study o f mental health (pp. 256-267). New York, 
NY: Cambridge University Press.
Rosenfield, S., Vertefuille, J., & Mcalpine, D. (2000). Gender stratification and
mental health: An exploration of dimensions of the self. Social Psychology 
Quarterly, 63(3), 208-223.
PORTFOLIO
54
Seedat, S., Scott, K., Angermeyer, M., Berglund, P., Bromet, E., Brugha, T...
Kessler, R. (2009). Cross-national associations between gender and mental 
disorders in the World Health Organization World Mental Health 
Surveys. Archives o f  General Psychiatry, dd(7), 785-795.
Tong, R. (2009). Feminist thought (3rd ed.). Boulder, CO: Westview Press.
Turpin, G. (2004). Widening access within undergraduate psychology education and 
its implications for professional psychology: Gender, disability and ethnic 
diversity. Leicester, UK: The British Psychological Society.
Wilkins, D. (2010). Untold problems: A review o f the essential issues in the mental 
health o f men and boys. London, UK: Men’s Mental Health Forum.
Wilkins, D., & Kemple, M. (2011). Delivering male: Effective practice in male 
mental health. London, UK: Men’s Mental Health Forum.
Willyard, C. (2011). Men: A growing minority? gradPSYCH, 9(1), 40.
Wisch, A., Mahalik, J., Hayes, J., & Nutt, E. (1995). The impact of gender role
conflict and counseling technique on psychological help seeking in men. Sex 
33(1), 77-89.
Wong, Y., Pituch, K., & Rochlen, A. (2006). Men’s restrictive emotionality: An
investigation of associations with other emotion-related constructs, anxiety, 
and underlying dimensions. Psychology o f  Men and Masculinity, 7(2), 113- 
126.
World Health Organisation. (1998). Gender and Health: Technical paper. Retrieved 
from http://www.iiav.nl/epublications/1998/ gender_and_health.pdf
World Health Organisation. (2002). Gender and mental health. Retrieved from 
http ://whqlibdoc. who .int/gender/2002/a85573 .pdf
PORTFOLIO
55
Problem-Based Learning (PBL) Reflective Account One: 
‘The Relationship to Change’
PBL Reflective Account 1 
Year 1 
March 2011
PORTFOLIO
The Relationship to Change
56
The Original ‘Problem’ Task
The catalyst topic of ‘The relationship to change’ was first introduced to our
cohort in an introductory lecture for the Personal and Professional Learning 
Discussion Groups (PPLDG). We were told that it was up to our group to interpret 
the theme, with the goal of presenting on it after six Problem Based Learning (PBL) 
group sessions. Our group consisted of seven trainees, six females and one male, and 
a female facilitator.
The Group Process
My2 initial thoughts about the topic were that it was abstract and ambiguous.
I was unsure about how we were going to develop a consensus, as there seemed to be 
multiple ways of unpacking it. We were not given guidelines on tackling the 
exercise, which left me feeling confused and anxious as to where to begin or what to 
expect. Still, as it was the beginning of the course, I took comfort in the small groups 
and I was excited about the opportunity to form relationships and get to know other 
trainees better. I had not done a PBL exercise before and it seemed like an interesting 
way of working.
In the early sessions, we used the article by Wood (2003) to allocate roles such 
as scribe and chair; we set ground rules and an agenda and soon began to talk about 
each of our backgrounds, beliefs and reactions towards change. A big part of this 
discussion was the change we were currently going through from our previous roles 
to that of trainee clinical psychologists. Hearing about people’s different experiences 
and routes to the course was reassuring as it highlighted that there was no ‘right’ path
21 wrote in the first person as this is an account of my subjective experiences
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to take. Additionally, it was soon clear that the rest of the group also shared my own 
apprehensions about the process. This disorientation gave us a common ground and 
pulled us together. From the start, people were respectful and open to sharing their 
experiences and as a group we were very task-focused. In these first sessions we also 
spent a lot of time brainstorming ideas for the exercise and choosing an area for each 
of us to research. We allocated five minutes at the end of each session in order to 
write reflective notes and often referred to the marking criteria for the presentation 
and this write-up. Looking back, we were very aware of being evaluated for this 
process and found it difficult to include reflections in an assessed presentation.
Over the next few weeks, we began to unpack the ‘problem’ and to choose how 
we would focus our presentation. We considered theoretical models of change and 
looked at how they applied to us personally and professionally. Soon however, we 
became overwhelmed about how to integrate everything in a coherent way. We felt 
confused about what each of us was doing and had to have an emergency meeting. 
The desire for structure was very clear and we all expressed feeling more 
comfortable once we delegated our roles more clearly. Another defining point was 
when a group member brought in a diagram representing her personal relationship to 
change and journey of getting on the training course. We used this diagram as a 
template upon which the theories of change could be illustrated, and this helped us 
bring everything together. We spent the last sessions running through the 
presentation and by the end we were optimistic and felt a collective sense of 
achievement.
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The Presentation
At first the title for the presentation was ‘The challenges to change’. We all 
agreed however that this was quite negative and instead formulated the task as our 
‘Journey of change’. This captured the individual differences and paths we have all 
taken in the past, and that we might take in the future. Another factor that influenced 
our presentation was referring to the Chinese translation of the word ‘change’, which 
meant a combination of danger and opportunity. This showed to us the significance 
of language for communicating different meanings of change and it was important 
for us to highlight how everyone creates their unique relationship to change. One 
theory that particularly captured my transition to the role of trainee was the ‘Process 
of transition’ model because it illustrated some of the emotions associated with 
change, such as anxiety, happiness, fear and gradual acceptance (Fisher, 2003). 
Another theory applied was the ‘Transtheoretical model’, which can be used to 
assess one’s readiness to change depending on the stage they are in (Prochaska & 
DiClemente, 1992). This was particularly useful as took takes into account the pre­
contemplation and relapse stages.
In the presentation we focused on the different types of change we had 
identified, the different theories of change and our reflections. We divided this so 
that everyone in the group had the opportunity to present something. My part was to 
present the ‘take home message’. I remember that I was excited until just before I 
had to present, by which time my anxiety had increased. I was also conscious of 
comparing our presentation to that of the other groups. Throughout, I was 
wondering how other groups understood the topic and if there was anything we were 
missing out by deciding on a focus. Although some groups seemed more entertaining 
and had role-plays, I felt connected to my group’s perspective and was confident that
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we performed well. If we were to do something differently it would be to have more 
discussions about links to practice. We should have also reflected more as a group as 
well as individually. Finally, in our attempt to cover everything, we probably 
included too much. Although we were able to make it cohesive by the end, it may 
have taken away from the depth of our presentation.
Re-evaluation of the PBL Task 
Reflection on task and group processes.
Looking back at the PBL task, it has been very useful as it facilitated the 
reflection of our past experiences and future expectations in an explicit way. I was 
also able to learn from other trainees and to think about how to apply the principles 
to my clinical placements. The abstract nature of the task allowed the group to define 
and interpret the task without any preconceived notions of what was right or wrong. 
Still, I was slightly taken aback by the PBL scenario. I had just finished my MSc and 
was trying to adjust to the new course with new expectations. This left me feeling 
exposed and overwhelmed. Along with already feeling de-skilled, I was anxious 
about how I could contribute to the group. In hindsight, I was going through a lot of 
changes at the time and it was quite difficult to be asked to talk about them while 
they were happening. Trying to formalise this personal process also seemed forced. I 
remember feeling that the more theories I read, the more distant I felt to the task. I 
think this was because I was trying to fit my experience into the available models 
and nothing seemed to match. It seems a vital part of the scientist-practitioner role to 
use theories and evidence to guide practice. Going through the PBL process however 
made me aware of the discomfort of trying to do this.
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Reflection on theory and clinical practice.
This led me to think about how clients may feel when practitioners use models 
to make sense of their difficulties. Using theories too rigidly may similarly leave 
clients feeling like they are not being heard or understood. This could be very 
alienating and distance clients from their own experiences. On the other hand, I have 
encountered clients who have found the use of theories to be validating and 
normalizing. Either way, what seems important from this is to discuss issues in a way 
that is personally meaningful to each client as everyone reacts uniquely to change. 
Also, experiencing my own anxiety and vulnerability about the uncertainty of what 
to expect in the exercise, I became aware that this might be how some clients feel 
when they first come to therapy and are dealing with change.
Some factors that have been found to facilitate positive change are the presence 
of social support, creating a new sense of identity, changes in the environment, 
attribution of internal control, and crisis events that trigger the re-evaluation of goals 
(Heatherton & Nichols, 1994). On placement I have found these themes to be 
particularly important in either motivating clients or acting as barriers to change. 
Also, Bandura’s (1977b) social learning theory highlights the importance for 
therapists to model and reinforce a positive understanding and attitude towards 
change. Additionally, the theory of planned behaviour could be used to emphasise 
the role of intention, subjective norms and attitudes to change (Ajzen, 1985). As 
well as one’s beliefs about whether change is positive, this theory includes whether 
significant others are thought to be in favour of change. Thus, a client’s wider 
context should be considered to understand how the systems around that person are 
facilitating or hindering change. Furthermore, this is linked to self-efficacy, whereby 
beliefs about one’s capacity to change can affect motivation (Bandura, 1977a). This
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has been central to my own journey to the course because the greatest motivator for 
applying was my belief that I would be able to get on.
With the benefit of hindsight, I now see clear parallels between the structure of 
the PBL process and that of second-wave cognitive behavioural therapy (CBT). The 
initial steps of setting ground rules, agendas, goals and homework tasks were present 
in both the PBL and the therapeutic processes. The process of being curious about 
how the person got to be in the room with you was also a similarity, as was trying to 
formulate and unpack the ‘problem’ in a collaborative way. Finally, the arrangement 
of having six PBL sessions and then reviewing also mirrored the CBT process.
Reflection on placement in the National Health Service (NHS).
Beyond work with individual clients, the group process was also a useful 
template for multi-disciplinary teams within the NHS where each person offers 
something unique. The open nature of the PBL topic allowed us to contribute in 
different ways considering our varied experiences, differences in learning styles and 
decision-making processes. This facilitated collaboration rather than competition 
with each other. Furthermore, the topic of change was very relevant to the 
organizational changes taking place in the NHS and the clear vision and learning 
needed to successfully re-emerge through the chaos of transformational change (lies 
& Sutherland, 2001).
In retrospect, comparisons could also be made between the PBL facilitator’s 
role and my placement supervisor. As a group, we depended on the facilitator, who 
was viewed as an authority figure with more expertise and knowledge. Similarly, this 
is how I have often felt towards my supervisor, and perhaps may be how clients feel
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towards me. This task made me realize that in fact we all have something to offer, 
making each of us an expert in our own way.
Reflection on ethical issues, diversity and difference.
There was a lot of diversity in our groups in terms of age, levels of academic 
and work experience, and social/personal roles such as parenthood. We were able to 
pick up on each of these and we viewed our diverse backgrounds as a valuable 
resource for understanding the different ways of relating to change. Looking back I 
became aware that males and ethnic minorities were underrepresented in our group. 
As one of the only foreign trainees, I felt very conscious of how change can 
challenge many of our own culturally held beliefs, biases, assumptions and values. 
For example, I have been aware on placement of the importance of suspending such 
beliefs when working with clients and of having “an appreciation of one’s own social 
position, preferences and desire, and how they impact and constrain what can be 
known” (Chinn, 2007, p. 13). This has helped me be sensitive and empathetic to 
what I can know and to respect what I cannot know.
Reflection on relationship between personal and professional.
The exercise provided me with an opportunity to evaluate my own personal 
experiences of change and how these can be utilised to understand myself, clients, 
supervisors and organisational contexts better. This has been paramount in 
developing the confidence in my knowledge and resources as well as recognizing 
them in others.
Due to the dynamic interactional and interpersonal nature of the therapeutic 
relationship, my personal experiences and beliefs are likely to contribute to my work 
with clients. An awareness of the assumptions and constraints that theories and
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models pose was made clearer when trying to use them to understand my own 
change. Throughout the PBL process and within my clinical placement, the 
willingness to explore, understand and be curious about a theme has been integral. 
The extent to which people allow the personal and professional to interrelate can 
vary. I realized that in my attempt to appear professional I had undervalued the 
importance of my own journey. This has been the most helpful learning outcome for 
me during the ‘Relationship to change’ exercise.
Summary
Change is inevitable, constant and can be a fluid or discontinuous process. 
Going through the PBL process and my experiences on placement, I have examined 
my learning needs and past journey of change. This process is likely to affect my 
future personal and professional relationships in a positive way. By reflecting on this, 
I have become more sensitive and open to the individual ways in which we all relate 
to both the danger and the opportunities brought about by change, and the factors 
affecting this in theory and practice.
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Problem-Based Learning (PBL) Reflective Account 
The Original ‘Problem’ Task
The Problem Based Learning (PBL) exercise was emailed to us approximately 
a month before we began to think about it in the Personal and Professional Learning 
Discussion Groups (PPLDG). This allowed us time to read the exercise and think 
about it individually first. The exercise focused on “The Stride Family” and the 
professional network around them. We were provided with prompting questions to 
focus our attention on particular issues. Our task was to work within our groups to 
put together a presentation. Our group consisted of seven trainees, six females and 
one male, and a male facilitator.
The Group Process
My3 initial thoughts about the topic were that it was complex and multi­
layered. I felt somewhat apprehensive about it as I had not started the learning 
disabilities placement and had no previous experience of working with this 
population. I therefore did not feel confident in my knowledge and abilities to find a 
solution to “The Stride Family’s” problem. This was the second PBL task that we 
were doing as a group, however, so I felt assured that we would be able to unpack it 
when we all came together.
Our first task as a group was to decide whether we would allocate a chair and 
a scribe, as was recommended by Wood (2003) and as we had done in the first PBL 
task. We decided to rotate the chair so we all had an opportunity to take on the role, 
but chose not to have a scribe and to keep notes individually. We had already been
31 have written in the first person as this is an account of my subjective experience of the group 
process
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functioning well as a group for a year so we found no need to re-establish ground 
rules. An important change from our first PBL task was that many of our meetings 
were outside of the PPLDG times and thus the group facilitator was not present, 
leaving us to take charge of the PBL exercise.
Having swiftly negotiated all the logistics, we then began to share our first 
impressions of ‘the problem’ we were given. Similar to my initial reaction, other 
group members felt overwhelmed by the scenario and were unsure of where to start. 
As we discussed the task, we realised that our approach was problem-focused and 
our dialogues were dominated by negative assumptions about the family. From the 
early sessions, the themes of assumptions and professional scripts shaped and guided 
our approach to the task. The more we discussed ‘the problem’, the more questions 
arose. We thus decided to use the presentation to reproduce our group thinking 
process rather than trying to find ‘the solution’. At this point we were still very 
unclear about what the end result would look like. Rather than this causing anxiety, 
however, I noticed we were relaxed and open to being exploratory.
As the weeks progressed, our group began to translate our ideas into a 
coherent presentation. We settled on doing a role-play and considered using visual 
aids to illustrate our process, such as using tangled ropes to symbolise the family 
being trapped by the professionals and systems around them. Once we had chosen 
our roles, we each had to refer back to the vignette and think of the issues that were 
particularly relevant to our ‘character’. We each had to research, write the script and 
take responsibility for our role while also coordinating with other group members to 
ensure that we were accurately representing the dynamic relationships between the 
people involved. For example, as the solicitor, I was more focused on the legal 
system and child protection issues. At the same time, I had to consider how my role
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interacted with other professionals in the network and how I communicated with the 
family. We decided that the psychologist in the role-play would be positioned as 
outside the network looking in, using systemic techniques, such as circular 
questioning, to highlight the various processes we observed.
At periods, however, it was difficult to negotiate and develop all our different 
ideas. As time was running out this became more frustrating. To deal with this, we 
agreed to go through each idea and prioritise the more practical ones, which gave us 
more structure. As we did this we realised that our earlier idea of using ribbons 
would be difficult to implement and so we had to re-evaluate our presentation and 
find new ways of representing the family’s perspective. One of our reflections was 
that it felt like the professionals lost sight of the family in the role-play. We decided 
to demonstrate this in our presentation using cardboard boxes. We each labeled 
boxes with issues that we perceived to be barriers that prevented our character from 
being heard or understood. For example, one barrier between the solicitor and the 
family were assumptions about comprehension. Each time an issue was raised, a box 
would be placed in front of the family. By the end, these boxes, or issues, would 
create a visual wall between the family and the professional network. We all 
responded with excitement to this idea and quickly divided the tasks of finding boxes 
and printing off labels. By the end, we felt that it had all come together and everyone 
had contributed to their part.
The Presentation
On the actual day of the presentation I remember feeling nervous, wondering 
whether we had made the right choices and whether we answered the prompting 
questions we were given. I was aware that service users and carers had been invited
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too many assumptions. My anxiety also went up as we watched other groups. 
Although we were creative and playful in our planning, our presentation felt serious 
compared to others that used more humour or were more didactic. I also think we 
lost sight of the children’s perspective in the role-play. Looking back, we could have 
done things differently to add some of these elements. However, the final 
presentation was a culmination of our group thought process throughout weeks of 
preparation. By the end, I felt excited as our group had a unique perspective to offer 
and felt confident that we stayed true to our ideas.
Re-evaluation of the PBL Task 
Reflection on task and group processes.
Reflecting back on the group processes, I was struck by how different our 
process was compared to the first PBL task. Last year we relied heavily on 
PowerPoint slides and hid behind psychological models that formed the bulk of our 
presentation. This year we felt more confident and creative, allowing ourselves to 
explore and relate personally to the PBL task. Looking back, this willingness to take 
more risks could be understood using Mason’s (1993) notion of ‘safe uncertainty’. 
As a group, we evolved greatly and moved towards feeling more comfortable with 
taking time to be curious about different perspectives and not knowing the ‘right’ 
answers, while still owning our own expertise. This was reflected in our willingness 
to do a role-play and meet without our facilitator, which we would not have 
considered doing last year. Although we did feel pressure at times to find a 
‘solution’, we were able to step back and reflect on why we felt that way rather than 
reacting impulsively. Using Tuckman’s (1965) stages of group development, it
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appeared that our group was predominantly between the ‘norming’ and ‘performing’ 
phases during the PBL process. This was shown as we shared a collective vision and 
took individual responsibility, while having limited input from the facilitator. We 
also drew on our knowledge to contribute ideas and make decisions.
Reflection on theory and clinical practice.
The PBL task was helpful in developing scientist-practitioner skills by 
promoting the use of using theory and research evidence to support our group 
decision-making. For example, we relied on research to challenge negative 
assumptions about the ability of people with learning disabilities to parent (Booth, 
2000), which was particularly powerful in demonstrating how theory and practice 
were linked. Reviewing the relevant literature was also useful for understanding the 
effects of witnessing domestic violence on children, applying theories of attachment 
and finding publications to guide our recommendations about appropriate evidence- 
based support packages for the family.
Looking back, our active engagement with the PBL task allowed us to collect 
additional evidence by using our responses to the task as sources of information. For 
example, I reflected on my experience at the start of the task of feeling overwhelmed 
by the size and complexity of the professional network. This led me to wonder 
whether this could be how service users feel in similar situations. Another theme that 
was raised during our engagement with the task was issues of power and language 
that affect how problems are constructed. This will be something I will pay close 
attention to on placement, particularly when working with vulnerable populations. 
Overall, having done the PBL task I learned the value of spending time to understand 
the complexity of situations from multiple perspectives before attempting to
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intervene. This can ensure that any intervention strategies offered have been adapted 
to provide support that matches the specific needs of the system.
Reflection on working in the National Health Service (NHS).
The group process was also a useful template for working within multi­
disciplinary teams in the National Health Service (NHS). Thinking back to the 
position of ‘safe uncertainty’ that our group held during the PBL process (Mason, 
1993), that felt very different to some of my experiences of working in the NHS. In 
practice, teams may often manage complex cases by focusing on assessing risk in 
order to eliminate uncertainty. This attitude amongst professionals could be more 
dangerous as it leads to a position of ‘unsafe certainty’ and makes positive risk- 
taking less probable (Mason, 1993). The temptation to be risk averse amongst 
professionals was particularly prevalent in our PBL vignette and in similar cases 
dealing with vulnerable adults. These ‘scripts’ may have developed out of a blame 
culture created over the years following various high profile cases being publicised 
in the media.
In hindsight, I also became conscious of how several groups, including mine, 
presented different professions in a polarised manner. For instance, while 
psychologists were presented as heroes, community psychiatric nurses and social 
workers were stereotyped as the ‘bad guys’. These views reflected those that I have 
observed on placement. Importantly, other professionals have often viewed 
psychologists as outsiders as they feel under pressure to make difficult decisions and 
to carryout recommendations made by psychologists. The PBL task thus highlighted 
the need to be mindful of these dynamics and splits when working in a multi­
disciplinary way. Additionally, we could use our skills as psychologists to break
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through professional barriers by taking a process-perspective and using our 
formulation skills to provide alternative ways of working that focus on the strengths 
and resilience of teams. Other skills that could be transferred from our PBL group to 
working within teams in the NHS were our abilities to support each other, exchange 
knowledge, share responsibility and resources, and to collaborate rather than 
compete. Additionally, recognising and utilising each person’s strengths and 
expertise within the group to maximise efficiency, communication, task delegation 
and organisation also reflected useful skills for working in the NHS, particularly in 
roles of leadership.
Reflection on ethical issues, diversity and difference.
Issues of diversity and difference were considered greatly in relation to the 
PBL task, our personal lives and our experiences on placement. In the PBL 
presentation we paid particular attention to issues of social exclusion and social 
mobility. For example, “The Stride Family” was affected by poverty that could have 
affected their ability to access to services and engage with social support networks. 
Similarly, depending on the parents’ level of comprehension, they may have been 
inadvertently excluded from decision-making and could have experienced 
discrimination in the care proceedings (Booth, 2000). We also considered how the 
family’s ethnicity and culture could have affected discussions about kinship care.
We were aware of the diverse experiences and backgrounds that shaped our 
individual values and beliefs within the group. We were able to acknowledge these 
and use our differences as valuable resources for conceptualising and representing a 
variety of perspectives in our role-play. This tool has also been useful to use with 
clients and teams in clinical practice to aid creative problem solving and generate
PORTFOLIO
73
alternative ways of understanding. It has also been valuable personally to challenge 
my assumptions and biases and to be mindful of how my experiences affect and 
constrain what I can and cannot know (Chinn, 2007).
Reflection on relationship between personal and professional.
The PBL process allowed me to develop new knowledge and consolidate 
existing skills that have been important, for both my personal and professional 
growth. Looking back at my development, I have gained a greater understanding of 
the complexity involved when working with vulnerably populations, such as people 
with learning disabilities and children. Having the time to consider these issues will 
be important for how I will deal with complex cases in my clinical practice in the 
future. Additionally, it has been a continuous learning experience to work in teams 
and to watch the group and individuals within it develop. As an individual, I have 
gained more confidence in my knowledge and my ability to communicate my ideas 
to others. I have also developed my learning style by being actively engaged, my 
capacity to reflect in the moment and to take a position of ‘safe uncertainty’ (Mason, 
1993). As a trainee this often feels like a difficult position to take in clinical practice 
as one feels pressure to perform and offer solutions. This group exercise offered a 
positive experience and opportunity to practice this skill, making me feel more 
confident in my ability to use it with clients and teams in the future.
Summary
As professionals we can lose sight of our clients due to the tendency to focus 
on problems and differences, which can create barriers and restrict positive risk- 
taking. Going through the PBL process, I have become more aware of professional
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scripts, their function and developed confidence in using my skills as a psychologist 
to find ways of seeing through these barriers. I have also become more mindful of 
how group processes can affect decision-making. This makes it our collective 
responsibility to reflect on the multiple perspectives, needs and anxieties within a 
system to gain a better understanding of complex situations before offering solutions.
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Personal and Professional Learning Discussion Groups (PPLDG): 
Process Account One (Summary)
Year 2 
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Abstract
As part of our ongoing training and development, we took part in Personal and 
Professional Learning Discussion Groups (PPLDG). The objective of the groups was 
to offer trainees a safe space to synthesise and reflect upon the different types of 
knowledge and experiences gained throughout the training. This process account 
details the group work tasks that were undertaken and the skills gained in that 
process. It also offers my personal reflections of the group experience and how it has 
added to my personal and professional development. I additionally reference theories 
and models that helped deepen my understanding of the factors facilitating and/or 
hindering group progress. Moreover, I reflect on the various roles that group 
members took and explore the meaning and contribution of my own role to the group 
process. Each member offered something distinct and we all helped define our 
unique journey. Importantly, a consideration is also made of how my professional 
skills developed alongside my personal experiences of the group as I gained 
insightful feedback and knowledge to use in my clinical practice.
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Personal and Professional Learning Discussion Groups (PPLDG): 
Process Account Two (Summary)
Year 2 
July 2012
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Abstract
The Personal and Professional Learning Discussion Groups (PPLDGs) were 
introduced at the start of the clinical training course. We have been meeting in our 
groups for two years now. During this time we experienced multiple changes, 
including changes to the course team and ongoing large-scale restructuring of the 
National Health Service (NHS). Within this context, the PPDLG operated as a 
protective space offering a sense of constancy and continuity. Looking back to the 
first process account, most of my reflections were regarding the contribution of 
individual group members, my personal learning and the development of my clinical 
skills with an emphasis on direct therapeutic relationship with clients. This emphasis 
reflected my main concerns during the initial stages of clinical training. Overtime, 
my focus has broadened as I became more aware of the wider context in which we 
work. Alongside this, our discourses within the group evolved as we thought about 
the variety of roles that we would be taking on post-qualification, and the type of 
group members, leaders, decision-makers and supervisors we would like to develop 
into.
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• Overview of Clinical Experience
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Overview of Clinical Experience 
Adult Mental Health Placement (One Year)
My adult placement was based in an outpatient NHS Community Mental 
Health Team (CMHT) multi-disciplinary team and a Family Therapy Clinic.
During this placement I worked with clients of different ages, genders and 
from a range of socioeconomic and ethnic backgrounds. Clients presented with a 
range of complex mental health difficulties, including anxiety, depression, post- 
traumatic stress, psychosis and personality disorders. I also worked with people who 
had physical health problems, memory problems and learning difficulties. On this 
placement I worked directly and indirectly with clients, and offered consultation and 
supervision to staff teams. Furthermore, I completed various mandatory training 
events and attended a workshop on Mindfulness-based therapy.
I mainly worked within a Cognitive Behaviour Therapy (CBT) model in the 
CMHT to provide evidence-based interventions but also integrated systemic, 
narrative and psychodynamic thinking to inform my practice. I also completed 
cognitive neuropsychological assessments using a range of psychometric tests, 
including the WAIS-III, WMS-III and WTAR. I also used a variety of standardised 
outcome measures as part of my clinical work and completed risk assessments.
In the Family Clinic for people with psychosis I worked as part of a systemic 
reflective team, working with families and couples. I also co-facilitated a Mind over 
Mood group with a fellow trainee in an acute inpatient setting. Moreover, I worked 
with clients from a primary care IAPT service.
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I additionally completed a service related research project on this placement, 
auditing how well the team was meeting NICE guidelines for depression. I presented 
the feedback of this audit, along with recommendations, to the CMHT. As part of the 
placement I also visited various local NHS services and service user and carer 
organisations.
Older Adult Mental Health Placement (Six Months)
This placement was based in a NHS CMHT for older adults. I also worked as 
part of a Challenging Behaviour Service (CBS) for older adults.
On this placement I worked with adults from 65 to 94 years of age from a 
variety of demographic backgrounds. Clients presented with a range of complex 
difficulties, including anxiety, depression, bereavement, challenging behaviour, 
dementia and physical health conditions. My work was split between functional and 
neuropsychological work. As part of the latter I carried out dementia assessments 
using a range of psychometric tests, including the WAIS-IV and WMS-IV. I worked 
within CBT, systemic and behavioural models when working directly and indirectly 
with clients.
As part of the CBS, I provided weekly case discussions, consultation and 
training to staff at a nursing home. I also co-facilitated a training workshop for staff 
on how to use communication techniques with people with dementia.
I further attended and facilitated a group for service users and carers with 
dementia run by a voluntary sector organisation. I also visited a range of local 
services.
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Learning Disabilities Placement (Six Months)
On this placement I worked within a multi-disciplinary Local Authority 
Community Learning Disabilities Team.
On this placement I worked with clients from a range of backgrounds. Clients 
presented with a range of complex mental health difficulties, learning disabilities, 
Autistic Spectrum disorder (ASD), challenging behaviours, dementia and physical 
health conditions. I carried out a range of assessments (e.g. ASD, risk and eligibility 
assessments) and behavioural observations. I used integrative approaches for 
working with this group, including CBT, psychoeducation, positive behavioural 
support, Intensive Interaction, systemic and psychodynamic approaches.
I worked both directly and indirectly with clients, carers and residential home 
staff. I also had opportunities for joint working with professionals from other 
disciplines and teams. I further offered consultation to staff and supervision to an 
assistant psychologist. Furthermore, I co-presented a workshop to staff on working 
with people with learning disabilities who presented with challenging behaviour.
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Child Mental Health Placement (Six Months)
This placement was split between a Child and Adolescent Mental Health 
Service (CAMHS) and a Behavioural Pupil Referral Unit (PRU).
During this placement I worked with clients ranging from 4 to 17 years of age 
who presented with a variety of complex difficulties, including anxiety, obsessive- 
compulsive disorder, depression, self-harm, attachment disorders, learning 
difficulties, ASD, physical health and behavioural difficulties.
I gained experience in individual work, family work and joint working with 
other therapists. I worked mainly within CBT but integrated attachment, 
mentalisation, systemic and behavioural models. I also worked jointly with a 
psychodynamic therapist. I completed behavioural observations and carried out 
neuropsychological assessments. I also carried out a number of initial assessments of 
new clients.
I attended weekly MDT case discussion groups and academic presentations, 
and presented my own research work during one of the academic CPD meetings. 
There were also opportunities to visit other services and observe other professionals, 
for example observing a HALO assessment, ADHD clinics and a Parent-Child game 
intervention.
At the PRU I worked with young people who were excluded, or at risk of 
exclusion, from mainstream schools. I worked directly with young people and 
parents to build therapeutic relationships, provide therapy and psychoeducation. 
Additionally, I co-facilitated an Anger management group. I also worked indirectly 
with pastoral and teaching staff providing consultation, and co-presented a training 
workshop to staff on how to support pupils presenting with anxiety.
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Specialist Placement: Early Intervention Service (Six Months)
For my specialist placement I worked within an NHS multi-disciplinary Early 
Intervention Service (EIS) for young people aged between 18 to 35 years of age 
presenting with a first episode of psychosis or bipolar disorder.
On this placement I worked with clients from a range of backgrounds 
presenting with psychosis as well as a range of other complex difficulties, such as 
anxiety, depression, post-traumatic stress, ASD, learning difficulties, low self­
esteem, self-harm, sleep difficulties and social isolation. I worked jointly with other 
professionals and provided consultation to the EIS team. I also supervised an 
assistant psychologist during this placement and presented teaching about clinical 
psychology to medical students. Furthermore, I produced service leaflets to inform 
clients, carers and referrers about the role of the EIS and how to access the service.
I mainly used CBT and narrative frameworks incorporating third-wave CBT, 
systemic, psychodynamic, behavioural, motivational interviewing and solution- 
focused techniques. I also completed neuropsychological testing and used 
standardised outcome measures.
Furthermore, I completed training on family work and used this to provide 
family interventions and consultation sessions to family members and carers of 
clients. I also attended training workshops on CBT for persecutory delusions, as well 
as Trauma-focused CBT for PTSD.
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RESEARCH DOSSIER
• Service Related Research Project
• Qualitative Research Methods Group Project (Abstract)
• Major Research Project
• Research Log
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A CMHT service audit of adherence to the NICE 90 guideline for
depression in adults
Service Related Research Project 
Year 1 
June 2011
Identifiers of names and places have been removed or changed to preserve 
anonymity and confidentiality.
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Abstract 
Rationale
The National Institute for Health and Clinical Excellence (NICE) has published a set 
of national guidelines recommended for the treatment of psychological and 
psychiatric disorders. As part of their implementation, National Health Service 
(NHS) practitioners are encouraged to carry out audits of how well they are meeting 
the guidelines. Audit reports are also requested by the local Healthcare 
Commissioners as evidence of service quality and compliance. The Community 
Mental Heath Team (CMHT) in this study had never undertaken an audit regarding 
the NICE guidelines for depression; doing this would provide useful information 
about the service’s standards of care.
Objective
To investigate how far a CMHT in South-West London was meeting the NICE 
(2009) clinical guidelines for the treatment and management of adults with 
depression.
Design and Participants
A retrospective audit study. Twenty-seven clients were identified by CMHT staff to 
participate in the study.
Results
The results suggested areas where the CMHT met guidelines, for example assessing 
risk, meeting standards for electroconvulsive therapy (ECT) and developing 
multidisciplinary care plans, and areas that require improvement, such as having 
advance decisions, offering psychological interventions and sharing written 
information.
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Conclusion
The implications of the findings on clinical practice were considered, while taking 
into account the limitations of the study. It was also suggested the CMHT re-audit in 
the future, emphasizing a continuing process of change implementation. This 
information will be fed back to the CMHT and findings will also be disseminated in 
a NICE meeting.
PORTFOLIO
89
Introduction
Background and Rationale
The National Institute for Health and Clinical Excellence (NICE) was 
developed to provide an authoritative body that would offer national standards for 
client care in the National Health Service (NHS). These top-down driven 
recommendations were based on an evaluation of the available practice literature and 
evidence for various therapeutic interventions (Rawlins, 1999). This was done as part 
of a government initiative to improve the quality, access and cost effectiveness of 
service delivery and clinical practice in the NHS in England and Wales (Department 
of Health, 1998).
The responsibility for the implementation of these guidelines lies with local 
healthcare providers as part of clinical governance (NICE, 2009). It is expected that 
healthcare professionals will self-regulate and evaluate their services against the 
NICE standards, and implement changes where necessary to improve practice. 
Additionally, local Healthcare Commissioners and NHS trust boards monitor and 
request clinical audit reports as evidence of NHS service quality and compliance 
(Department of Health, 2004). It is therefore important for healthcare providers to 
undertake local clinical audits to measure the extent to which their service is meeting 
the predetermined standards of care.
This audit process was undertaken by a Community Mental Health Team 
(CMHT) to assess the extent to which the service was meeting the NICE guidelines 
for the treatment of depression. This was chosen as it was estimated that in 2010 
almost one-third of the team’s caseload was comprised of clients diagnosed with 
depression. Moreover, this audit had never been done before in the CMHT and,
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although this presented some challenges, it was considered essential for improving 
the quality of care provided to the community, helping in decision-making and 
promoting best practice.
NICE Clinical Guideline for Depression
In October 2009, NICE published clinical guideline 90 (CG90) for the 
identification, treatment and management of adults with a primary diagnosis of 
depression. This updated and replaced the previous NICE guideline 23 published in 
2004. The guideline, commissioned by NICE, was developed by the National 
Collaborating Center for Mental Health (NCCMH) and reviewed by an independent 
panel.
The CG90 is based on a ‘stepped-care’ model {see Figure 1), which identifies 
and organizes the provision of appropriate interventions for depression depending on 
the focus and nature of care needed (NICE, 2009). As the CMHT primarily provides 
‘Step 4’ care, it was decided that the audit would focus on the criteria applicable to 
this level.
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Focus o f  th e  
In te rv en tio n
STEP a: severe and complex3 
depression; rtsk to life; severe 
self-neglect
STEP 3 : Peislstent subthreshold 
depressive symptoms or mild to 
moderate depression with Inadequate 
response to Initial Interventions;
moderate and severe depression
STEP z  Peislstent subthneshold 
depressive symptoms; mild to moderate 
depression
N atu re  o f  th e  
In te rv en tio n
Medication, hlgh-lntenslty 
psychological interventions, 
etectroconvulsive therapy, cnsls 
service, combined treatments, 
multlprofessicnal and Inpatient care
Z"Medication, hlgh-lntenslty si
psychological intenrentions. combined 11 
treatments, odlahoratfve care4 and i
referral for further assessment t
and interventions y
Low-lntenslty psychological and 
psychosocial Interventions, medication 
and referral for further assessment 
and Interventions
r
step  i :  All known and suspected presentations 
I of depression
L
Assessment, support, psychoeducation, active 
monitoring and referral for further assessment 
and interventions
Figure 2. The ‘stepped-care’ model (NICE, 2009).
Aims and Objectives
The aim of this audit was to investigate the research question, ‘How far does 
the CMHT meet the NICE CG90 standards for the treatment and management of 
adults with depression?’ Standards for all the guideline criteria were set at 100% 
(NICE, 2009). Specifically, the audit will evaluate the relevant clinical criteria for 
depression {see Appendix A) grouped by NICE as:
• Advance decisions and statements
• Psychological interventions
• Psychological interventions for relapse prevention
• Complex and severe depression
• Electroconvulsive therapy (ECT)
e Person-centered care
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Method 
Design
A retrospective case-note study design was used.
Setting
A CMHT in South-West London.
Cases
To select cases, eleven CMHT staff members (six care coordinators, two 
consultant psychiatrists, one associate specialist, one specialist registrar to a 
consultant and one consultant psychologist) were asked to identify clients on their 
current caseload who were over 18 years of age and had a primary diagnosis of 
depression. Eight staff members responded and twenty-seven clients were identified 
to participate in the study.
Materials
An information sheet was given to CMHT staff that detailed the rationale for 
the audit and instructions on how to complete the questionnaire {see Appendix B).
A standard audit questionnaire was used to measure current practice. This 
questionnaire was adapted from an existing data collection tool provided by NICE 
(2009) to accompany the CG90 {see Appendix C), and focused on the six groups of 
clinical criteria specified earlier. In the adapted version, questions about 
interpersonal therapy and counseling were not included as they were not relevant to 
the service. The same questionnaire was used to collect information about client 
demographic characteristics.
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Procedures
The CMHT staff was approached and involved in helping the researcher 
identify and develop the research question. The researcher then referred to the 
national standards and chose the appropriate measure to investigate the question.
With the help of the field supervisor, the measure was adapted to match the specific 
CMHT practice priorities and concerns. The final information sheet and 
questionnaire was then posted online. The team was informed of this during a team 
meeting and an email was circulated with the online link to the questionnaire. 
Subsequent emails were sent to the team as reminders. Additionally, the researcher 
offered half hour individual meetings to all team members to provide help and to 
answer any questions regarding the audit process.
One questionnaire was completed for each client by the key CMHT worker 
involved in the identified person’s care. All questionnaires were completed online 
using information from pre-existing client records, letters and clinician notes. Online 
data responses were then extracted for analysis.
Ethical Considerations
The study was determined to be a clinical audit and so it did not require review 
or approval by a Research Ethics Committee as stated by current National Research 
Ethics Service (NRES) guidance (Barker, Pistrang & Elliot, 2002; NRES, 2009). To 
ensure that the CMHT was fully informed about the audit an information sheet was 
given. Additionally, all identifying information of the service, staff and clients were 
removed from the study to ensure confidentiality.
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Results 
Data Analysis
Once data was collected, the statistical software package SPSS version 18.0 
was used to analyse the data. Quantitative descriptive and summary statistics were 
used to calculate demographic information and the frequency with which each 
clinical criterion was met in the client sample.
Demographic Information
Information on the age, gender and ethnicity of the twenty-seven clients was 
summarized in Table 1.
Table 1
Clients ’ Demographic Information
Characteristic («= 27) Frequency (%)
Gender
Female 15 (55.6)
Male 12 (44.4)
Age (years)
18-24 1 (3.7)
25-34 9 (33.3)
35-44 5 (18.5)
45-54 6(22.2)
55-64 6 (22.2)
65-74 0
75+ 0
Ethnicity
White British or Irish 19 (70.4)
White Other 3(11.1)
Mixed 0
Asian British or Irish 1 (3.7)
Asian Other 4 (14.8)
Black British or Irish 0
Black Other 0
Chinese British or Irish 0
Chinese Other 0
Not stated 0
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Clinical criteria for depression
In relation to ECT, 3.7% of clients (i.e. one) in the CMHT had received this 
and in this case all criteria recommended by NICE had been met 100% {see 
Appendix Dl). The results for the other criteria groups were included in Tables 2 to 
4. Figure 2 indicates the number of clients who received or were referred for 
psychological interventions and relapse prevention. The raw data have been included 
in Appendix E l. Figure 3 indicates the number of sessions of psychological therapy 
actually received by clients, and Figure 4 illustrates the duration of therapy.
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Table 2
Frequency o f Cases Meeting Criteria for Advance Decisions and Statements
Advance decisions and statements
Yes
Frequency
(%)
No
Frequency
(%)
Total
Valid
Does the person have an advance decision 
or statement?
6 (22.2) 21 (77.8) 27
Has a copy been given to the person with 
depression?
5 (18.5) 22 (81.5) 27
Has a copy been given to the family or 
carer?
1 (3.7) 26 (96.3) 27
Was the person asked about suicidal 
ideation and intent?
27 (100) 0 27
Was the patient considered to be at 
increased risk of suicide?
13 (48.1) 14(51.9) 27
If no, were they seen 2 weeks after they 
were started on antidepressants?
12 (85.7) 2 (14.3) 14
Were they seen regularly thereafter (every 
2 to 4 weeks for the first 3 months)?
13(92.9) 1 (7.1) 14
If the response was good, were they then 
seen at longer intervals?
13 (92.9) 1 (7.1) 14
Was the patient younger than 30 years? 8 (29.6) 19 (70.4) 27
Were they seen 1 week after being started 
on antidepressants?
10 (58.8) 7(41.2) 17
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Figure 2. The number o f clients referred for psychological interventions and relapse 
prevention {n= 27).
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Figure 4. The duration o f therapy for clients in the CMHT {n- 27).
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Table 3
Frequency o f  Cases Meeting the Criteria for Complex and Severe Depression
Complex and Severe depression
Yes
Frequency
(%)
No
Frequency
(%)
Total
Valid
When the person was referred, did their 
assessment include:
Their symptom profile, suicide risk and, where 
appropriate, previous treatment history?
25 (92.6) 2(7.4) 27
Associated psychosocial stressors, personality 
factors and significant relationship difficulties, 
particularly where the depression is chronic or 
recurrent?
23 (85.2) 4 (14.8) 27
Associated co-morbidities, including alcohol 
and substance misuse, and personality 
disorders?
21 (77.8) 6 (22.2) 27
If the person with depression was started on 
medication in secondary care mental health 
services, was it started under the supervision of 
a consultant psychiatrist?
Does the person’s multidisciplinary care plan:
19 (70.4) 8 (29.6) 27
Clearly identify the roles and responsibilities 
of all health and social care professionals 
involved?
26 (96.3) 1 (3.7) 27
Develop a crisis plan that identifies potential 
triggers that could lead to a crisis and 
strategies to manage such triggers?
25 (92.6) 2(7.4) 27
Get shared with the GP, the person with 
depression and other relevant people involved 
in the person’s care?
24 (88.9) 3(11.1) 27
Was it developed with the person with 
depression (and their family of carer, if agreed 
with the person)?
22 (81.5) 5(18.5) 27
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Table 4
Frequency o f Clients and Carers Offered Written Information
Person-centred care
Yes
Frequency
(%)
No
Frequency
(%)
Total
Valid
Patient offered written information about:
Their illness or condition? 17(63) 10(37) 27
The treatment and care they should be 
offered?
22 (81.5) 5 (18.5) 27
Including being made aware of the 
‘Understanding NICE guidance’ booklet?
0 27(100) 27
The service providing their treatment and 
care?
Carer(s) offered written information 
about:
20 (74.1) 7 (25.9) 27
The patient’s illness or condition? 8 (29.6) 19 (70.4) 27
The treatment and care the patient should 
be offered?
9 (33.3) 18 (66.7) 27
Including being made aware of the 
‘Understanding NICE guidance’ booklet?
0 27 (100) 27
The service providing the patient’s 
treatment and care?
9 (33.3) 18 (66.7) 27
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Discussion
Summary of Findings
Advance decisions and statements.
The results indicated that the CMHT was meeting the requirements for asking 
clients about risk but this information was not regularly used to make an advance 
decision or statement, nor was a copy routinely given to clients or carers. 
Additionally, results suggested that more monitoring might be needed for at risk 
clients who were newly started on antidepressants.
Psychological interventions.
The CMHT offered individual CBT to 51.9% of clients. The results indicated 
that clients may not have received CBT sessions as frequently as recommended by 
the NICE (2009) guidelines for clients with depression, and they were seen for 
longer than recommended.
Similarly, clients receiving behavioural activation (11.1%) and couples therapy 
(7.4%) were receiving fewer sessions and were seen over a longer period of time 
than recommended. From the sample, 22.2% of clients were referred for 
psychotherapy. Clients receiving short-term psychodynamic psychotherapy (11.1%) 
were seen for more sessions than recommended and for longer.
Delivering psychological interventions for relapse prevention.
Results showed that 11.1% of clients in the CMHT received or were receiving 
individual CBT for relapse prevention, the majority receiving fewer sessions than 
recommended and over more time. No clients in the CMHT were referred for 
Mindfulness-based CBT as part of relapse prevention.
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Complex and severe depression.
Concerning the management and treatment of clients with complex and severe 
depression, results revealed that client referrals and care plans included the 
recommended information between 77.8% and 96.3% of the time. Moreover, 
findings indicated that a consultant psychiatrist supervised clients with complex and 
severe medication starting on medication in 70.4% of cases.
Electroconvulsive therapy (ECT).
All clinical criteria recommended by NICE (2009) for ECT were met 100%.
Person-centred care.
Results showed that the CMHT shared written information with clients in 63% 
to 81.5% of cases. Written information was offered to carers in only 29.6% to 33.3% 
of cases. No clients or carers were given written information about the 
‘Understanding NICE guidance’ booklet (NICE, 2009). These findings signify that 
the team is not fully meeting the NICE standards for providing written information, 
particularly to carers.
Limitations
When drawing conclusions from the findings, the limitations of the audit first 
need to be considered. Firstly, as the questionnaires were completed by the CMHT, 
the socio-political context of this should be taken into account. Audits can sometimes 
be considered threatening to a service and this may introduce a response bias. 
Additionally, staff who already had a full workload may not have considered the 
audit to be a priority, which could have affected the quality of data they provided. To 
minimize these issues, the audit process was done in a transparent way and the team 
was clearly involved and informed about the purpose of the audit from the start. Even
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so, it could be that results do not capture the true standard of practice. Moreover 
although there was no missing data, information was sourced from pre-existing 
records and the accuracy of those was unknown.
Furthermore, the data collected was from one CMHT and so findings should 
not be generalised to represent all local services. In future studies, a larger sample 
size with data from other local CMHTs would be useful for identifying how well 
local practice is meeting the national standards. Another limitation of the study was 
that results do not indicate why standards were not met. For example, it is unclear 
how to interpret the result that the majority of carers were not offered written 
information. This could be interpreted to show that the standards were not being met 
but it could also be that no carers were identified or that clients did not want carers to 
be informed. It would therefore be helpful for future studies to also include 
qualitative information to help interpret the results. It is thus beyond the scope of the 
current study to make causal inferences and any interpretations offered remain 
speculative.
Another limitation was in relation to the criteria for psychological 
interventions. At times, clients may receive behavioural activation or relapse 
prevention as part of individual CBT rather than separately. Unless the team 
members completing the questionnaires were fully aware or informed of the content 
of the psychological work, the data may not accurately represent all psychological 
interventions received.
Implications and Recommendations
Regarding the original question, ‘How far does the CMHT meet the NICE 
clinical guideline (CG90) standards for the treatment and management of adults with
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depression’ the information obtained from the audit proposes particular areas where 
the CMHT met criteria for treating adults with depression, for example assessing 
risk, meeting standards for ECTs and developing multidisciplinary care plans. The 
audit also suggests areas that require improvement, such as having advance 
decisions, offering psychological interventions (particularly for relapse prevention) 
and sharing written information (particularly with carers). This information was fed 
back to the CMHT in a team meeting and findings were also disseminated in a NICE 
meeting in September 2011 (Appendix F).
These findings could be directly relevant for informing the delivery and 
development of services in the CMHT. Particularly the information could be used to 
redesign the service to target best practice recommendations. Where this leads to 
specific action plans, it is recommended for another audit to be conducted in the 
future to ensure that improvements are put into practice. This ongoing feedback 
process should be done systematically to monitor successful service change, barriers 
to change and to review practice standards.
One recommendation that could be included in the action plan is for clients and 
carers to be provided with more information regarding treatment options. This could 
be done by sending a service booklet with appointment letters, and where possible 
carers should be involved. Doing this would enable clients to make more informed 
decisions regarding their care, while also helping the team meet the guidelines. 
Moreover, given the limited resources and funding in the NHS, it is crucial that 
resources are used efficiently. Accordingly, it could be beneficial for clients to be 
seen more frequently but for less time and for the service to be clearer about the 
reasons why clients are referred for psychological interventions. As has been 
considered with the clinical psychologist in the CMHT, it is also recommended that a
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Mindfulness-based CBT group be started. Further recommendations can be 
developed with the involvement of the CMHT staff.
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Appendix A: Clinical Criteria for Depression
Advance decisions and statements
Criterion
1
.
For people with recurrent severe depression or depression with psychotic 
symptoms or have been treated under the Mental Health Act and who have developed 
advance decisions or statements:
• The advance decision or statement should be recorded.
• A copy should be included in the care plan in primary and 
secondary care.
• A copy should be given to the person
• A copy should be given to the family or carer, if the person agrees.
Exceptions A There is no family or carer involved/ Patient does not want their carer involved
Standard 100%
Definitions The guidance states advance decisions and advance statements
Criterion
2
People with depression should be asked about suicidal ideation and intent
....
Exceptions None
Standard 100%
Definitions None
Criterion
3
Patients started on antidepressants who are not considered to be at increased 
risk of suicide should normally be seen after 2 weeks. They should then be seen 
regularly.
Exceptions None
Standard 100%
Definitions Patients should be seen regularly, for example at intervals o f 2 to 4 weeks in the 
first 3 months, and then at longer intervals if  response is good.
Criterion
4
Patients with depression started on antidepressants who are considered to 
present an increased suicide risk or are younger than 30 years should normally be 
seen after 1 week and frequently thereafter as appropriate until the risk is no longer 
considered clinically important.
Exceptions None
Standard 100%
Definitions In people younger than 30 years there is a potential increased prevalence o f suicidal 
thoughts in the early stages of antidepressant treatment.
PORTFOLIO
106
Psychological interventions
Criterion
5
People with dépression having individual cognitive behavioural therapy (CBT) 
should typically have 16 to 20 sessions over 3 to 4 months.
Exceptions None
Standard 100%
Definitions
Also consider providing two sessions per week for the first 2 to 3 weeks of 
treatment for people with moderate or severe depression, and follow-up sessions typically 
consisting of three to four sessions over the following 3 to 6 months for all people with 
depression.
Criterion
6
People with depression having interpersonal therapy (IPT) should typically 
have 16 to 20 sessions over 3 to 4 months.
Exceptions None
Standard 100%
Definitions
For people with severe depression, consider providing two sessions per week for the 
first 2 to 3 weeks of treatment.
Criterion
7
People with depression having behavioural activation should typically have 16 
to 20 sessions over 3 to 4 months.
Exceptions None
Standard 100% l
Definitions
Also consider providing two sessions per week for the first 3 to 4 weeks of 
treatment for people with moderate or severe depression, and follow-up sessions typically 
consisting of three to four sessions over the following 3 to 6 months for all people with 
depression.
Criterion
8
People receiving couples therapy for depression should have 15 to 20 sessions 
over 5 to 6 months.
Exceptions None
Standard 100%
Definitions None
Criterion
9
People with persistent subthreshold depressive symptoms or mild to moderate 
depression having counselling should typically have six to ten sessions over 8 to 12 
weeks.
Exceptions None
Standard 100%
Definitions None
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Criterion
10
People with mild to moderate depression having short-term psychodynamic 
psychotherapy should typically have 16 to 20 sessions over 4 to 6 months.
Exceptions None
Standard 100%
Definitions None
Deli vc ring psychological interventions for relapse prevention
Criterion
11
People with depression having individual CBT for relapse prevention should 
typically have 16 to 20 sessions over 3 to 4 months.
Exceptions None
Standard 100%
Definitions
If the duration of treatment needs to be extended to achieve remission it should:
• consist o f two sessions per week for the first 2 to 3 weeks o f treatment
• include additional follow-up sessions, typically consisting o f four to six 
sessions over the following 6 months.
Criterion
12
People receiving mindfulness-based cognitive therapy for relapse prevention 
should normally be in groups of 8 to 15 participants and have weekly 2-hour 
meetings over 8 weeks. They should also have four follow-up sessions in the 
12 months after the end of treatment.
Exceptions None
Standard 100%
Definitions None
Complex and severe depression
Criterion
13
The assessment of a person with depression referred to specialist mental 
health services should include:
• their symptom profile, suicide risk and, where appropriate, previous 
treatment history
• associated psychosocial stressors, personality factors and significant 
relationship difficulties, particularly where the depression is chronic or recurrent
• associated comorbidities including alcohol and substance misuse, 
and personality disorders.
Exceptions None
Standard 100%
PORTFOLIO
108
Definitions Depression is described as ‘chronic’ if symptoms have been present more or less 
continuously for 2 years or more.
Criterion
14
Medication in secondary care mental health services should be started under 
the supervision of a consultant psychiatrist.
Exceptions None
Standard 100%
Definitions None
Criterion
15
Teams working with people with complex and severe depression should 
develop comprehensive multidisciplinary care plans in collaboration with the person 
with depression (and their family of carer, if agreed w ith the person), which should:
• clearly identify the roles and responsibilities of all health and social 
care professionals involved
• develop a crisis plan that identifies potential triggers that could lead 
to a crisis and strategies to manage such triggers
• be shared with the CP, the person with depression and other 
relevant people involved in the person’s care.
Exceptions None
Standard 100%
Definitions Other relevant people involved in the person’s care will need to be identified 
locally.
Electroconvulsive therapy (ECT)
Criterion
16
A decision to use ECT should be made jointly w ith the person.
Exceptions None
Standard 100%
Definitions ECT should be considered for acute treatment of severe depression that is life- 
threatening and when a rapid response is required or when other treatments have failed. It 
should not be used routinely for people with moderate depression but considered if  the 
depression has not responded to multiple drug treatments and psychological treatment. The 
decision to use ECT should take into account the requirements of the Mental Health Act 
2007.
Criterion
17
Valid informed consent should be obtained.
Exceptions None
Standard 100%
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Definitions Valid informed consent should be obtained (if the person has the capacity to grant 
or refuse consent) without the pressure or coercion that might occur as a result o f the 
circumstances and clinical setting.
Criterion
18
The person should be reminded of their right to withdraw consent at any time.
Exceptions None
Standard 100%
Definitions None
Criterion
19
Advocates or carers should be involved to facilitate informed discussions.
Exceptions A There is no family or carer involved/ Patient does not want their carer involved
Standard 100%
Definitions None
Criterion
20
If informed consent is not possible, ECT should only be given if it does not 
conflict with a valid advance decision and the person’s advocate or carer should be 
consulted.
Exceptions B The person is capable of giving informed consent
Standard 100%
Definitions None
Criterion
21
The person’s clinical status should be assessed after each ECT treatment using 
a formal valid outcome measure and treatment should be stopped when remission 
has been achieved, or sooner if side effects outw eigh the potential benefits.
Exceptions None
Standard 100%
Definitions None
Criterion
22
The person’s cognitive function should be assessed before the first ECT 
treatment and monitored at least every three to four treatments and at the end of a 
course of treatment.
Exceptions None
Standard 100%
Definitions Assessment of cognitive function should include:
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• orientation and time to reorientation after each treatment
• measures of new learning, retrograde amnesia and subjective memory 
impairment carried out at least 24 hours after a treatment.
Criterion
23
If the person’s depression has responded to a course of ECT, antidepressant 
medication should be started or continued to prevent relapse.
Exceptions None
Standard 100%
Definitions Lithium augmentation of antidepressants should be considered.
Person-centred care
Criterion
24
Patients should be offered written information about:
• their illness or condition
e the treatment and care they should be offered, including being made 
aware of the ‘Understanding NICE guidance’ booklet (www.nicc.org.uk/CG90)
• the service providing their treatment and care.
Exceptions None
Standard 100%
Definitions Patients should be offered written information to help them make informed 
decisions about their healthcare. This should cover the condition, treatments and the health 
service providing care. Information should be available in formats appropriate to the 
individual, taking into account language, age, and physical, sensory or learning disabilities.
Criterion
25
Carers should be offered written information about:
• the patient’s illness or condition
• the treatment and care the patient should be offered, including 
hoinp mmle aware of the ‘Understanding NICE guidance’ booklet 
(www.nice.org.uk/CC90)
• the service providing the patient’s treatment and care.
Exceptions A Where there is no carer involved/Patient does not want their carer 
involved
C Where sharing information may compromise the patient’s confidentiality or
wishes
Standard 100%
Definitions If the patient agrees, families and carers should have the opportunity to be involved 
in decisions about treatment and care.
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Appendix B: Information and Instruction Sheet
Audit: Implementing Nice Guideline 90 
Patient data collection tool for ‘Depression’
Project Title
A CMHT service audit of adherence to NICE guidelines for depression.
Background and Rationale 
The National Institute for Health and Clinical Excellence (NICE) has published a set of 
clinical guidelines on best practice that are recommended for all mental health clinicians. As 
part of the implementation process, NHS services are encouraged to carry out audits of how 
well they are meeting the NICE guidelines. The rationale for doing this service-related 
research is to do an audit locally and to implement changes for improvement where there are 
any gaps. Audit reports are additionally requested by the local Healthcare Commissioners as 
evidence of service quality and compliance. Since the CMHT has never undertaken an audit 
in relation to the NICE guidelines for depression, this audit was considered essential for best 
practice.
Objectives
The objective is to find out how far the CMHT was meeting the NICE clinical guideline 
(CG90) for the treatment and management of adults with depression.
Setting 
The xxx CMHT service.
Instructions
COMPLETE ONE FORM FOR EACH CLIENT YOU HAVE IDENTIFIED ON YOUR 
CURRENT CASELOAD WITH A PRIMARY DIAGNOSIS OF DEPRESSION. Please 
complete each questionnaire in one go.
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Appendix C: Audit Questionnaire (adapted)
Audit: Implementing Nice Guideline 90 
Patient data collection tool for ‘Depression’
Care Coordinator identifier: Sex: Age: Ethnicity:
(categories)
No. Dataitem Criteria
Yes No Exceptions
NICE
guideline ref.
Advanee decisions and statements
1 1.1
1.2
1.3
Does the person have an advance 
decision or statement?
Has a copy been given to the person with 
depression?
Has a copy been given to the family or 
carer?
(Data source: patient record)
U
0
□
U
□
□
If no, jump to 
No. 2
Y/N
A
Y/N
1.1.2.1
2 2.1
Was the person asked about suicidal 
ideation and intent? □ □ Y/N 1.1.4.6
3 3.1
3.2
3.3
3.4
3.5
Was the patient considered to be at 
increased risk of suicide?
If no, were they seen 2 weeks after they 
were started on antidepressants?
Were they seen regularly thereafter 
(every 2 to 4 weeks for the first 
3 months)?
If the response was good, were they then 
seen at longer intervals?
U
0
□
□
U
0
□
□
Y/N
Y/N
Y/N
Y/N
Text Box
1.5.2.6
If not, why not?
(Data source: patient record/prescriber)
4 4.1
4.2
4.3
Was the patient considered to present an 
increased suicide risk?
Was the patient younger than 30 years?
If yes to either, were they seen 1 week 
after being started on antidepressants? 
(Data source: patient record)
U
0
0
U
□
□
Y/N
Y/N
Y/N
1.5.2.7
No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
Psvc lological interventions (page 2)
5 5.1
Has the person received Step 2/ Step 3 
Psychological Interventions in Primary Care 
(Right Steps)?
If yes, what interventions?
U U Y/N
If no, go to 
5
Text Box
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No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
6 5.1
Have they been offered CBT in the CMHT? 
How many sessions of individual CBT has 
the person had?
Y /N If no, go to 
6
Categories
1.5.3.2
5.2
Over what time period?
(Data source: patient record/psychology 
notes)
Categories
7 7.1
How many behavioural activation sessions 
has the person had?
1.5.3.4
7.2
Over what time period?
(Data source: patient record/psychology 
notes)
8 8.1
How many couples therapy sessions has the 
person had?
1.5.3.5
8.2
Over what time period?
(Data source: patient record/psychology 
notes)
10 10.1
Has the person been referred for 
psychotherapy?
If the person has mild to moderate 
depression, how many psychodynamic 
psychotherapy sessions have they had?
Y/N If no, go to 
11
1.5.3.7
10.2
Over what time period?
(Data source: patient record/psychology 
notes)
Delr/ering psychological interventions for relapse prevention
11 11.1
Is the person having individual CBT for 
relapse prevention?
How many sessions have they had?
Y/N If no, go to 
12
Textbox
1.9.1.9
11.2
Over what time period?
(Data source: patient record/psychology 
notes)
Textbox
12 12.1
If the person is in remission but had 3 
previous episodes, have they been referred 
to Mindfulness based CBT?
Y/N
1.9.1.10
No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
Comnlex and severe depression (page 3)
13
13.1
When the person was referred, did their 
assessment include:
Their symptom profile, suicide risk and, 
where appropriate, previous treatment 
history?
□ □ Y/N
1.10.1.1
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No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
13.2
13.3
Associated psychosocial stressors, personality 
factors and significant relationship 
difficulties, particularly where the depression 
is chronic or recurrent?
Associated comorbidities, including alcohol 
and substance misuse, and personality 
disorders?
(Data source: patient record)
U
□
u
□
Y/N
Y/N
14 14.1
If the person with depression was started on 
medication in secondary care mental health 
services, was it started under the supervision 
of a consultant psychiatrist?
(Data source: patient record)
U u Y/N
1.10.1.4
15 Does the person’s multidisciplinary care plan: 1.10.1.5
15.1
15.2
15.3
15.4
Clearly identify the roles and responsibilities 
of all health and social care professionals 
involved?
Develop a crisis plan that identifies potential 
triggers that could lead to a crisis and 
strategies to manage such triggers?
Get shared with the GP, the person with 
depression and other relevant people involved 
in the person’s care?
Was it developed with the person with 
depression (and their family of carer, if agreed 
with the person)?
(Data source: patient record/CPA)
u
□
□
□
u
□
□
□
Y/N
Y/N
Y/N
Y/N
No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
Elecl roconvul sive therapy (ECT) (page 4)
16 16.116.2
Has the person received/ is receiving ECT?
If yes, was the decision made jointly with 
them?
(Data source: patient record/clinician)
U u Y/N
If no, go to 
24
Y/N
1.10.4.5
17 17.1
Was valid informed consent obtained? 
(Data source: patient record)
u u Y/N 1.10.4.5
18 18.1
Was the person with depression reminded of 
their right to withdraw consent at any time? 
(Data source: patient record)
u u Y/N
1.10.4.5
19 19.1
Were the person’s advocates or carers 
involved to facilitate informed discussions? 
(Data source: patient record)
u u Y/N
A 1.10.4.5
20
20.1
20.2
If informed consent was not possible:
Did the decision to give ECT conflict with a 
valid advance decision?
Was the person’s advocate or carer consulted? 
(Data source: patient record)
□
□
□
□
B
Y/N
Y/N
1.10.4.5
21 21.1
21.2
21.3
Was the person’s clinical status assessed after 
each ECT treatment?
Was a formal valid outcome measure used?
If remission was achieved, was treatment 
stopped?
u
□□
u
□□
Y/N
Y/N
Y/N
1.10.4.7
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No.
Data
item
no.
Criteria Yes No
NA/
Exceptions
NICE
guideline
ref.
21.4
If side effects outweighed the potential 
benefits, was treatment stopped?
(Data source: patient record)
U U Y/N
22 22.1
22.2
Was the person’s cognitive function assessed 
before the first ECT treatment?
Was the person’s cognitive function 
monitored at least every three to four
U
□
u
□
Y/N
Y/N
1.10.4.8
22.3
treatments?
Was the person’s cognitive function 
monitored at the end of a course of treatment? 
(Data source: patient record)
□ □ Y/N
23 23.1
23.2
Did the person’s depression respond to a 
course of ECT?
If yes, was antidepressant medication started 
or continued to prevent relapse?
(Data source: patient record)
u
□
u
□
Y/N
Y/N
1.10.4.10
No. Data item no. Criteria
Yes No NA/Exceptions
NICE
guideline ref.
Person-centred care (page 5)
24
Patient offered written information about:
Person- 
centred care
24.1 Their illness or condition? □ □ Y/N
24.2
24.3
The treatment and care they should be 
offered?
Including being made aware of the 
‘Understanding NICE guidance’ booklet?
□
□
□
□
Y/N
Y/N
24.4 The service providing their treatment and 
care?
(Data source: patient records)
U U Y/N
25 Carer(s) offered written information 
about:
A / C Person- 
centred care
25.1 The patient’s illness or condition? □ □ Y/N
25.2
25.3
The treatment and care the patient should 
be offered?
Including being made aware of the 
‘Understanding NICE guidance’ booklet?
□
□
□
□
Y/N
Y/N
25.4 The service providing the patient’s 
treatment and care?
(Data source: patient records)
□ □ Y/N
Note. Exception codes
A -  There is no family or carer involved/ Patient does not want their carer involved 
B - Person is capable of giving informed consent
C -  Sharing information may compromise the patient’s confidentiality or wishes
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Appendix D: Electroconvulsive Therapy Results
Table D1
Frequency o f Clients given ECT and Frequency o f  Meeting Relevant Criteria
Electroconvulsive therapy (ECT)
Yes
Frequency
(%)
No
Frequency
(%)
Total
Valid
Has the person received/is receiving ECT? 1 (3.7) 26 (96.3) 27
If yes, was the decision made jointly with 
them?
1 (100) 0 1
Was valid informed consent obtained? 1 (100) 0 1
Was the person with depression reminded 
of their right to withdraw consent at any 
time?
1 (100) 0 1
Were the person’s advocates or carers 
involved to facilitate informed discussions?
If informed consent was not possible:
1 (100) 0 1
Did the decision to give ECT conflict with 
a valid advance decision?
0 1 (100) 1
Was the person’s advocate or carer 
consulted?
1 (100) 0 1
Was the person’s clinical status assessed 
after each ECT treatment?
1 (100) 0 1
Was a formal valid outcome measure used? 1 (100) 0 1
If remission was achieved, was treatment 
stopped?
1 (100) 0 1
If side effects outweighed the potential 
benefits, was treatment stopped?
1 (100) 0 1
Was the person’s cognitive function 
assessed before the first ECT treatment?
1 (100) 0 1
Was the person’s cognitive function 
monitored at least every three to four 
treatments?
1 (100) 0 1
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Was the person’s cognitive function 
monitored at the end of a course of 
treatment?
1 (100) 0 1
Did the person’s depression respond to a 
course of ECT?
1 (100) 0 1
If yes, was antidepressant medication 
started or continued to prevent relapse?
1 (100) 0 1
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Appendix E: Psychological Interventions Results
Table El
Frequency o f Cases Meeting Criteria for Psychological Interventions and Relapse 
Prevention
Psychological Interventions
Yes
Frequency
(%)
No
Frequency
(%)
Total
Valid
Has the person received Step 2/Step 3 
Psychological Interventions in Primary Care 
(Right Steps)?
3(11.1) 24 (88.9) 27
Have they been offered CBT in the CMHT? 14(51.9) 13 (48.1) 27
Has the person been referred for 
psychotherapy?
6 (22.2) 21 (77.8) 27
Delivering Psychological interventions for  
relapse prevention:
Is the person having individual CBT for 
relapse prevention?
3(11.1) 24 (88.9) 27
If the person is in remission but had 3 
previous episodes, have they been referred 
to Mindfulness based CBT?
0 27 (100) 27
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Appendix F: Evidence of feedback to service
From:
Sent: 16 September 201110:02 
To: Trigeorgis, Christina 
Subject: Presentation
Christina
Thank you for the presentation of your audit for meeting the NICE guide lines for depression  
you did yesterday, I have had som e positive feed back from team members on how helpful it 
was.
Many thanks
Team Manager
CMHT
Hospital
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The Public Perception of Clinical Psychologists: 
An Interpretative Phenomenological Analysis study
Qualitative Research Methods Group Report (Abstract)
June 2011 
Year 1
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Abstract 
Objectives
This study aims to gain a better understanding of the public perception of 
clinical psychologists in the UK, with the research question “What is the 
public perception of clinical psychologists?” Given the relatively limited 
research in this area, a qualitative approach was thought to be most 
suitable; this allows for open-ended questioning and a non-directive 
approach from the researchers.
Method
A semi-structured interview schedule was designed to elicit different 
aspects of the participants’ understanding of the role of a clinical 
psychologist. The main question was open ended to encourage the 
participants to share their own opinion and prompts were used. Three male 
participants were interviewed individually. The interview transcripts were 
analysed using Interpretative Phenomenological Analysis (IPA) (Smith, 
Flowers & Larkin, 2009) as it has a strong epistemological basis and places 
emphasis on the understanding the participant’s experience.
Results
Four super-ordinate themes were revealed from the data analysis that 
captured participants’ limited but largely positive perceptions of clinical 
psychologists. These themes were labeled as (a) ‘Specialist role’ (b) 
‘Uncertainty’ (c) ‘Focus on mental illness’ and (d) ‘Positive personality 
attributes’.
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Conclusions
Using IP A, the current study uncovered new and rich understandings of 
how clinical psychologists are perceived by the public. In particular, it was 
conceptualised that clinical psychologists fulfill a ‘specialist or expert role’, 
but there was ‘uncertainty’ about what exactly this role entails, that there is 
a ‘focus on severe mental illness’ in the profession and that clinical 
psychologists themselves generally have or should have ‘positive 
personality attributes’. The findings highlight the need for clinical 
psychologists to educate the general public about the profession and make 
information more accessible. Efforts also need to be made by professionals 
to increase awareness about mental health difficulties and for help seeking 
to be normalised. Limitations of the study and directions for future research 
are discussed.
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An investigation of the relationship between shame and substance 
use: Aggression, disclosure and self-related constructs in clients with
drug dependence
by
Christina Ariana Trigeorgis
Submitted for the degree of Doctor of Psychology 
(Clinical Psychology)
School of Psychology 
Faculty of Arts and Human Sciences 
University of Surrey
July 2013
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Abstract 
Objectives
The central objective of this study was to investigate the relationship between shame 
and substance use. The Experiences of Shame Scale (ESS) was used to differentiate 
between different sources of shame, namely character, behaviour and body shame. 
Drug-related shame was examined as a possible additional source of shame. The 
study also aimed to investigate potential constructs underlying the association 
between shame and substance use. Aggression was considered alongside the self­
related concepts of self-ambivalence and self-esteem as potential mediators. Finally, 
the relationship between shame and distress disclosure was examined.
Method
100 participants were recruited for the study; 50 poly-drug users were recruited from 
drug and alcohol services for the substance use (SU) group and 50 non-substance 
using participants were recruited online via mental health charities for the 
comparison group. The study used a cross-sectional design to investigate differences 
between the groups. Standardised self-report questionnaire measures were used. 
Results
Findings indicate that the SU group participants scored higher on all ESS subscales. 
After adjusting for demographic differences between the groups, only differences on 
Character shame remained significant. Aggression was found to be a significant 
mediator of the relationship between Character shame and substance use. Findings 
also suggest that the highest level of shame experienced by SU participants is related 
to substance use. Moreover, self-ambivalence, self-esteem and willingness to 
disclose distress were associated with shame, regardless of substance use.
PORTFOLIO
125
Conclusions
The findings of this study support the association between shame about one’s 
character and substance use, with aggression identified as an important factor in this 
relationship. The current study further contributes to the wider shame literature, 
suggesting self-related constructs to be useful in understanding experiences of 
shame. Implications for clinical practice are discussed. Directions for future research 
are considered in light of this study’s limitations.
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Introduction
“I f  you put shame in a Petri dish, it needs three things to grow exponentially: 
secrecy, silence and judgment” (Brown, 2012).
In recent years there has been an influx of studies looking at the role of shame 
on the onset, maintenance and progression of various psychopathologies (Tangney & 
Bearing, 2002). These include depression (Andrews, Qian & Valentine, 2002;
Matos, Pinto-Gouveia & Costa, 2013), generalised and social anxiety (Fergus, 
Valentiner, McGrath & Jencius, 2010; Gilbert, 2000; Hedman, Strôm, Stimkel & 
Mortberg, 2013), post-traumatic stress disorder (Andrews, Brewin, Rose & Kirk, 
2000; Harman & Lee, 2010; Lee, Scragg & Turner, 2001; Leskela, Dieperink & 
Thuras, 2002), obsessive-compulsive disorder (Valentiner & Smith, 2008), eating 
disorders (Goss & Allan, 2009; Kelly & Carter, 2013; Swan & Andrews, 2003; 
Troop & Redshaw, 2012), borderline personality disorders (Rusch et al., 2007) and 
psychosis (Birchwood et al., 2007). Past research has highlighted the clinical 
implications of shame in relation to its impact on psychological adjustment, help 
seeking, disclosure, treatment outcomes and the therapeutic relationship (Black, 
Curran & Dyer, 2013; MacDonald & Morley, 2001; Pal, Yadav, Joy, Mehta & Ray, 
2003).
This study aims to examine the relationship between shame and substance 
misuse. Before examining what is known about this relationship, a working 
definition and understanding of shame is needed.
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What is Shame?
Shame, along with emotions such as guilt, pride, envy and embarrassment, are 
self-conscious emotions (Tangney & Tracy, 2012). These emotions are related to our 
sense of self, but also to our consciousness and awareness of others’ reactions to us.
A distinction has been made between internal shame, which involves negative 
evaluations of the self, and external shame, which involves fears of being negatively 
evaluated by others (Gilbert, 1998; Lewis, 2000). Higgins’s self-discrepancy theory
(1987) has further conceptualised shame as a perceived discrepancy between the 
actual self (from one’s own perspective) and the ideal self (from the other’s 
perspective). This also relates to Gilbert’s (1997) social rank theory of shame, which 
proposes that emotions are influenced by one’s perceived social standing. According 
to Gilbert (2000), shame can result from feelings of comparative inferiority, 
subordination, powerlessness and concern over others’ perceptions of one’s self. 
Shame thus relates to a perceived failure in meeting others’ expectations, social and 
moral standards.
Self-conscious emotions are also higher-order emotions, as they require the 
cognitive capacities of self-reflection and self-evaluation (Tangney & Tracy, 2012). 
Cognitive attribution theories propose that shame-related negative self-attributions 
are internal (versus external), global (versus specific) and result in defensive and 
submissive behaviours. For example, interpersonal failure may be attributed to one’s 
perceived lack of ability, competence, self-control, negative personal attributes and 
aesthetic standards (Orth, Berking & Burkhardt, 2006; Weiner, 1985). As a result, 
individuals experiencing shame may use avoidance, blaming or hiding to protect 
aspects of the failed self and prevent rejection (Lewis, 1992).
From an evolutionary perspective, self-conscious emotions, particularly shame
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and guilt, are considered ‘social’ and ‘moral’ emotions that regulate antisocial 
behaviour (Tangney & Tracy, 2012). Barrett’s (1995) Functionalist model of shame 
suggests that shame serves the adaptive function of maintaining social standards, 
rules and goals (learned through socialisation) by preserving others’ acceptance and 
one’s self-esteem.
These understandings of shame are important in highlighting the influence of 
significant others and sociocultural standards on individuals’ experiences of shame. 
Moreover, that shame might develop from more basic emotions, such as frustration 
or disappointment in childhood (Lewis, 1992; Campos, Thein & Owen, 2004). 
Shame can become internalised as part of a one’s sense of self, suggesting that early 
attachment relationships and family environments may contribute to shame 
proneness (Bennett, Sullivan & Lewis, 2010; Pulakos, 1996; Schafer, 2011). This 
developmental view of shame is explored further in later sections.
Shame versus guilt.
In the past, shame and guilt have been used interchangeably. Much has been 
written, however, about the distinction between these two self-conscious emotions. 
Two main differences relate to the focus and meaning of these emotions (i.e. self 
versus behaviour) and their associated consequences (i.e. hiding versus making 
amends).
The first important difference between shame and guilt was highlighted by the 
psychoanalyst H.B Lewis (1971). Lewis conceptualised shame as an interpersonal 
emotion whereby rejection by significant others is understood as a rejection of the 
self. Shame involves a meaning about one’s sense of self as inferior, faulty or 
worthless, while believing that others’ view you in the same light. For people
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experiencing shame, the self becomes both the agent and the object of negative self- 
evaluations (Tangney & Tracy, 2012). This can be experienced as particularly 
intense and painful (Tangney & Tracy, 2012). Guilt, on the other hand, involves the 
rejection of one’s behaviour. Potter-Efron (1987) summarised this distinction by 
describing shame as a failure of “being” and guilt as a failure of “doing”.
The second important difference between shame and guilt relates to the actions 
they motivate. Individuals feeling guilt are likely to experience regret and remorse as 
a result of their ‘bad’ behaviour (Tangney & Tracy, 2012). Guilt can motivate people 
to make amends, confess to or resolve a situation. Guilt is therefore a more adaptive, 
constructive and proactive emotion. Research indicates that guilt proneness is 
negatively associated to psychopathology and criminal offending (Stuewig & 
McCloskey, 2005; Tangney & Dearing, 2002; Tibetts, 2003). Shame, on the other 
hand, relates to a more vulnerable self-image and is associated with defending or 
distancing the self with the aim of reducing exposure to negative evaluation. Shame 
is likely to motivate actions of hiding, escapism, secrecy, denial and separation 
(Tangney & Tracy, 2012). Shame proneness has accordingly been positively linked 
to secondary psychopathy, aggression and antisocial personality characteristics 
(Morrison & Gilbert, 2001), as well as to psychological distress and alcohol and drug 
related problems (Tangney, Stuewig, Mashek & Hastings, 2011).
Shame and Substance Misuse 
Conceptual links.
In the UK it is estimated that one in three adults have taken an illicit drug 
during their lifetime (Home Office, 2012). It is also estimated that 3.3% of adults are 
frequent drug users (on average taking an illicit drug more than once a month over
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the past year). Illicit drug use is as high as 7% in people aged 16 to 59 years old. 
Additionally, drug related crimes cost 13.3 billion pounds a year in the UK 
(Department of Health, 2013). Substance misuse is a complex field with the 
widespread effects of illicit drug use affecting individuals, families, the community 
and public health. In terms of problematic drug use, the International Classification 
of Diseases-10 has described the Dependence syndrome as a cluster of three altered 
states: physiological/ biological, behavioural and cognitive (World Health 
Organization, 2013).
Theoretical links have been made between substance use and feelings of 
shame. The self-medication hypothesis of drug use states that drugs are used to 
compensate for ego dysfunction by cutting-off or defending against painful 
unconscious emotions (such as shame) and parts of the self (Khantzian, 1985; 1997). 
The self-medication hypothesis is supported by the high rates of co-morbid mental 
health difficulties in people with substance use disorders (Conway, Compton,
Stinson & Grant, 2006; Crum et al., 2013; Swendsen et al., 2010). Drug use can also 
disrupt self-reflection and cognitive capacities needed to experience higher-order 
emotions, thus serving to protect the self from processing feelings such as shame 
(Hull, Young & Jouriles, 1986). Baker, Piper, McCarthy, Majeskie and Fiore (2004) 
offered a reformulation of the negative reinforcement model of drug addiction, 
suggesting that escaping negative affect is the motivational core for continuing drug 
use. Shame may thus be both a predisposing and maintenance factor in relation to 
substance use.
In addition, shame could also be a consequence of substance misuse given that 
it can emerge from a failure to maintain social standards. It is possible that
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substance use, may be vulnerable to experiencing high levels of shame. This may 
particularly be the case for individuals who already have a vulnerable self-image and 
are additionally exposed to social stigma, rejection and exclusion due to their illicit 
substance use. Substance users may also feel shame in relation to their perceived lack 
of self-control, as motivation and medical models predominantly place the burden of 
addiction on the individual. Consequently, it might be that shame is involved in a 
vicious bi-directional maintenance cycle of drug use, whereby drugs are taken to 
self-medicate from negative emotions such as shame, but in the long-run drug use 
negatively reinforces and perpetuates chronic shame (Treeby & Bruno, 2012).
Empirical studies.
Empirical links between shame and substance use were documented as early as 
the 1980s. In one of the first studies, Blatt and colleagues (1984) found that opiate 
users were significantly more depressed than psychiatric patients, and that this 
depression was primarily focused around difficulties with self-criticism, guilt and 
shame. In 1987, Cook developed the Internalised Shame Scale (ISS) and showed that 
alcohol abuse was related to higher levels of shame in a student population. Brown 
(1991) hypothesised about the clinical implications of shame, presenting a case study 
to illustrate shame as a relapse factor for a chemically dependent client. Gomberg
(1988) further found that issues of shame were particularly important for women 
recovering from alcohol dependence and that shame posed a barrier to treatment. 
This was supported by Ehrmin (2001) who found shame to be a barrier to treatment 
for substance dependent African American women. Similarly, Wiechelt and Sales 
(2001) used the ISS and found that shame impacted on the recovery of women
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members of Alcoholics Anonymous by negatively affecting relapse rates, and social 
and interpersonal adjustment.
One of the first studies to use a standardised measure of shame with a 
substance using population was conducted by O’Connor, Berry, Inaba, Weiss and 
Morrison (1994). Their study used the Test of Self-Conscious Affect (TOSCA: 
Tangney, Wagner & Gramzow, 1989) and found that proneness to shame and 
depression was higher in recovering substance users compared to available TOSCA 
norms. Meehan, O'Connor and colleagues (1996) found similar results. In line with 
these earlier findings, Dearing, Stuewig and Tangney (2005) used the TOSCA and 
found that shame-proneness correlated with substance use, while guilt-proneness did 
not, in a sample of undergraduate students and jail inmates.
Two more recent studies used the TOSCA to assess the relationship between 
shame proneness and alcohol use. Treeby and Bruno (2012) found that in a non- 
clinical undergraduate student sample, shame proneness is positively related to 
problematic alcohol use, while guilt proneness is again negatively related, and that 
drinking is used as a means of coping with negative affect. Hequembourg and 
Dearing (2013) also found that shame proneness is positively related, and guilt- 
proneness negatively related, to substance use in a sample of sexual minority men 
and women. In another recent study, Randles and Tracy (2013) used alternative 
measures of shame (self report and non-verbal behavioural measures) to assess levels 
of shame in recovering members of Alcoholics Anonymous. They found that the 
non-verbal behavioural displays of shame predicted the tendency and severity of 
relapse, as well as declines in health, in alcohol users. The authors reported that 
shame about past behaviours could increase the likelihood of future problematic 
behaviours.
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Recent research has also put particular emphasis on the stigma experienced by 
people in recovery from substance use. Corrigan, Watson and Miller (2006) found 
that stigma experienced by families in relation to substance dependence is worse than 
with other mental health conditions and that families are likely to be shunned by the 
general public. Luoma and colleagues (2007) also found that substance use patients 
report high levels of self-stigma. They further found that people with more treatment 
episodes report greater stigma-related rejection, suggesting that current treatment 
services may contribute to this stigma. In related research, findings show that self­
stigma can affect treatment engagement, outcome, client empowerment and 
professional empathy (Boekel et al., 2013; Cellucci, Krogh & Vik, 2006; Luoma,
2011). In a qualitative study, Gray (2009) described that high shame and stigma 
experienced by those in treatment for substance use related to one’s identity as “the 
addict”. Staff actions, the treatment model and coercive treatment settings that focus 
on diagnosing, blaming and labeling were also found to contribute to shame. Gray 
(2009) also reported that staff identified shame as a vulnerability and trigger for 
substance use and as a barrier to treatment and recovery. Similarly, it was found that 
stigmatising identities of substance users as immoral, unreliable, violent and lacking 
motivation are held by substance users, professionals and social systems at large 
(Luoma, 2011; van Boekel, Brouwers, van Weeghel & Garretsen, 2013). In another 
qualitative study, Norris (2011) found that shame negatively affects the relationship 
between mothers with substance user problems and child social workers, with 
professionals playing an important role in easing or contributing to feelings of shame 
and stigma.
Empirical studies linking shame and addictive behaviours have recently begun 
to investigate treatment interventions that focus on shame. Phillip, Hart, Hibbard and
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Carroll (2010), using an undergraduate student sample, found that shame moderates 
the relationship between alcohol use and self-forgiveness in that high self- 
forgiveness was related to low alcohol misuse but only in the high-shame group. This 
suggests that enhancing levels of self-forgiveness in people who experience intense 
shame could help reduce alcohol misuse. McGaffin, Lyons and Deane (2013) 
additionally found that shame is negatively associated with self-forgiveness and that 
acceptance had an indirect effect on this relationship. Furthermore, Luoma, 
Kohlenberg, Hayes, and Fletcher (2012) examined a group-based intervention in a 
substance use treatment facility. They offered three, two-hour group sessions of 
Acceptance and Commitment Therapy (ACT) that specifically targeted shame, and 
compared this to treatment as usual (TAU). They found that the ACT group 
focusing on shame, using mindfulness and acceptance techniques, had better 
treatment attendance and reduced substance use at follow-up compared to the TAU 
group. In another study, Witkiewitz, Bowen, Douglas and Hsu (2013) found that 
acceptance and non-judgmental attitudes mediated the relationship between 
Mindfulness-based Relapse Prevention (MBRP) and self-reported levels of substance 
craving.
Overall, the above empirical literature supports the potential link between 
shame and substance use. These findings suggest that understanding the relationship 
between shame and substance use could contribute to our understanding of how 
psychological factors and emotions, such as shame, affect help-seeking, engagement 
with treatment services, relapse rates and recovery. Moreover, they indicate that 
social and institutional stigma may be contributing to the feelings of shame 
experienced by substance users. As a result, empirical work has recently begun to 
investigate shame-based treatment programs to address these issues. The shame-
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substance use link is of particular clinical significance because, contrary to static 
factors such as biological or genetic vulnerabilities underlying mainstream medical 
models of addiction, dynamic psychological variables and emotions relating to 
substance misuse are likely to be more effective targets of treatment programs 
(Tangney & Tracy, 2012).
Limitations of past studies
Despite the valuable findings of empirical research thus far, previous studies 
on shame have several limitations. First, some of the earlier studies used indirect or 
non-standardised measures of shame (e.g. Blatt et al., 1984; Brown, 1991). In their 
recent study, Randles and Tracy (2013) used non-standardised indirect behavioural 
measures (i.e. chest narrowing and shoulder slumping) to infer shame. The use of 
such non-standardised measures might compromise the reliability and validity of 
these interesting findings. Importantly, it also makes it difficult to assess the severity 
of shame and to distinguish between shame and other similar but distinct constructs, 
such as guilt, embarrassment or fear that have potentially differing consequences.
A further limitation of some past studies involves the use of non-clinical 
samples, such as undergraduate students, which limits the extent to which findings 
are generalisable to problematic substance users (e.g. Cook, 1987; Dearing et al., 
2005; Phillip et al., 2010; Treeby & Bruno, 2012). Similarly, O’Connor and 
colleagues (1994) and Meehan and colleagues (1996) used the available TOSCA 
norms as a comparison group, but it is unclear what the characteristics of that group 
were and how robust the comparison was. Other studies investigated the link 
between shame and substance use in specific populations, such as women, offending 
populations, African Americans or sexual minorities, and again the generalisability
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of these specific findings may be limited (Dearing et ah, 2005; Ehrmin, 2001; 
Hequembourg & Dearing, 2013; Wiechelt & Sales, 2001).
Additionally, many of the previous studies investigated shame in populations 
who had a primary alcohol misuse problem (e.g. Cook, 1987; Gomberg, 1988; 
Randles & Tracy, 2013; Treeby & Bruno, 2012; Wiechelt & Sales, 2001). It is 
unclear whether levels, mechanisms and sources of shame vary between alcohol and 
illicit drug use, or between different types of illicit drugs. Due to the more severe 
public stigma attached to illicit behaviours, it may be that using illegal substances 
elicits greater shame and barriers to treatment than does alcohol use.
A further limitation is that most studies used a correlational design, making it 
difficult to determine causality. For instance it is still unclear whether shame is an 
antecedent and/or a consequence of substance misuse, or whether both shame and 
substance misuse are related to other underlying variables. Furthermore, although 
studies have demonstrated a clear link between generalised shame and substance use, 
there has been less emphasis on understanding the different components of shame or 
indeed the risk factors that may underlie or mediate the shame-substanee use 
relationship. Moreover, previous studies have only inferred that shame in substance 
users is related to their drug use. A measure of shame directly assessing àmg-related 
shame has not yet been used except by Andersen (2002).
Finally, past findings are constrained by the limitations of the standardised 
measures of shame used in previous studies. The most common measures used in the 
studies reviewed were the Test of Self-Conscious Affect (TOSCA: Tangney et ah, 
1989) and the Internalised Shame Scale (ISS: Cook, 1987). The TOSCA is a 
scenario-based indirect measure of proneness to self-conscious emotions, such as 
shame, guilt and embarrassment. The TOSCA-Shame subscale measures global
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shame and negative self-evaluations. Although the TOSCA has been found to have 
good validity and reliability psychometric scores (Tangney et ah, 2000), it has 
several limitations. For instance, a high correlation between the TOSCA-Shame and 
TOSCA-Guilt subscales has been reported, suggesting that the TOSCA may not be 
adequately distinguishing between the two constructs (Chester, 2010). Furthermore, 
the TOSCA measure is based on hypothetical scenarios that indirectly measure 
shame. This may restrict participants to only consider experiences of shame pre­
defined by the measure (Brewin & Andrews, 1992). Situation-specific measures are 
also culturally bound and thus limit the generalisability of findings (Leeming & 
Boyle, 2004). It has also been argued that situational measures cannot adequately 
evaluate trait aspects of shame because they capture only situation-specific 
behavioural responses rather than general, enduring feelings (Cook, 1996; Giner- 
Sorolla, Piazza & Espinosa, 2011). A further criticism of the TOSCA is that the scale 
focuses exclusively on behavioural aspects of shame and does not take into account 
other sources, such as personal characteristics or internal events (Andrews, 1998). 
Additionally, the TOSCA may lack ecological validity in that the responses selected 
may not reflect how respondents would actually feel or respond in those situations
(Brewin & Andrews, 1992).
The second widely used measure is the Internalised Shame Scale (ISS: Cook, 
1987). This is a 30-item self-report personal attributes measure of shame. The ISS 
asks participants to rate how they feel in response to a series of statements indirectly 
assessing shame. The ISS has been criticised for measuring a construction of shame, 
internalised shame, which is too similar to other constructs (Andrews et al., 2002; 
Tangney, 1996). For example, shame on the ISS has been found to correlate highly 
with low self-esteem (Cook, 1989 as cited in Rybak & Brown, 1996; Tangney, 1996)
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and depression (Allan, Gilbert & Goss, 1994). This suggests that the ISS may be 
mood-dependent and measuring a global negative affect rather than shame proneness 
in particular.
An Alternative Measure of Shame 
Experiences of Shame Scale.
The Experiences of Shame Scale (ESS: Andrews, Qian & Valentine, 2002) was 
developed based on the interview method used previously by the authors to predict 
depression and post-traumatic stress symptoms (Andrews, 1995; Andrews et al., 
2000). The ESS does not only assess generalised shame, rather it conceptualises 
shame as multi-factorial consisting of bodily, behavioural and character components 
(Andrews et al., 2002). Rousseau (2005) compared the three shame measures, ESS, 
ISS and TOSCA. Her factor analyses revealed that the three-factor ESS model 
provided the best fit of the data, compared to the two-factor ISS model (of shame and 
self-esteem) and the one-factor global shame model of TOSCA. Rousseau (2005) 
concluded that it would be useful to use the subscale divisions of the ESS to further 
understand shame as a construct. Furthermore, Andrew and colleagues (2002) found 
that the ESS, the TOSCA Shame and TOSCA Guilt subscale were all significantly 
related to depression at Time One, but that only the ESS predicted additional 
variance of depressive symptoms at Time Two (re-tested after 11 weeks) when Time 
One was controlled for. This led them to argue that the ESS is less mood-dependent 
and measures a specific proneness to shame rather than a non-specific state of 
negative affect. Given that the ESS is a measure of proneness to shame with a 
relatively low sensitivity to general negative affect, it could be considered a more 
appropriate measure to use when assessing shame in a substance misuse population.
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Another feature of the ESS that distinguishes it from other measures is that it 
does not use hypothetical scenarios or indirect questions about shame. The ESS 
items ask respondents directly about whether they feel shame. The ESS includes 
items about affective/experiential (e.g. feeling shame), cognitive (e.g. being 
concerned about others’ opinions) and behavioural (e.g. engaging in avoidance or 
hiding) components for each of the three dimensions of shame (bodily, behavioural 
and character shame). This is in line with cognitive-attribution theories of shame 
(Andrews et al., 2002). Conceptually, these components of the ESS also map onto 
the three dimensions of the ICD-10 Dependence syndrome (physiological, 
behavioural and subjective/ cognitive) and may thus be particularly useful in 
understanding shame within a substance misuse population. Having richer 
information of the different sources and components of shame should be helpful in 
informing psychological models of shame and psychosocial interventions with 
substance users.
To date, the ESS has only been used in one study to assess the relationship 
between shame and substance use. In an unpublished thesis Andersen (2002) found 
that, compared to non-users, chronic drug users scored higher on only Character 
shame when controlling for depression and aggression. The ESS Character shame 
subscale assesses one’s shame about their (1) personal habits, (2) manner with 
others, (3) personal abilities, and (4) the sort of person one is. The current study 
seeks to confirm Andersen’s (2002) findings and extend them by hypothesising 
further about the relationship between Character shame and substance use.
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The Self, Shame and Substance Misuse 
Developmental view of shame and substance misuse.
In order to further understand how shame about one’s character comes about, it 
is useful to take a developmental view of shame (Mills, 2005). One aspect of shame 
that all theories agree on is that shame is about the self within a relational or 
interpersonal context, i.e. how one perceives the self to be seen and influenced by 
others (Mills, 2005). Of particular interest to the developmental view of character- 
based shame are affect, object relations and attachment theories.
According to these theories, shame proneness is thought to develop during the 
early child-parent relationship when the relational or attachment bond is unsettled 
(Mills, 2005). Using affect theory, Nathanson (1992) proposes that the physiological 
experience of shame functions to strengthen or weaken affect. Nathanson (1992) 
believes that shame is related to one’s basic needs and can be triggered by 
disruptions to one’s sense of connectedness. Overtime, disruptions in affect, 
physiological drives and basic interpersonal needs affect a child’s interpersonal 
functioning and sense of self (Mills, 2005).
A caregiver’s contingent responding, attunement and attachment security can 
further affect a child’s responsiveness to others and to the self. Schore (1996, 1998) 
suggests that attunement is used early on to regulate an infant’s affective states. 
Misattunements are used to socialise and restrict a child’s positive affect to promote 
the development of self-control and autonomy. Schore (1996) believes that the 
change from a positive affect state to a negative state (a normal part of development) 
may produce shame. The process and quality of shame regulation and re-attunement 
influences early brain development, temperament, and becomes internalised through
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one’s internal working models of self and others (Mills, 2005). Schore (1996, 1998) 
posits that a child’s attachment style is effectively their style of affect and shame 
regulation. For instance, if a parent is consistently unavailable the child may develop 
self-regulating strategies, such as disengagement or avoidance of negative affect 
(anxious-avoidant attachment). When the parent is inconsistently unavailable this 
may interfere with the child’s disengagement and lead to difficulties and 
preoccupation with affect regulation, leading to irritability, hostility, anger and 
impulsivity (preoccupied-ambivalent attachment). In studies linking shame and 
attachment (using Bartholomew’s model of adult attachment, 1990), shame 
proneness was inversely related to secure attachment, unrelated to dismissive 
attachment and positively related to preoccupied and fearful attachment (Gross & 
Hansen, 2000; Lopez et al., 1997).
Kauffman (1989) proposes that social and interpersonal triggers can activate 
shame later in life if one is unable to meet the expectations of others. These 
interpersonal triggers can vary throughout the developmental lifespan. For example, 
in infancy the parent-child relationship may be a source of shame, while in childhood 
triggers can include the family, school, peers or society. In adulthood, relationships, 
work, social functioning and status can trigger shame (Mills, 2005). To cope with 
these shamed aspects of self, defenses such as externalising behaviours, denial and 
withdrawal are often used, which further reinforce the negative perceptions of a 
person’s sense of self (Mills, 2005; Tangney & Dearing, 2002).
Research literature has also applied a developmental perspective to substance 
use. Using Bowlby’s attachment theory (1973), researchers have proposed a self­
regulation model of addiction with substances being used as an attempt to regulate 
one’s attachment systems, including one’s sense of self, interpersonal relatedness,
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and emotional, cognitive, behavioural and physiological subsystems (Padykula & 
Conklin, 2010). The effect of attachment on affect regulation and interpersonal 
functioning has been supported in a sample of substance users (Thorberg & Lyvers, 
2010). Furthermore, Panksepp (1998; Zellner, Watt, Solms & Panksepp, 2011) 
combined evolutionary, attachment and neuroscientific research to suggest that the 
endogenous opioid and dopaminergic systems involved in attachment relationships, 
which have evolved to regulate pleasure seeking and separation distress, are similar 
to the neurochemical reward systems maintaining addiction cycles. To this regard, 
addiction can be understood as a self-soothing substitute used in the absence of 
secure attachment objects (MacLean, 1990; Insel, 2003). Such findings suggest that 
attachment difficulties are an important part of addiction, with researchers 
advocating for group, couples and family therapies to be incorporated into substance 
misuse treatments (Cook, 1991; Flores, 2001; Vetere & Henley, 2001). To this end, 
behavioural couples therapy is now a psychosocial intervention for drug abuse 
recommended by the National Institute for Health and Clinical Excellence (2007).
In empirical studies examining substance use and attachment patterns, insecure 
attachment style has been found to be a risk factor for problematic alcohol use 
(Vungkhanching, Sher, Jackson & Parra, 2004). Kotov (2006) reports that young 
adults with insecure attachment might be particularly vulnerable to substance use 
disorders as they replace their early inconsistently available attachment objects 
(caregivers) with substances when they leave home. McNally, Palfai, Levine and 
Moore (2003) examined the links between attachment (using Bartholomew’s model 
of adult attachment, 1990), coping and alcohol use in undergraduate students. They 
found that preoccupied and fearful attachment styles are related to problematic 
alcohol use, and that this is mediated by emotion regulation drinking motives.
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Kassel, Wardle and Roberts (2007) similarly found anxious attachment (preoccupied 
and fearful) to be related to frequency of drug use and stress-motivated drug use in 
college students, mediated by dysfunctional attitudes and self-esteem. Other studies 
have found that quantity (Cooper, Shaver & Collins, 1998) and frequency of drinking 
(Magai, 1999) are most related to an ambivalent-preoccupied attachment style.
Magai (1999) found that individuals with preoccupied-ambivalent attachment use 
drinking as a way of reducing negative affect, while people with dismissive-avoidant 
attachment use drinking to enhance positive affect. Regarding illicit substance use, 
Schindler and colleagues (2005) reported opiate dependency and severity of drug use 
to be predominantly related to fearful rather than dismissive attachment. Caspers, 
Cadoret, Langbehn, Yucuis and Troutman (2005) found a higher incidence of 
substance use in people with insecure attachment compared to those with secure 
attachment styles. They additionally found that perceived social support mediates the 
relationship between preoccupied-ambivalent attachment and substance use.
Self-ambivalence.
Guidano and Liotti (1983) noted that children who have a preoccupied- 
ambivalent attachment style go on to internalise this as an ambivalent view of the 
self. A person who has an ambivalent sense of self simultaneously holds extreme and 
conflicting views of their personal characteristics, for example as being both lovable 
and unlovable, worthy and unworthy, moral and immoral (Guidano & Liotti, 1983). 
This ambivalence creates an internal conflict or dividedness about one’s sense of 
self. The ambivalent person is preoccupied with this internal conflict and tries to 
resolve it by looking to other people for resolution about their sense of self-worth 
and morality (Frost, Kyrios, McCarthy & Matthews, 2007). This may leave the
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ambivalent individual vulnerable to experiencing shame if others’ responses towards 
them are negative. A self-ambivalent person can feel particularly vulnerable in 
interpersonal situations that may be supportive but are experienced as demanding or 
rejecting (Guidano & Liotti, 1983), such as may be the case with some families, 
treatment settings and other potential shame-generating systems. Interpersonal 
situations can trigger further ambivalence about whether the person is fulfilling 
moral and social norms (Bhar & Kyrios, 2007; Guidano & Liotti, 1983). Ambivalent 
individuals may use defenses such as approach-avoidance, denial or secrecy to 
protect their sense of self-worth (Bhar & Kyrios, 2007).
Self-ambivalence has been positively associated with psychopathologies, such 
as obsessive-compulsive symptoms (Bhar, 2004; Bhar & Kyrios, 2007; Frost et al., 
2007), eating disorders and body dysmorphic disorder (Labuschagne, Castle, Dunai, 
Kyrios & Rossell, 2010). In these studies self-ambivalence was considered a meta­
vulnerability for the development and maintenance of psychopathology, and an 
important construct when attempting to identify specific cognitive-affective factors 
that underlie dysfunctional perceptions of self, self-worth and moral-social 
acceptance (Guidano & Liotti, 1983). This suggests that self-ambivalence might be a 
useful factor to consider in relation to self-conscious emotions such as shame.
This self-construct may also have particular applicability to the experiences of 
substance users. Ambivalence over change is often reported as an issue in treatment, 
as substance users experience both relief and distress from drug use. For example, 
ambivalence is a concept used in substance misuse services when considering 
Prochaska and DiClemente’s (1983) cycle of change model, particularly in the 
Contemplative stage. Moreover, self and identity issues are thought to play a crucial 
role in recovery from addiction (Larkin & Griffiths, 2002). Discrepancies between
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self-standards and substance use have been found to be important identity-related 
motivators for abstinence (Downey, Rosengren & Donovan, 2000). Najavits (2002) 
also suggests that cognitive splitting and ambivalence over different sides of the self 
are common psychic defenses for people with substance use, and that a task of the 
treatment should be the integration of the split self. This task could be particularly 
difficult for substance users. For example, trying to assimilate a cohesive view of the 
self as "good" while experiencing stigma due to the “bad addict” self can be 
challenging, as is recognised within the 12-step literature (Flores, 2007). Despite 
these conceptual links, self-ambivalence has never been empirically investigated 
within the substance abuse field.
Self-esteem.
Self-esteem is a widely used construct in personality research. Although 
several definitions of self-esteem have been given, it is generally considered to 
involve a global evaluation of the self and self-worth. The sociometer theory 
proposes that self-esteem acts as a monitor of one’s perceived relational value, with 
drops in self-esteem related to higher risks of social rejection (Leary & Baumeister, 
2000). The perceived negative evaluation from significant others, one’s relational 
value, social rejection and the need for belonging all affect levels of self-esteem 
(Orth et al., 2006). Conceptually, this seems closely related to shame, as the negative 
evaluations involved in shame are likely to also affect self-esteem.
Indeed, Cook (1989 in Ryback & Brown, 1996) found a strong inverse 
relationship between internalised shame and self-esteem. This finding, however, was 
later criticised by Tangney (1996) who argued that Cook’s ISS shame measure 
overlapped with self-esteem and so could not sufficiently differentiate between the
PORTFOLIO
148
two distinct constructs. In their study, Tangney and Dearing (2002) found only a 
moderate negative correlation between shame and self-esteem. The shame-self 
esteem relationship was also examined in other studies. Woien, Ernst, Patock- 
Peckham, and Nagoshi (2003) found shame to be related to self-esteem, while Mills 
(2005) found that people with low self-esteem are vulnerable to experiencing shame- 
rage cycles. Self-esteem has also been found to negatively correlate with self­
ambivalence across four studies (Riketta & Ziegler, 2006).
Furthermore, Donnella, Trzesniewski, Robins, Moffitt and Caspi (2005) found 
a robust association between self-esteem and externalising behaviours, such as 
aggression, anti-social behaviour and delinquency. Nathanson (1994) argued that 
externalising behaviours, such as addiction and aggression, can be seen as 
narcissistic behaviours and may be a result of people trying to defend against their 
low self-esteem and high shame. The link between self-esteem and substance use has 
also been supported by correlational (Griffin-Shelley et al, 1990; Leary et al, 1995) 
and prospective studies (Walitzer & Sher, 1996).
In brief, the current literature suggests that proneness to shame seems likely in 
individuals who experience early attachment disruptions. Attachment disruptions can 
also contribute to the development of an unstable sense of self-worth and (perceived) 
poor relational functioning, as is the case with individuals with high self­
ambivalence and low self-esteem. A crucial motivation for substance misuse could 
be the regulation of such negative affects and fragmented self-states, particularly 
when these are triggered by interpersonal factors. In the long run, however, 
continued substance use puts the person at risk of social exclusion due to the “addict” 
self, which could reinforce feelings of shame, self-ambivalence and low self-esteem.
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These hypothesised processes require further investigation to clarify how these 
distinct but parallel constructs relate to each other.
Other Related Emotions
When investigating shame in the context of substance use, it is important to 
also consider other emotions that might be related to shame, specifically anger and 
depression. Highlighting the need to explicitly identify shame, H.B Lewis (1971) 
notes that high levels of shame are often unacknowledged by both clients and 
therapists. M. Lewis (1992) suggests that this occurs due to the emotional 
substitution of shame with other closely related basic emotions such as anger or 
sadness. Prolonged exposure to unacknowledged shame, however, can trigger 
pathological depression, rage and aggression. According to H.B Lewis (1971), shame 
is the emotional origin of both anger and depression, expressed as sequences of anger 
when directed outwards and depression when directed inwards.
Anger and aggression.
As theorised by H. B Lewis (1971), when shame is triggered in an individual it 
may initially be directed at the self. However, due to the painful aversive nature of 
shame, individuals are prone to defend themselves against this emotion through 
hiding, avoidance or secrecy. Another defense is the externalisation of 
unacknowledged shame in order to reduce exposure to the flawed self. This can lead 
to emotions of anger and externalising behaviours, such as aggression and substance 
use. People can become trapped in a shame-rage spiral, as externalising behaviours 
often lead to further shame and narcissistic ‘humiliated fury’ (Lewis, 1971; Scheff & 
Retzinger, 1991). Grosch (1994) and Nathanson (1994) argue that shame and 
narcissistic rage are by-products of narcissistic vulnerabilities and self-object failure,
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with addiction and psychopathology resulting from an attempt to control and defend 
against the fragmented self by externalising blame and responsibility to others.
Several empirical studies have supported these hypotheses, linking shame to 
high levels of anger, aggression, hostility and violence. Harper and Arias (2004) 
found that shame proneness is related to anger as well as depression. Gilbert, Pehl 
and Allan (1994) found shame to be related to high self-consciousness, helplessness, 
anger at self, sense of personal inferiority and submissive behaviours. Hoglund and 
Nicholas (1995), using a sample of undergraduate students with a history of abusive 
family environments, reported that shame proneness is associated with covert 
hostility and unexpressed anger. Similarly, Bennett, Sullivan and Lewis (2005) found 
that shame is related to anger, and anger to behavioural and externalising problems, 
in children with a history of maltreatment and physical abuse.
Tangney and colleagues have further contributed important findings to this 
area using the TOSCA. Using an undergraduate student sample, Tangney, Wagner, 
Fletcher and Gramzow (1992a) reported that shame proneness is consistently related 
to regulation of anger arousal, suspiciousness, resentment, irritability, blame towards 
others and indirect hostility. Similarly, shame proneness (but not guilt) is related to 
maladaptive responses to anger, such as aggression and self-directed hostility, and 
long-term negative interpersonal consequences in individuals across the lifespan 
(Tangney, Wagner, Hill-Barlow, Marschall & Gramzow, 1996). Stuwig, Tangney, 
Heigel, Harty and McCloskey (2010) found an indirect relationship between shame 
proneness and aggression mediated by the externalisation of blame.
In another recent study, Farmer and Andrews (2009) found that shame- 
proneness is related to anger in undergraduate students, but not in young male 
offenders. A possible explanation offered by the authors is that, in line with Gilbert’s
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social rank theory of shame (1997), anger is an adaptive tool for youth offending 
subcultures that protects self-esteem and social status and thus is unrelated to shame. 
Hejdenberg and Andrews (2011) further enriched the shame-anger relationship, 
finding that shame proneness and trait anger are only associated in reaction to 
criticism or provocation. Authors suggested that this also substantiated both Lewis’ 
(1971) and Gilbert’s (1997) theories as anger appears to be triggered by criticism and 
unacknowledged shame. Studies of adolescents have likewise found that shame 
relates to increased hostility, aggression and the potential for anti-social behaviour 
when shaming experiences are considered to threaten one’s social status (Aslund, 
Starrin, Leppert & Nilsson, 2009; Heaven, Ciarrochi & Leeson, 2009). Additionally, 
it was found that shameful events make adolescents angry, particularly in those 
scoring high on narcissism, indicating the link between shame and ‘humiliated fury’ 
(Thomaes, Stegge, Olthof, Bushman & Nezlek, 2011).
In a review, violent behaviour, trauma and substance abuse were also 
connected, with shame again identified as an agent for rage permeating individual, 
family, institutional and community levels (Dunnegan, 1997). Furthermore, anger 
and shame have been reported to predict impulsive-compulsive behaviours, such as 
drinking (Abramowitz & Berenbaum, 2007), while aggression and domestic violence 
have also been linked to alcohol use and psychoactive substances (Hallos & Vetere, 
2009). A two-way association between high rates of substance use and aggression 
has also been documented, with psychological, biological, socioeconomic and 
pharmacological factors thought to play a role (Boles & Miotto, 2003; Moss & 
Tarter, 1993).
As seen in the relevant literature, there are clear links between shame and 
aggression, as well as aggression and substance use. Following from past findings, it
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appears that aggression may mediate the relationship between shame and other 
externalising problems, particularly when these problems are related to one’s social 
standing. In these instances aggression may be related to unacknowledged shame and 
can lead to a cycle of shame and rage. The current study hypothesises that this link 
may have particular relevance for people with substance misuse problems, who are 
vulnerable to experiencing social marginalisation and stigma due to their drug 
dependence. In the present study, aggression will be investigated as a possible 
mediator between shame and substance use.
Depression.
The link between shame and depression has also been substantiated in 
numerous empirical studies. Cook (1996) reported that the correlation between 
shame and depression ranged between .59 and .79. Allan and colleagues (1994) 
found that shame scales measuring global negative beliefs were related to depression. 
Similarly, Fontaine, Luyten, DeBoeck and Corveleyn (2001) found the TOSCA- 
Shame scale to be positively related to depression measures. Other studies also 
provided strong correlational evidence of a significant association between shame 
and depression (Averill, Diefenback, Stanley, Breckridge & Lusby, 2002; Harper & 
Alias, 2004). Andrews and colleagues (2002) used the ESS shame scale to predict 
depression in a non-clinical sample, showing that shame explained increases in 
depression over three months even when controlling for previous depression.
Part of the link between shame and depression could be explained by both 
sharing similar cognitive attribution styles (i.e. tendencies to make internal, stable 
and global negative attributions) (Reimer, 1996). Tangney, Wagner and Gramzow 
(1992b), however, found that shame-proneness explained variance in depression over
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and above similarities in attribution style. Additionally, Orth and colleagues (2006) 
found that shame (but not guilt) has a unique effect on depression. By further 
examining this relationship they found that rumination was an important mediator. 
Cheung, Gilbert and Irons (2004) similarly identified rumination as a partial 
mediator.
Other factors found to be associated with both shame and depression include 
experiences of trauma, abuse and maltreatment (Andrews, 1995; Andrews & Hunter, 
1997; Webb, Heisler, Call, Chickering, & Colburn, 2007). In a longitudinal study, 
Stuewig and McCloskey (2005) found associations between childhood maltreatment, 
shame proneness and depression in adolescents. Moreover, social rank (i.e. 
submissive behaviour and feeling inferior or subordinate in social situations) was 
also found to relate to depression and shame (Cheung et al., 2004; Gilbert, 2000).
The role of social factors in mediating the link between shame and depression is 
further supported by Scheff (1998, 2001) and Shohar (2001). These authors looked 
beyond individual factors, highlighting the effects of broken interpersonal social 
bonds, sense of belonging, stigma and labeling on shame and depression.
As reviewed previously, substance abuse can be understood as a means of self- 
medication (i.e. to defend against emotional distress) and several studies found 
proneness to both shame and depression to be higher in substance using populations 
(Meehan et al., 1996; O’Connor, et al., 1994; Treeby & Bruno, 2012). As seen in the 
literature, there are significant correlations and overlaps between shame and 
depression characteristics. This raises concerns that any relationship found between 
substance use and shame might be confounded by the high levels of co-morbid 
depression present in substance using populations (Conway et al., 2006; Crum et al.,
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2013; Swendsen et al., 2010). To address this issue, individuals with a diagnosis of 
Major Depressive Disorder were excluded from the current study.
Shame and Disclosure
As mentioned, an important distinction between shame and other related 
emotions, such as guilt, is that shame involves a tendency to conceal, hide and use 
secrecy. Studies show shame to be a barrier to help seeking (Gray, 2009; Potter- 
Efron, 1987) and disclosure of negative affect (Hill, Thompson, Cogar & Denman, 
1993; Kelly, 1998). Kushner and Sher (1989) conceptualised an approach-avoidance 
conflict to professional help seeking, suggesting that shame is an avoidance factor at 
the core of self-stigma with implications on treatment-seeking delays. Reluctance to 
disclose distress was also highlighted as an important interpersonal avoidance 
consequence of shame (MacDonald, 1998). In a review, Farber (2003) reported that 
most clients are ambivalent about self-disclosure to partners, friends and therapists 
because they experience tension between confessional relief and shame.
Furthermore, the effect of shame on disclosure was found to affect therapy 
engagement, including the timing, focus and depth of what is discussed. In a 
qualitative study, people referred for psychotherapy regularly (68% of the time) did 
not disclose negative emotional incidents to partners, friends or professionals. Non­
disclosure was associated with shame and the anticipation of negative interpersonal 
responses, such as labeling and judgment (MacDonald & Morley, 2001).
In a mixed-methods study, Farber, Berano and Capobianco (2004) investigated 
the benefits and consequences of disclosure in psychotherapy. They found that the 
disclosure process could trigger actual or anticipatory shame and challenge the 
therapeutic work. Nonetheless, disclosure offered numerous benefits including relief
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from physical and emotional tension, increased feelings of safety and pride, and 
made subsequent disclosures easier. Patients thus reported that therapists should 
actively encourage them to disclose distress (Farber et ah, 2004). Furthermore, 
disclosing distress can help reduce psychological stress by enabling the person to 
confront the problem and access the support available (Pennebaker, 1997).
The inverse effect of shame on disclosure in treatment has been reported in 
studies of people with eating disorders (Swan & Andrews, 2003), depression (Hook 
& Andrews, 2005) and gambling problems (Suurvali, Cordingley, Hodgins & 
Cunningham, 2009). In the studies by Andrews and colleagues, shame proneness was 
significantly related to non-disclosure of symptoms, with non-disclosure leading to 
continued shame and poorer outcomes. Still, the link between shame and disclosure is 
not completely clear. For example, Farber and Hall (2002) did not find shame 
proneness and overall disclosure to be significantly related.
The effect of shame on disclosure has scarcely been researched in people with 
substance use disorders. Most studies instead focus on self-stigma and help seeking 
(Cellucci et ah, 2006; Luoma, 2011; van Boekel et ah, 2013). In a qualitative study 
interviewing female patients in primary care, it was found that reluctance to 
disclosure information about issues such as drug use is mainly due to feelings of 
discomfort, embarrassment and shame (Sankar & Jones, 2005). The only study to 
directly investigate shame about drug use and distress disclosure in a substance 
misuse population, however, found no significant relationship (Andersen, 2002).
This might be due to the use of a non-standardised measure of disclosure and a small 
sample size. Given the important clinical implications of this link, further research is 
needed to establish the effects of shame on disclosure in a substance using 
population.
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The Current Study
The central aim of the current study is to confirm and further explore the 
relationship between shame and substance misuse in light of the limitations of past 
studies. One way I propose to do this is to use an alternative and robust standardised 
measure of shame, namely the Experiences of Shame Scale (ESS: Andrews et ah, 
2002). In addition to the three subscales of character, body and behaviour shame 
assessed by the ESS, an additional subscale will be included (used by Andersen, 
2002) to directly assess levels of drug-related shame in a clinical substance-misuse 
population. Identifying the relevance of these specific sources of shame should 
increase our understanding of this client group and strengthen the case for future 
intervention studies focusing on shame to be offered to clients with substance use 
difficulties.
In this study, I will further examine self-ambivalence, self-esteem and 
aggression as potential mediators to the relationship between shame and substance 
use. I will also investigate the relationship between shame and willingness to 
disclose psychological distress within the substance misuse context using a 
standardised measure of distress disclosure.
Research questions.
Specifically, this study aims to investigate the following research questions:
1. Do individuals with drug-dependence experience differing levels of overall 
shame from a comparison group of non-substance users?
2. Are differences related to shame in general or to particular aspects of 
charactereological, bodily and/or behavioural shame? That is, do people with
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drug-dependence experience differing levels of particular aspects of shame 
from a comparison group?
Is drug-related shame associated with other sources of shame (within the 
substance use group)?
Are self-ambivalence, self-esteem and/or aggression significant mediating 
factors between shame and substance use?
Are levels of shame related to the willingness to disclose or conceal 
psychological distress? Is this relationship particularly relevant to individuals 
with substance use problems?
Main hypotheses.
Based on previous studies and the theoretical background, I hypothesise that: 
People with drug-dependence will score higher on overall levels of shame. 
People with drug-dependence will score higher on all aspects of shame. 
Drug-related shame will be significantly associated with other aspects of 
shame in the substance misuse group, identifying it as an additional specific 
source of shame.
Substance use will be related to higher self-ambivalence, aggression and/or 
lower self-esteem and this will be related to higher levels of shame.
Higher levels of shame will be related to lower willingness to disclose 
psychological distress, particularly in clients with substance use difficulties.
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Method 
Design
This study used a cross-sectional design to investigate between and within 
group differences. Data was collected using self-report questionnaires at one point in 
time.
Participant Recruitment
To address group differences on shame, two groups were recruited. One group 
included individuals with substance use problems (SU group) and the other a non­
drug using comparison group.
Participants in the substance use group were recruited from National Health 
Service (NHS) outpatient drug and alcohol services and voluntary sector hostels in 
North London. Most drug-using participants were currently in treatment for 
substance misuse, predominantly in methadone maintenance treatment programs. 
Advertisements for recruitment were placed in NHS services. Comparison group 
participants were initially going to be recruited from Job Centres or NHS Improving 
Access to Psychological Therapies (IAPT) primary care services in London. The 
rationale for this was to match the SU group on demographic variables, as well as on 
levels of employment and mental health needs as much as possible. Insufficient 
numbers of participants were recruited this way, however. Advertisements and an 
online link to the study were then placed on mental health charity forums and their 
social networking sites (including Mind, Sane, The Mental Elf and Rethink).
Recruitment inclusion criteria for the SU group were poly-drug use.
Individuals with a primary alcohol dependency alone were excluded. 
Inclusion/exclusion was based on information from the care team, key workers and
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service users. Participants were also excluded if they were suffering withdrawal or 
were intoxicated on the day of testing, which was assessed by the staff and 
researcher looking for signs such as ability to answer questions coherently, slurring, 
disorientation, stumbling or smelling of alcohol. Comparison group participants were 
excluded if they were currently misusing illicit substances or had a recent history of 
substance misuse difficulties. This was assessed using self-report data and a 
screening measure for substance use problems. Additional exclusion criteria for both 
groups included being under 18 years of age or being unable to read or write. 
Participants were also excluded if they were currently diagnosed with, or had 
received treatment in the past two years, for Major Depressive Disorder (MDD). This 
was confirmed through self-report data, information from the care team, and the 
administration of depression screening tools.
Procedure 
Substance use group.
Potential participants for the SU group were initially identified and approached 
by a member of the care team at the services and asked if they would be interested in 
participating in the study. If someone expressed interest, the researcher would give 
the individual an Information sheet and be available to go through it to answer any 
questions. If the individual was willing to participate in the study then a date and 
time for this was arranged. Participants were incentivised to participate using a ’prize 
draw' model with a total budget of 200 GBP given as vouchers for high street stores 
(excluded participants were also added to the prize draw). A total of 40 vouchers 
were given, each worth 5 GBP.
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On the study day, participants met the researcher at the services and were taken 
to a private room. The researcher would ask the participant to read the consent form 
and provide written informed consent. Provided this was done, participants were then 
asked to complete the questionnaires. The researcher was available throughout to 
address any questions or concerns. Upon completion of the study, participants were 
debriefed and given an information sheet with contact details of local emergency, 
mental health and substance misuse services.
Comparison group.
To collect data using the online version of the study, an email was sent to 
various mental health charities and organisations requesting permission to post the 
advertisement and online link on their websites. Some charities also agreed to post 
the information on their social networking sites. Individuals who came across the 
advertisement had the option of clicking on the study link or ignoring it. If they 
chose to click on the link, they were taken to the online version of the study where 
they were presented with the Information sheet. The online version also included a 
consent form, and participants were asked to answer ‘Yes’ or ‘No’ to a series of 
questions to indicate that they had read the information provided and gave informed 
consent to take part in the study. Data from the questionnaires were stored on a 
secure server at the Surrey University Faculty of Arts and Human Sciences. The 
same ‘prize draw’ model was used as an incentive, with participants having the 
option to submit their email address to enter the draw. The online version of the 
study concluded with a debrief page and the researcher’s contact details in case 
respondents wanted further information, to provide feedback or to request a summary
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of the results of the study. Once enough responses were collected the study was 
taken offline.
Ethical Approval
The study was given a favourable ethical opinion by the London-Chelsea NHS 
Research Ethics Committee (Ref: 12/LO/0699) and by the Faculty of Arts and 
Human Sciences Ethics Committee at the University of Surrey (see Appendix A).
The Camden and Islington NHS Foundation Trust and South West London and St 
George’s NHS Trust granted R&D approval (see Appendix A). All data gathered 
during this study were collected and stored securely in accordance with the Data 
Protection Act (1998). Additionally, the British Psychological Society (BPS, 2009) 
and Health Professions Council (HPC, 2009) procedures for researchers were 
followed.
Service User and Carer Involvement
The coordinator of service user and carer activity at the Surrey University 
Faculty of Arts and Human Sciences was consulted about the project proposal and 
use of measures. The coordinator additionally provided helpful input when writing 
the Information and consent forms, particularly in regards to the language used when 
talking about issues of shame. Service users were also consulted at later stages of the 
study, for example in identifying possible recruitment strategies and online forums 
on which to post the advertisement.
Measures
The pack of measures with the study forms and questionnaires is outlined 
below, in the order of presentation. Copies of all the measures were included in the
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Appendices, except for one depression tool due to copyright reasons. Participant 
Information and consent forms were presented first (see Appendix B).
1) A demographic questionnaire was used to collect information about 
participants’ age, gender, ethnicity, education, employment and history of mental 
health difficulties (i.e. whether seen a mental health professional or taken medication 
in the past two years, and whether they currently had or were receiving treatment for 
a diagnosis of MDD) (Appendix Cl).
2) The Drug Abuse Screening Test-10 item (DAST-10; Skinner, 1982) was
used as a screening tool with both participant groups. This is a shorter version of the 
original 28-item questionnaire. This self-report measure assesses evidence of drug 
related problems and consequences (excluding alcoholic beverages) in the past 12 
months, asking participants to answer “Yes” or “No” to a series of questions (see 
Appendix C2). Possible scores range from 0 to 10, with higher scores indicating 
more drug related problems. Scores above six are considered to indicate substantial 
to severe drug related problems. Studies indicate that the DAST-10 has good internal 
reliability (a= .86), test-retest reliability (ICC= .71) and discriminant validity (Cocco 
& Carey, 1998). In a meta-analysis, the DAST was determined to have good 
reliability, validity, sensitivity and specificity (Yudko, Lozhkina & Pouts, 2007).
3) To assess and screen for levels of depression, two measures were used. The 
Beck Depression Inventory-II (BDI-II; Beck, Steer & Brown, 1996) was used 
with the substance use group. This widely used 21-item measure asks participants to 
indicate how they have been feeling in the past two weeks by circling one of four or 
six statements assessing a range of depressive symptoms. Total scores range from 0 
to 63, with higher scores indicating higher severity of depressive symptoms. Scores 
between 29 and 63 are considered to indicate severe levels of depression. The BDI-II
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has been found to have good psychometric properties when used with a chemically 
dependent population, including good validity, internal consistency and a three- 
factor structure (cognitive, affective and somatic symptoms), although it was 
suggested that population-specific normative data are needed and that a higher cut­
off be used for this population (Buckley, Parker & Reggie, 2001; Dum, Pickren,
Sobeli & Sobell, 2008). Due to copyright issues, the BDI-II could not be used in the 
online version of the study, however, so a different screening measure was used with
the comparison group.
The Patient Health Questionnaire-9 (PHQ-9: Spitzer, Kroenke & 
Williams, 1999) was used to assess severity of depression in the comparison group 
(Appendix C3). This 9-item self-report questionnaire asks participants to rate 
themselves over the last two weeks from 0 (“not at all”) to 3 (“nearly every day”) on 
each of the nine DSM-IV depression criteria. Scores can range from 0 to 27, with 
scores above 20 indicating severe levels of depression. Studies report high internal 
consistency for the measure (a= .83) and convergent validity (Cameron, Crawford & 
Lawton, 2008; Kroenke, Spitzer & Williams, 2001).
4) The Experiences of Shame Scale (ESS; Andrews et al., 2002) was used to 
measure levels of shame (Appendix C4). This self-report questionnaire was 
developed from Andrew and Hunter’s (1997) interview measure of shame. 
Participants were asked to rate themselves on items from 1 (“not at all”) to 4 (“very 
much”) according to how they have felt in the past year. Scores range from 25 to 
100, with higher scores indicating higher levels of shame. The ESS consists of 25 
items that measure global shame as well as three specific sources of shame: character 
(12 items), behaviour (9 items) and body (4 items). The scale assesses four areas of 
character shame (i.e. personal habits, manner with others, sort of person one is, and
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personal ability), three areas of behaviour shame (i.e. doing something wrong, saying 
something stupid and failing competitively) and one area of body shame. Each of the 
eight areas of shame was measured with an item assessing an affective component 
(e.g. “Have you felt ashamed o f ) ,  a cognitive (e.g. “Have you worried about what 
other people think o f )  and a behavioural component (e.g. “Have you tried to avoid/ 
conceal/ cover up?”). The ESS has been found to have high internal consistency (a= 
.92) and test-retest reliability (over 11 weeks) of the total score (r= .83) and the three 
subscale scores (Andrews et al., 2002). Factor analyses have confirmed the three- 
factor structure of the ESS and that there are cognitive, affective and behavioural 
components to shame (Andrews et al., 2002).
In the current study, the ESS was extended to include additional subscales 
specifically related to drug use as a source of shame (see Appendix C4). These drug- 
related items have previously been used by Andersen (2002). Two sets of scales were 
added assessing shame about having a drug problem and shame about activities 
associated with drug use. Each set was developed in line with existing ESS 
subscales, and thus included an experiential/ affective (e.g. “Have you felt ashamed 
of any of the things you have done in relation to taking drugs”), cognitive (e.g.
“Have you worried about what other people think of you having a drug problem?”) 
and behavioural item (e.g. “Other than for legal reasons, have you tried to cover up 
or conceal that you have a drug problem?”). Accordingly, a total of six drug-related 
items were added to the existing ESS scale.
5) The Self-Ambivalence Measure (SAM; Bhar & Kyrios, 2007), a 19-item
self-report questionnaire, was used to measure levels of self-ambivalence in 
participants (see Appendix C5). To complete the questionnaire, participants were 
asked to indicate how far they agreed with a series of statements on a Likert-style
PORTFOLIO
165
scale from 0 (“not at all”) to 4 (“agree totally”). Total scores range from 0 to 76, 
with higher scores indicating higher self-ambivalence. The SAM is made up of self- 
worth and moral ambivalence subscales, with items on each subscale measuring self­
uncertainty, conflicting appraisals about the self and preoccupation with self-worth. 
The subscales have been found to have good convergent validity, internal 
consistency ranging from .85 to .88 in clinical and non-clinical samples, and 
satisfactory rest-retest reliabilities (self worth: r= .44, moral: r= .57) (Bhar & Kyrios, 
2007).
6) The Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965) was used as a 
measure of global self-esteem (see Appendix C6). This widely used questionnaire 
consists of 10 items and asks respondents to evaluate how they feel about themselves 
on a list of statements using a Likert scale ranging from 0 (“strongly agree”) to 3 
(“strongly disagree”). The scale includes items assessing self-worth, self-efficacy, 
self-respect and self-acceptance. The scale provides a maximum score of 30, with 
higher scores indicating higher self-esteem. Studies have shown the RSES to be uni­
factorial, have acceptable internal consistency (a= .88) and test-rest reliability (r—
.82) and convergent validity (Gray-Little, Williams & Hancock, 1997; Rosenberg, 
1965).
7) The Distress Disclosure Index (DDI; Khan & Hessling, 2001) was used to 
measure self-disclosure, i.e. willingness to disclose rather than conceal psychological 
distress to others (Appendix Cl). A 5-point Likert-type scale is used to self-rate 12- 
items, with responses ranging from 1 (“strongly disagree”) to 5 (“strongly agree”). 
Total scores range from 12 to 60, with higher scores indicating greater willingness to 
disclose distress. The scale measures a single bipolar construct (i.e. concealment 
versus disclosure) (Kahn & Hessling, 2001). This measure has acceptable validity,
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internal consistency (between .92 and .95) and test re-test reliability (between .80 
and .81) (Khan & Hessling, 2001).
8) The Buss-Perry Aggression Questionnaire (AQ; Buss & Perry, 1992) was
used to measure levels of aggression (Appendix C8). This measure consists of 29- 
items and assesses four aspects of trait aggressiveness: anger, hostility, physical 
aggression and verbal aggression. This four-factor structure has been confirmed 
through factor analysis (Buss & Perry, 1992; Harris, 1997). Participants are asked to 
rate how far a series of statements relates to them from 1 (“extremely 
uncharacteristic of me”) to 5 (“extremely characteristic of me”). Total scores range 
from 29 to 145, with higher scores indicating higher levels of aggression. Studies 
have found this questionnaire to have good internal consistency for the four 
subscales and total score (alpha ranging from .72 to .89) and test-retest reliability 
over nine weeks (correlations ranging from .72 to .80) (Buss & Perry, 1992). The 
construct validity of the measure has also been indicated by high correlations of the 
AQ scores and other aggression measures (Buss & Perry, 1992; Harris, 1997).
Statistical Analysis
Quantitative methods were used to analyse the data using the Statistical 
Package for the Social Sciences (SPSS) Version 19.
Sample size.
The literature suggests that the direct effect of substance use on levels of shame 
is ‘medium-large’ and that a total sample size of 76 is sufficient to obtain a power of 
80% to detect this at the 5% level (Andersen, 2002; Meehan et al., 1996). A 
mediational analysis has not previously been done using these variables so it was 
difficult to estimate an effect size. To use the Bootstrapping methods recommended
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by Preacher and Hayes (2004) to detect mediation, a total sample size of 78-162 is 
needed assuming a medium effect size (Fritz and Mackinnon, 2007). In this current 
study, 10 people were excluded due to incomplete data from the SU group. From the 
comparison group, 16 participants were excluded due to incomplete data and 20 for 
being screened as having a diagnosis of MDD. A final total sample size of 100 was 
used, with 50 participants in each group.
Testing hypotheses.
First, the suitability of the data were checked for linearity, normality (using 
histograms, Q-Q plots and the Kolmogorov-Smirnov test) and homogeneity of 
variance (using Levene’s test) (Field, 2009). When these assumptions were not met 
non-parametric tests were used. The data were also screened for outliers (using 
Cook’s distance scores), missing values and incomplete data. An alpha level of .05 
was set for all statistical tests. The statistical analyses used to address each 
hypothesis are described in the Results section below.
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Results
Participant Characteristics
Descriptive statistics were used to obtain demographic information about the 
participants in each group. A summary of the demographic information is presented 
in Table 1.
Independent sample t-tests were used to analyse differences between the two 
groups on continuous variables (e.g. age, years in education) and Pearson Chi-square 
tests were used for categorical demographic variables (e.g. gender, ethnicity). Where 
there were significant violations to the assumptions of the Independent sample t- 
tests, the non-parametric Mann-Whitney U-Test was used. Where over 20% of cells 
had expected frequencies less than five, violating one of the assumptions of the Chi- 
square tests, the categories were combined.
The results indicate a statistically significant association between gender and 
group, [%2(1, N= 100)= 8.05,/?= .005], with more female participants in the 
comparison group. The two groups also significantly differed in terms of age, [<98)= 
4.00,/?< .001], with SU group participants on average being older. The ethnicity 
variable had 75% of cells with expected count less than five. The ethnicity categories 
were thus combined into three categories (White British or Irish, White Other, Other 
Ethnicities). No significant differences were found between the groups on ethnicity, 
\ / (2 , N= 100)= 1.11,/?= .611], with the majority of the overall sample classifying 
themselves as White British or Irish. In terms of education, the comparison group 
participants on average had higher levels of education, Df2(4, N= 100)= 57.56,/? < 
.001]. Finally, the groups were different in terms of employment, [%2(1, N= 100)= 
24,/? < .001], with more unemployed participants in the SU group.
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Table 1
Demographic Frequency Characteristics o f Participants in each Group
Group
Characteristic SU Comparison
Total participants (n) 50 50
% {n) Female 44% (22) 7294(36)
% (n) Male 56% (28) 28% (14)
Age range 25-61 2 0 -70
Age M  (SD) 42.28 (9.43) 33.70 (11.86)
% (n) Age categories
20-30 1094(5) 58% (29)
31-40 3294(16) 1694(8)
41-50 40% (20) 1896(9)
51-60 1694(8) 4% (2)
61-70 294(1) 4% (2)
% (n) Ethnicity
White British 6894(34) 7496(37)
White Irish 10% (5) 296(1)
White Other 10% (5) 16% (8)
Mixed Other 2% (1) 2% (1)
Black or Black British 4% (2) 0%(0)
Asian or Asian British 2% (1) 2% (1)
Other 4% (2) 4% (2)
% (n) Educational level
No formal qualifications 40% (20) 4% (2)
GCSE/NV Q/Equivalent 3694(18) 4% (2)
A-levels/Equivalent 14% (7) 1096(5)
Undergraduate Degree 10% (5) 44% (22)
Postgraduate 0% (0) 3896(19)
% (n) Unemployed 64% (32) 1696(8)
% (n) Employed 36% (18) 84% (42)
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In relation to the screening measures, participants who had reported currently 
receiving treatment or having a diagnosis of Major Depressive Disorder (MDD) were 
excluded from the study, thus 0% of either group participants reported having a 
diagnosis of MDD. The groups did not significantly differ on the number of 
participants having seen a mental health professional (e.g. psychologist or 
psychiatrist) in the past two years, [)f2(l, N= 100)= .36, p= .55], nor on the number 
of participants having taken medication for a mental health problem in the last two 
years, fc2(l, N= 100)= .36,/?= .55]. Finally, as expected, there was a significant 
association between DAST scores and group, (U= 14, z= -8.65,/?< .001), with SU 
participants reporting more drug-related problems (Mdn= 8) than non-substance 
misusers (Mdn= 0). No comparisons between the groups on the depression screening 
measures could be done due to the use of different measures between the groups. A 
summary of the information from the screening variables is presented in Table 2.
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Table 2
Screening Characteristics o f  Participants in each Group
Characteristic
Group
SU Comparison
Total participants {n) 50 50
% (n) Seen a mental health professional in 5094(25) 45% (23)
the past 2 years
% (n) Taken medication for a mental 50% (25) 44% (22)
health problem in the past 2 years
% (%) Have a diagnosis of or receiving 094(0) 0%(0)
treatment for Major Depressive Disorder
DAST score range 4 - 1 0 0 - 5
DAST score M  (SD) 7.80 (.26) .82 (.18)
BDI score range 0 - 5 9 —
BDI score M(SD) 24.82 (13.21) —
PHQ-9 score range - - 0 - 2 4
PHQ-9 score M(SD) — 5.76 (5.08)
Descriptive Information for Measures
A summary of the information describing each of the variables in the study, 
along with Cronbach’s alpha scores, is presented in Table 3. A summary of the 
correlations between all the variables is shown in Appendix Table D l.
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Hypothesis One
Do individuals with substance use difficulties experience differing levels o f  Total 
shame from a comparison group o f non-substance users? It was hypothesised that 
SU group participants would score higher on ESS Total shame.
To test this hypothesis, two General Linear Models (GLMs) were fit to produce 
Analysis of Variance (ANOVA) tables and adjusted mean scores. The data met the 
assumptions of linearity, homogeneity of variance and no outliers were found. 
Normality assumptions were examined and met (see Appendix El histogram).
The one-way ANOVA model included only a factor for Group and was used to 
determine if there were differences in levels of ESS Total shame between the two 
groups. Significant differences in Total shame scores were found, /F (l, 98)= 18.86, 
p< .001, partial rj2= .161], with SU participants scoring higher on levels of Total 
shame (M= 63.78, SD= 20.32) than participants in the comparison group (M= 48.16, 
SD= 15.30).
Given the demographic differences found between the groups, the second 
model included factors for Group and demographic variables. This was done to 
determine if the differences between the two groups on levels of Total shame 
remained when adjusting for the effects of age, gender, level of education and 
employment. Upon inspection of the data it could not be assumed that the continuous 
age and shame variables were linearly related, and thus a categorical age variable 
was used. The results indicate that after adjusting for the effects of the demographic 
covariâtes no statistically significant differences in Total shame mean scores remain 
between the groups, [F(l, 89)= 1.90,/?= .172, partial t/2= .021].
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The results are summarised in Table 4, along with the (unadjusted) means and 
the means adjusted for the demographic covariates. The full ANOVA results are 
presented in Appendix Table FI.
Table 4
Summary results o f Analysis o f Variance for ESS scales with Means
ESS ESS ESS ESS
Total Character Behaviour Body
Group unadjusted M  (SE)
SU 63.78 (2.54) 31.56 (1.32) 22.16(1.01) 10.06 (.54)
Comparison 48.16(2.54) 21.84 (1.32) 17.38(1.01 8.94 (.54)
F 18.86 27.04 11.32 2.18
Sig. ooo*** .000*** .001** .143
Group adjusted M  (SE)
SU 60.13(3.31) 30.19(1.79) 20.99 (1.29) 8.96 (.67)
Comparison 51.41 (4.25) 23.08 (2.92) 18.59 (1.66) 9.74 (.85)
F 1.90 4.32 .94 .383
Sig. .172 .040* .334 .538
Note. ESS= Experiences of Shame Scale.
*/?< .05, **p< .01, ***p< .001
The results suggest that the demographic covariates have an important impact 
on Total shame as they reduced the variance explained by Group. To better 
understand this finding, the adjusted means of the demographic variables were 
included in Table 5. These indicate that ESS Total adjusted means scores are higher 
for females, those between 30 to 50 years old, those with lower levels of education 
and who are unemployed. The effect of gender on shame neared significance, [F(l, 
89)= 3.51,7?= .064, partial tj2= .038]. As seen in Table 1, the majority of participants 
in the SU group are indeed between 30 to 50 years old, with lower levels of
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education and higher unemployment. This suggests that it is the effect of gender on 
Total shame that could possibly explain the non-significant effect of Group when 
adjusting for the demographic covariates, particularly given the higher number of 
females in the comparison group.
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Hypothesis Two
Do individuals with substance use difficulties experience differing levels o f  
particular aspects o f  shame (Character, Behaviour and Body shame) from a 
comparison group? It was hypothesised that SU group participants would score 
higher on all ESS subscales.
ESS Character subscale.
To test the hypothesis regarding Character shame, two General Linear Models 
(GLMs) were fit to produce ANOVA tables and adjusted means. The data met the 
assumptions of linearity, homogeneity of variance and no outliers were found. 
Normality assumptions were also met (see Appendix E2 histogram).
Significant differences in Character shame scores were found between the 
groups, [F(l, 98)= 2 7 . 0 4 , . 0 0 1 ,  partial i]2= .216], with SU group participants 
scoring higher levels of Character shame (M= 31.56, SD= 10.42) than participants in 
the comparison group (M== 21.84, SD= 8.13).
Due to the earlier demographic differences found between the groups, the 
second GLM model was fit to adjust for the effects of these covariates. Significant 
differences between the groups on levels of Character shame were found even after 
adjusting for the variance explained by the demographic covariates, [F(l, 89)= 4.32, 
p= .040, partial rj2= .046], with the SU group reporting on average higher levels of 
Character shame (M= 30.19, SE= 1.79) than the comparison group (M= 23.08, SE= 
2.92). The results of this analysis are summarised in Table 4. The full results from 
the two ANOVAs are shown in Appendix Table F2.
The data partly support hypothesis two, suggesting that Group (i.e. misusing 
substances or not) significantly explains variance in Character shame above and
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beyond that explained by demographic differences, with SU participants reporting 
higher levels of Character shame.
ESS Behaviour subscale.
Two GLMs were fit to produce ANOVA tables and adjusted means. The data 
assumptions of linearity and homogeneity of variance were met. No outliers were 
found. Normality assumptions were also met (see Appendix E3 histogram).
A one-way ANOVA was used to assess whether the two groups scored 
differently on levels of Behaviour shame. The findings suggest that there are 
significant differences between the groups on levels of Behaviour shame, [F(l, 98) = 
11.32,/?= .001, partial tj2= .104], with SU group participants on average scoring 
higher (M= 22.16, SD= 8.25) than comparison group participants (M= 17.38, SD= 
5.73).
Again, a second model was fit to adjust for the possible effect of the 
demographic variables on the differences found between the groups on ESS 
Behaviour subscale scores. After adjusting for age, gender, education level and 
employment, the differences between the groups on scores of Behaviour shame 
became non-significant, [F(l, 89)= .94,/?= .334, partial rj2~ .010]. This indicates that 
the variance in Behaviour shame scores accounted for by Group is not above that 
explained by the demographic variables. These results are summarised in Table 4 
along with the group adjusted and unadjusted means. The full results of the two 
ANOVAs are shown in Appendix Table F3.
Specifically, level of education, [F(4, 89)= 2.68,/?= .037, partial f]2= .107], was 
found to explain a significant amount of variance in Behaviour shame, with lower 
levels of education related to higher levels of Behaviour shame. This result is shown
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in Table 5. Given that there are more people with lower levels of education in the SU 
group (see Table 1), this could explain why the effect of Group is reduced when 
adjusting for the demographic covariates in this sample.
ESS Body Shame.
To test whether Body shame was related to Group, two GLMs were again fit to 
produce ANOVA tables and adjusted means. The data met the assumptions of this 
test (see Appendix E4).
The one-way ANOVA model included only a factor for Group and was used to 
assess whether the two groups scored differently on levels of Body shame. The 
results of this analysis indicate that the differences between the groups on levels of 
Body shame are not significant, [F(l, 98)= 2.18,7?= .143, partial rj2= .022].
The second model included factors for Group and demographic variables. 
Again the differences based on Group were not significant, [F(l, 89)= .38,/?= .538, 
partial tj2= .004]. These results are summarised in Table 4 and the full ANOVA 
results are included in Appendix Table F4. When including the demographic 
covariates, gender was found to have a significant effect on shame above and beyond 
the effects of the other demographic covariates and Group, [F(l, 89)= 12.87,/?=
.001, partial rj2= .126]. Females on average scored higher (M= 10.85, SE= .49) than 
males (M= 7.84, SE= .69) on Body shame. This result is shown in Table 5 and 
suggests that gender is an important factor to consider in explaining the variance in 
Body shame.
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Hypothesis Three
Is drug-related shame associated with other sources o f shame within the SU group?
It was hypothesised that drug-related shame would he positively associated with all 
shame subscales in the substance misuse group.
A Pearson’s correlation was conducted to assess the relationship between Total 
shame and drug-related shame in the SU group. The data met the assumptions of this 
test. The results suggest that Total shame and drug-related shame are strongly 
positively correlated, [r(48)= .15,p< .001], with drug-related shame explaining 
56.85% of the variance in Total shame within the clinical group.
Similarly, drug-related shame is positively associated with the other shame 
subscales. Drug-related shame is correlated with Character shame, [r(48)= .73,/?< 
.001], accounting for 52.56% of the variance. Drug-related shame is also correlated 
with Behaviour shame, [r(48)= .12, p< .001], with drug-related shame explaining 
51.26% of the variance. Finally, drug-related shame is associated with higher Body 
shame, [r(48)= A l,p<  .001], accounting for 21.90% of the variance.
The above suggests that drug-related shame is an important aspect of overall 
shame for participants seeking help for substance use, with higher levels of drug- 
related shame being associated with higher scores in all shame subscales. The data 
therefore support hypothesis three.
Additionally, each ESS subscale SU total mean score (see Table 3) was divided 
by the number of items in each subscale. This produces the mean item score on the 
4-point Likert-scale for each ESS subscale (i.e. from 1 (“not at all”) to 4 (“very 
much”). The findings from this show that on average, participants in the SU group 
felt “a little” to “moderate” levels of ESS Total, Character, Behaviour and Body 
shame, while the mean item score on the drug-related subscale was “moderate”.
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Hypothesis Four
Are self-ambivalence, self-esteem and/or aggression mediating factors between 
shame and substance use? It was hypothesised that all three factors would 
significantly mediate the main relationship.
Based on the research literature, it was hypothesised that these mediators could 
help us understand the mechanisms underlying the relationship between shame and 
substance use. Before testing mediation, Pearson’s first-order correlations were 
estimated. The correlation results are summarised in Table 6.
Table 6
Pearson Correlation Matrix among Shame, Self-Ambivalence, Self-esteem and 
Aggression scale scores in the total sample (N=100)
ESS Total ESS Character SAM RSES AQ
ESS Total 1 .937* .789* -.719* .438*
ESS Character 1 .709* -.660* .431*
SAM 1 -.738* .571*
RSES 1 -.548*
AQ 1
*p< .001 (2-tailed).
Self-ambivalence (as measured by SAM), self-esteem (RSES) and aggression 
(AQ) are all significantly correlated with ESS Character shame, and thus all three 
were considered as possible mediators. Each potential mediator was considered
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separately. Figure 1 shows the path of mediation model adapted from Preacher and 
Hayes (2004) used to guide the mediation analyses.
T ot a l Ef fe e t
D e p e n d e n t  V a r i a b  le
E S S  C h a r a c t e r
I n d e p e n d e n t  V a r  iab le
Group
Indi r e c t  Ef fe e t
M ediat  or
Se l f - a m b i  va lenc e 
Se lf-es teem
I n d e p e n d e n t  V ar iab le
Group
D e p e n d e n t  V a r  iab le
E S S  C h a r a c t e r
Figure 1. The simple mediation model, adapted from Preacher and Hayes (2004).
According to Baron and Kenny (1986), for mediation to hold the following 
four causal steps must be met:
1. The total effect of X on Y, (c), must be significant.
2. The effect of X on M, (a), must be significant.
3. The effect of M on Y controlling for X, (b), must be significant.
4. The direct effect of X on Y, adjusted for M, (c’), must be non-significant or 
less than the total effect, (c).
To estimate the total, direct and indirect effects (ab or c -  c’), the bootstrap test 
of mediation was run using the Process macro for SPSS (Hayes, 2013) and the 
results were compared against Baron and Kenny’s (1986) causal steps for mediation. 
The non-parametric bootstrapping approach was used as it provides an estimate of 
the indirect effects, it is suitable for small sample sizes and it is more robust against 
violations of normal distribution assumptions when calculating indirect effects 
(Preacher & Hayes, 2004). The bootstrapping approach takes a random sample from 
the data with replacement and computes an estimate of the indirect effect. This is 
repeated 5,000 times, forming a bootstrap distribution of the estimates. The bootstrap 
test then computes 95% bias-corrected confidence intervals using the 2.5% highest 
and lowest scores of the bootstrap distribution. Indirect (or mediation) effects are 
significant when the confidence interval does not contain zero.
In line with the current results, when adjusting for demographic differences 
between the groups only the means of the ESS subscale of Character Shame were 
found to vary. The only dependent variable used in the mediation analysis was 
therefore the ESS Character subscale. As before, the demographic covariates were 
adjusted for in the mediation analyses. The bootstrapping macro assumes covariates 
are continuous or binary. Therefore in order to include the categorical variables of 
age and education level, a series of binary dummy variables were created (after 
collapsing some of the categories). Additionally, the assumptions of the analyses 
were examined and met (see Appendix Figures E5-E7 for histograms).
Results of the bootstrapping analyses are shown in Table 7. When not adjusting 
for the demographic covariates, the results show that all three mediators are 
significant in explaining the relationship between Character shame and substance 
use. After adjusting for demographic differences, the mediation analysis between the
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only found aggression to mediate the relationship between ESS Character shame and 
Group (95% Cl [-5.26, -.33]). Those in the SU group scored higher on the aggression 
measure and this was associated with higher levels of Character Shame. The results 
of the aggression analysis also met the four statistical criteria for mediation proposed 
by Baron and Kenny (1986).
The indirect effects of self-ambivalence (95% Cl [-8.32, 1.07]) and self-esteem 
(95% Cl [-7.22,1.44]) were not found to be significant after adjusting for the 
demographic covariates. Comparing the results against the Baron and Kenny (1986) 
criteria for mediation, Step 2 was not met in that there were non-significant effects of 
Group on se lf ambivalence and on self-esteem. All other Baron and Kenny (1986) 
criteria were met.
Importantly, the effects of se lf ambivalence (b— .41, SE— .05, p< .001) and 
self-esteem (b= -.91, SE= .13,/>< .001) on Character shame were significant after 
adjusting for the effects of demographic covariates and Group (i.e. Step 3 or path b). 
The results indicate that the model that includes self-ambivalence explains 56.58% of 
the variance in Character shame compared to 24.63% of the variance explained by 
Group and the covariates (i.e. self-ambivalence explains 31.95% extra variance in 
Character shame). Similarly, the model that includes self-esteem explains 51.73% of 
the variance in Character shame compared to the model without self-esteem that 
explains 26.60% of the variance (i.e. 25.13% extra variance explained by self­
esteem). These findings suggest that, even though they were not found to mediate the 
relationship with substance use, self-ambivalence and self-esteem explain a 
significant amount of variation in Character shame, above that explained by Group 
and the demographic covariates.
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Hypothesis Five
Are levels o f shame related to willingness to disclose distress? Do SU individuals 
express differing levels o f  willingness to disclose distress from a comparison group?
It was hypothesised that higher levels o f shame will he related to lower willingness to 
disclose psychological distress, particularly in the SU group.
To test whether shame was related to willingness to disclose distress, Pearson’s 
correlations were conducted. The test assumptions were met. The data indicate that 
Total shame and willingness to disclose are significantly negatively correlated,
[>(98)= -.47,/?< .001], supporting the hypothesis that greater shame is related to 
lower willingness to disclose distress.
To test whether there were differences between the groups on the willingness 
to disclose distress measure, GLM models were fit to produce ANOVA tables and 
adjusted means. The assumptions for the test were met (see Appendix Figure E8).
The first model included a factor for Group only to test for main effects. The results 
indicate that DDI scores vary between the groups, [F(l, 98)= . 1 5 . 7 0 , . 0 0 1 ,  partial 
t/2= .138], with lower willingness to disclose scores in the SU group (M= 31.76, SD=
11.16) compared to the comparison group (M= 40.04, SD= 9.68). The results of this 
analysis are shown in Table 8.
To test whether levels of disclosure between the groups varied by levels of 
shame, an interaction effect between Total shame and Group on disclosure levels 
was tested. This interaction was found to be non-significant, [F(\, 96)= .80,/?= .374, 
partial rj2= .008]. This analysis is summarised in Table 9. These findings indicate that 
shame and disclosure levels are generally related and this relation does not
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significantly vary according to group (i.e. hypothesis five is partially supported by 
the data).
In the second GLM model, the demographic differences between the groups 
were adjusted for. When doing this, willingness to disclosure did not significantly 
vary by group, [F(l, 89)= 1.05,/?= .308, partial //2= .012], suggesting that the 
differences found earlier between the groups on willingness to disclose might have 
been confounded by the demographic variables. The results of this analysis are 
presented in Table 8. As Group no longer had a significant main effect on DDI when 
adjusting for the demographic covariates, an adjusted interaction effect was not 
tested.
Table 8
Analysis o f  Variance Summary o f Group effect on DDI adjusting for Demographic
covariates
Source Sum of 
Squares
df Mean
Square
F Sig. Partial Eta 
Squared
Group 1713.96 1 1713.96 15.70 .000* .138
Error 10697.04 98 109.15
Group 121.85 1 121.85 1.05 .308 .012
Age 142.38 3 47.46 .41 .747 .014
Gender 138.59 1 138.59 1.20 .277 .013
Education 94.65 4 23.66 .20 .936 .009
level 121.74 1 131.74 1.05 .308 .012
Employment
Error 10323.16 89 115.99
*p< .001
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Table 9
Analysis o f Variance Summary o f the Interaction between Shame and Group on DDI
Source Sum of 
Squares
df Mean
Square
F Sig. Partial Eta 
Squared
Group 242.49 1 242.49 2.55 .114 .026
ESS Total 1563.11 1 1563.11 16.44 .000* .146
Group x ESS 75.84 1 75.84 .80 .374 .008
Total
Error 1078.75 89 12.12
Note. ESS Total= Experiences of Shame Scale Total score.
*p< .001
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Discussion
The objective of this study was to examine and explore in more depth the 
relationship between shame and substance use. In this discussion section, the current 
findings relating to each hypothesis are reviewed and discussed in the context of 
previous studies and the wider literature. The theoretical and clinical implications of 
the current findings are then highlighted. Finally, a consideration of the limitations of 
the present study will follow, leading to possible directions for future work.
Demographic differences
The two groups of participants were matched on ethnicity and current mental 
health (seeing a professional or taking medication for a mental health problem in the 
last two years). In this sample, the SU group participants were on average older, 
proportionally more male, had lower levels of education and higher unemployment 
levels.
Hypotheses 
Hypotheses one and two.
The Experiences of Shame Scale (ESS: Andrews et al., 2002) was used to 
compare a group of participants with substance use problems to a comparison group 
of non-substance users. It was hypothesised that individuals with drug dependence 
would experience higher levels of shame, including overall, character, behaviour and 
body shame. The findings of this study support the hypothesis that SU participants 
on average reported higher levels of all shame components. The current study further 
found that of the different shame components measured by the ESS, only character- 
based shame was significantly related to substance misuse when adjusting for
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demographic differences between the groups. The adjusted analyses suggests that the 
higher levels of overall, behaviour and body shame in the SU group might be related 
to differences in the demographic composition of the groups rather than to something 
inherent in being a substance user. In this sample, it appeared that gender had an 
influence particularly on levels of overall and body shame. This is consistent with 
past studies reporting that females are more likely to experience shame, particularly 
in relation to body image (Ehrmin, 2001; Gross & Hansen, 2000; Swan & Andrews, 
2003). Given the proportionally higher number of females in this sample’s 
comparison group, the influence of gender could explain why the differences 
between the groups lessened when accounting for this demographic variable. 
Education was also found to be an important factor in this sample, accounting for a 
significant amount of variance in Behaviour shame. Lower levels of education were 
related to higher levels of behaviour shame. In the current sample, there were a 
higher proportion of individuals with lower levels of education in the SU group 
suggesting that the education-shame link is important to consider when working with 
this population. These links should be investigated further in future studies.
The choice of comparison group generally impacts on the results and 
interpretation of findings. To further understand why the effect of group on shame 
decreased in the adjusted analyses, it is helpful to also consider the composition of 
the comparison group. For example, the fact that overall levels of shame did not vary 
significantly between the groups in the adjusted analysis does not necessarily suggest 
that the SU group did not experience high levels of shame. It simply suggests that 
they did not experience significantly higher levels of shame (when adjusting for 
demographic covariates) than the comparison group, which in the current study was 
comprised of people recruited through mental health charities. Given that individuals
with mental health difficulties also experience shame and stigma (Rusch, Todd, 
Bodenhausen, Olschewski & Corrigan, 2010; Scheff, 1998), the current findings may 
reflect that both substance use and mental health difficulties are associated with 
experiences of shame. Differences in the choice of comparison group may also 
explain why previous studies that used undergraduate student samples or TOSCA 
norms as comparisons (e.g. O’Connor et al., 1994; Meehan et al., 1996) did find 
differences in overall levels of shame based on group. Importantly, when inspecting 
the mean scores of the SU group in this study, on average individuals reported 
experiencing “a little” to “moderate” levels of shame across all ESS shame 
subscales. Thus, although the findings of the current study did not indicate 
statistically significant differences by Group in the Total, Behaviour and Body shame 
adjusted analyses, the levels of shame experienced by participants with substance 
misuse problems could still be important from a clinical and pragmatic point of view 
of working with this population.
The current finding that shame about one’s character is related to substance use 
(after adjusting for demographic covariates) is in line with findings by Andersen 
(2002) and studies that found one’s identity as “an addict” to be a source of shame 
and stigma for those seeking treatment for substance use (e.g. Gray, 2009; Larkin & 
Griffiths, 2002). Character shame is defined as shame about one’s personal habits, 
manner with others and the sort of person one is (Andrews et al., 2002). It could be 
understood that individuals who experience shame in relation to their sense of self 
may use substances to self-medicate or defend against this (Khantzian, 1985, 2007). 
Based on the wider literature, it is likely that the character shame - substance use 
relationship is bi-directional. According to Higgin’s self-discrepancy theory (1987) 
and Gilbert’s (1997) social rank theory, substance users are also likely to experience
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shame as a consequence of other’s negative perceptions of their habit and their own 
negative self-evaluations. This can result in a vicious self-reinforcing cycle of shame 
and substance use. Although the direction of this association cannot be determined in 
this study, the current findings have important implications, which will be considered 
in later sections.
Hypothesis three.
With the exception of Andersen (2002), previous studies that found a link 
between shame and drug use have measured global aspects of shame and could thus 
only indirectly infer that the shame experienced by substance users was related to 
their drug use. By adding specific items to the ESS relating to substance use, the 
current study was able to examine whether overall levels of shame were actually 
associated with shame about substance use (i.e. shame about having a drug problem 
and actions done in relation to taking drugs). The current findings indicate that the 
more shame individuals in the SU group experienced regarding drug use, the more 
shame they were likely to experience about their character, behaviour and body, and 
vice versa. This suggests that feelings of shame about one aspect of the self may 
extend to other aspects. This is in line with cognitive attribution theories of shame 
that view shame-related self-attributions to be negative, internal and global (Lewis, 
1992).
The results indicate that drug-related shame explains over 50% of the variation 
in Total, Character and Behaviour shame. The SU group felt the most ashamed about 
drug use, on average reporting “moderate” levels of drug-related shame compared to 
“a little” to “moderate” levels on the other shame subscales. This supports the 
hypothesis that shame specifically related to drug use is an important aspect and
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source of shame in people with substance use problems. The implications of this 
finding are discussed in subsequent sections.
Hypothesis four.
Furthermore, the possible mechanisms underlying the relationship between 
character-based shame and substance use were explored. In this study, it was 
hypothesised that self-ambivalence, self-esteem and aggression might mediate this 
relationship. Of these, aggression was found to be the only significant mediator when 
adjusting for demographic differences between the groups.
The current findings indicate that aggression mediates the effect of being a 
substance user on shame in that substance use is associated with higher levels of 
aggression and this is associated with higher levels of character-based shame. This is 
supported by previous studies that report links between aggression and substance use 
(Abramowitz & Berenbaum, 2007; Hallos & Vetere, 2009; Dunnegan, 1997) and 
aggression and shame (Harper & Arias, 2004; Gilbert et al., 1994; Tangney et al., 
1992a; Tangney et al., 1996). The current findings are also in line with those with 
Bennett and colleagues (2005) who found anger to mediate the relationship between 
shame and externalising behaviours.
Unfortunately, the design of the study does not allow causal inferences to be 
made and thus the direction of the substance use -  aggression -  shame link cannot be 
concluded. The relationship might be bi-directional in that substance use may 
contribute to aggression, which in turn may enhance shame, and vice versa. As the 
wider literature suggests, individuals may become trapped in a shame-rage spiral as 
externalising behaviours, such as substance use, are used to defend against 
unacknowledged shame with the externalising behaviours further perpetuating
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experiences of shame and ‘humiliated fury’ (Lewis, 1971; Lewis, 1992; Scheff & 
Retzinger, 1991). The support of a substance use -  aggression -  shame association in 
the current study is important and contributes to a greater understanding of how to 
work clinically with a substance use population.
In relation to the other two mediators, the hypotheses were not supported. This 
could be due to self-ambivalence and self-esteem not varying between the two 
groups when adjusting for demographic covariates, as this was the only Baron & 
Kenny (1986) criterion for mediation not met. The non-significant effects of group 
on these variables are inconsistent with past research that relates substance use to 
se lf discrepancies and ambivalence (Downey et al., 2000; Najavits, 2002) and to 
self-esteem (Griffin-Shelley et al., 1990; Leary et al., 1995; Walitzer & Sher, 1996). 
The non-significant group effects could be due to the group composition factors 
discussed earlier or other limitations of the current study that will be considered in a 
later section. Nonetheless, the findings do suggest that both self-ambivalence and 
self-esteem are important in understanding character-based shame in general.
With regard to self-ambivalence, the current study found that the shame that 
someone may experience about one’s character could partly be explained by him/her 
holding conflicting views of one’s self. This novel finding suggests that self­
ambivalence is an important cognitive-affective factor to consider in explaining 
dysfunctional perceptions of self that are associated with shame. This is in line with 
developmental and attachment theories underpinning both shame and self­
ambivalence (Mills, 2005). Specifically, it has been proposed that people with a 
preoccupied-ambivalent attachment style go on to internalise this as an ambivalent 
sense of self (Guidano & Liotti, 1983). Correspondingly, people with a preoccupied- 
ambivalent attachment style are prone to experiencing shame (Gross & Hansen,
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2000; Lopez et al., 1997). A fragmented view of self may thus increase vulnerability
to shame, and vice versa.
In this study, self-esteem is also found to be important in explaining character 
shame, whereby lower self-esteem is associated with higher levels of shame about 
one’s character across both groups. This is in line with previous empirical work 
linking shame and self-esteem (Cook, 1989 in Rybak & Brown, 1996; Tangney & 
Bearing, 2002; Woien et al., 2003). The association between shame about one’s 
character and self-esteem could be understood in that both involve negative 
evaluations about one’s sense of self and one’s relational value (Andrews et al.,
2002; Leary & Baumeister, 2000; Orth et al., 2006).
Hypothesis five.
Finally, it was hypothesised that higher levels of overall shame would be 
related to lower willingness to disclose (and higher willingness to conceal) 
psychological distress, particularly in the substance misuse group. The present study 
found a significant inverse association between shame and willingness to disclose 
distress, although this finding did not vary between the groups. This is in line with 
Andersen (2002). The association between shame and disclosure is also consistent 
with previous empirical work that found shame to be related to lower self-disclosure 
(Farber, 2003; Hill et al., 1993; Hook & Andrews, 2005; Kelly, 1998). People who 
feel shame are motivated to use secrecy, to hide and conceal aspects of their self 
(Tangney & Tracy, 2012). This shame avoidance is due to the anticipation of 
negative responses, judgment and labeling by others (MacDonald & Morley, 2001; 
Swan & Andrews, 2003). The implications of this finding are considered below.
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Theoretical and Clinical Implications
The above findings provide us with various implications for clinical practice, 
service delivery and further research. I will first discuss the implications of the 
current findings specifically relating to shame and substance use, followed by a 
discussion of how the findings contribute to the broader shame literature.
Illicit substance use has great costs for individuals, families and communities 
and the current findings can contribute to the understanding of factors implicated in 
substance use. On a clinical level, the finding that all sources of shame are relevant 
for substance users, and shame relating to one’s character significantly so, can 
inform practice at various stages, including engagement, assessment, formulation and 
intervention. Individuals who experience shame are likely to worry about what others 
think of them, fearing that they will be negatively evaluated if they are seen for who 
they really are. Black and colleagues (2013) found that shame impedes engagement 
and alliance building in therapeutic work. Engaging clients within substance use 
settings may thus need to be done thoughtfully. To facilitate a therapeutic alliance 
with potentially shame-prone individuals, psychologists can be mindful of their 
verbal and non-verbal communication styles, proceeding at the client’s pace, being 
collaborative to avoid clients feeling subordinated, and using supervision to address 
their own potential stigma around substance use so as not to transfer this to clients 
(Andersen, 2002; Gilbert, 1998; Nielsen, 1987). The current findings suggest that 
taking a compassionate professional stance may be particularly pertinent when 
engaging and working with substance users who experience shame and exhibit 
aggression, particularly as previous studies show the shame -  aggression link to be 
triggered when individuals feel provoked or threatened in interpersonal and social 
contexts (Aslund et al., 2009; Heaven et al., 2009; Hejdenberg & Andrews, 2011).
Once a therapeutic relationship begins to develop, issues of shame can be more 
safely addressed. To address shame appropriately, however, one must first be able to 
identify it as a relevant theme. Assessing and acknowledging shame can be 
particularly difficult for clients and professionals as it often overlaps with other 
emotions, such as guilt, embarrassment and sadness (Lewis, 1971; Lewis 1992). The 
current findings suggest that considering demographic factors such as gender and 
level of education may be helpful to consider when assessing shame. Notably, the 
association found between shame, aggression and substance use suggests that 
clinicians should be especially vigilant about identifying possible unacknowledged 
shame in people with drug dependence who present with behavioural difficulties 
(such as anger, hostility, physical and verbal aggression).
Where relevant, the substance use -  aggression -  character shame link could 
also aid the idiosyncratic formulation of a person’s substance use difficulties. A 
richer appreciation of an individual’s difficulties could be developed by exploring 
the view one holds of themselves and the meaning of shame experiences, to assess 
whether these could be predisposing, precipitating or perpetuating factors for 
substance use. Formulations that include an understanding of shame issues can be 
shared with clients to enhance collaboration and, importantly, to normalise their 
experiences. For example, clinicians could discuss the possible function of 
aggression, substance use and other externalising behaviours in protecting one’s self 
from feelings of shame, while acknowledging the potential long-term consequences 
of these strategies in maintaining difficulties.
The current findings also suggest possible areas for intervention work. The 
finding that substance users felt the most shame in relation to using drugs suggests 
that this source of shame could be a valuable initial focus of therapy. Addressing
specific drug-related shame experiences may also help to challenge other associated 
sources of shame and shift one’s negative, internal and global self-attributions (van 
Vliet, 2009). In recent years, studies have reported benefits in incorporating shame- 
focused techniques to existing psychological models and evidence-based 
interventions for the treatment of drug and alcohol. Shame-based interventions 
investigated within substance using populations include Cognitive Behaviour 
Therapies using acceptance and mindfulness-based techniques (Luoma et al., 2012; 
Witkiewitz et al., 2013) and self-forgiveness interventions (McGaffin et al., 2013; 
Philip et al., 2010; Scherer, Worthington, Hook & Campana, 2011). Bowen and 
colleagues (2006) found reductions in substance use following a mindfulness 
meditation treatment in an incarcerated population. Milliken (2008) also described 
using a dance movement therapy group in a prison addictions program to address 
issues of substance use, violence and shame.
The relevance of shame for individuals with substance use difficulties also has 
implications on a wider institutional and social level. Past studies have found that 
social stigma, treatment models (e.g. that focus on diagnosis, labeling and coercive 
strategies) and service settings may all impact and contribute to the level of shame 
experienced by substance users (Gray, 2009; Luoma et al., 2007; Norris, 2011). 
Unfortunately, individuals with substance misuse and aggression may be particularly 
likely to be inadvertently treated by services and institutions, such as the criminal 
justice system and methadone dispending services, in ways that could be experienced 
as punitive, stigmatising and shaming (Antice, Strike & Brands, 2009; Drew, Bitar, 
Gee, Graff & Springer, 2007). The current findings suggest that service models and 
design should be considered to ensure that a non-shaming environment is promoted 
at all levels. Additionally, clients are likely to be seen by a number of professionals
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and their relationships with others, such as keyworkers, are crucial. Training 
programmes could thus include an awareness of the interpersonal nature of shame 
and its links with substance use and aggression.
Social stigma against substance users further contributes to feelings of shame 
(Luoma, 2001; van Boekel et al., 2013). To some extent, criminalising and 
stigmatising drugs use can deter some people from engaging in it. For instance, 
according to Barrett’s (1995) Functionalist model, shame can serve the adaptive 
function of regulating antisocial behaviour as people aim to preserve their social 
standing. For individuals who are already experiencing marginalisation and 
addiction, however, negative societal attitudes may in fact feed into their negative 
view of themselves and further perpetuate the substance use -  shame cycle. These 
wider systemic issues highlight the complexity of understanding and addressing 
issues of shame (and aggression) in the context of substance use.
This study also adds to the broader shame literature. The current findings 
indicate that feelings of shame about one’s character may be related to ambivalence 
about one’s sense of self-worth, moral acceptance, and self-esteem. This adds to the 
theoretical literature and current understandings of what cognitive-affective factors 
are related to shame. Additionally, they suggest the importance of considering a 
developmental view of shame. These self-related concepts can be used to assess 
resistance to change, aid formulation around shame and suggest addressable focus 
points for therapeutic work. Moreover, the current findings indicate that shame is 
related to gender, levels of education, and could be a relevant emotion to assess for 
in people with substance use and mental health difficulties.
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Current findings additionally support the inverse relationship between shame 
and willingness to disclose distress. This finding is clinically important as disclosure 
of psychological distress is an important element of therapy affecting help seeking 
(Kahn & Hessling, 2001; Kahn, Lamb, Champion, Eberle & Schoen, 2002; Ward, 
Doherty & Moran, 2007), symptomatology outcomes (Hook & Andrews, 2005;
Kahn, Achter & Shambaugh, 2001; Kahn et ah, 2002) and overall psychological well 
being (Kahn & Hessling, 2001; Ward et ah, 2007). It is thus important for shame 
feelings to be addressed and that people are encouraged to talk about fears and 
concerns around disclosure in therapeutic contexts.
Strengths and Limitations
The above implications should be considered within the context of the study’s 
strengths and limitations as these affect the applicability and generalisability of the 
current findings. Issues relating to the design, sample and measurements used in the 
current study are discussed next.
Design.
The use of a correlational design in the current study limits the conclusions that 
can be drawn and impedes any inferences regarding causal pathways connecting the 
psychological constructs examined. It cannot be determined from this study alone 
whether character-based shame is a cause, concomitant or a consequence of 
substance use, or whether they are both related to other variables that were not 
included in this study. Similarly, regarding the mediation analysis, it cannot be 
determined whether aggressive behaviours are a result of substance use that lead to 
shame about one’s self, or whether aggression is a consequence of and a defense 
against shame and a concomitant of substance use, and so on.
201
Sample.
A difficulty inherent in this research area involves identifying an appropriate 
comparison group for the substance use population. As seen, the choice of 
comparison group is important and can affect differences found between the groups, 
and thus any meaning or inferences that can be drawn. A balance needs to be struck 
between finding a comparison group that is not too different to the SU group (e.g. on 
demographic variables) so that differences between groups might be expected for 
reasons other than substance misuse difficulties, or too similar (e.g. on presenting 
conditions) so that differences between groups are minimised. Various alternatives 
were considered when choosing a comparison group in the current study and 
previous empirical studies were consulted. Initially it was planned that unemployed 
individuals would be recruited, as they were considered to be broadly similar in 
socioeconomic status and basic demographic factors to the SU group. I hoped to 
access this population through Job Centres in a geographically similar location to the 
drug services. Due to recruitment difficulties, I was unable to pursue this. An 
alternative comparison group considered was members of the public with mild levels 
of mental health difficulties (excluding a diagnosis of Major Depressive Disorder) as 
it was thought that this population could reasonably match the SU group on co- 
morbid mental health factors. Primary care mental health services and voluntary 
sector services (in similar geographic regions to the drug and alcohol services) were 
approached in this regard. Again due to unexpected recruitment difficulties and time 
constraints, a sufficient number of comparison group participants could not be 
recruited in this way. As a feasible alternative strategy, participants for the 
comparison group were recruited online through mental health charities (as detailed
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in the recruitment procedure in the Methodology section). This choice was not ideal 
and inadvertently may have impacted some of the findings in the current study.
Moreover, the differences found in the demographic composition of the groups 
(e.g. the comparison group being younger, more educated, employed and consisting 
of more females) could partly be explained by the differences in recruitment methods 
(i.e. online versus face-to-face). Due to the differences in recruitment methods it is 
also unknown whether the online sample may have different characteristics to the SU 
group beyond those measured or adjusted for. For example, the motivation to take 
part in the study may differ. While SU participants were approached in person, the 
online group actively self-selected participation after viewing postings of the study 
online. However, as both groups gave informed and voluntary consent to take part in 
the study, motivation possibly may not have been an important factor. Additional 
considerations when recruiting online are whether the ads reached the target group, 
the veracity of results and geographical differences.
A particular strength of the current study was being able to recruit a relatively 
high number of SU group participants, as this is often difficult to do in the substance 
use research field. This required a considerable amount of time and effort in 
negotiating access to services and participants. The overall sample size, however, 
may have limited the statistical power and findings of the study. For example, the 
probability associated with group differences in overall shame (after adjusting for 
demographic covariates) was p= .11. Similarly, the probability associated with group 
differences (adjusting for demographic covariates) in self-ambivalence was/?= .10, 
and in self-esteem was .16. It could be that these statistically non-significant 
results reflect a lack of statistical power to detect the effects, rather than a lack of a 
real effect. This is supported by examining the adjusted and unadjusted means of the
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SU group on the shame, self-ambivalence and self-esteem variables as these were 
consistently in the direction expected, suggesting that there could be something 
different about being in the SU group but that the sample size was possibly too small 
to detect this.
Additionally, although the two groups in the study were homogenous in terms 
of ethnic background, a limitation could be that both groups were predominantly 
from White British or Irish ethnic backgrounds. This limits the representativeness of 
the sample and the applicability of current findings for people from other ethnic 
backgrounds. One’s ethnic background may be relevant in the area of shame as 
shame is bound to social-moral practices and standards that vary between cultures. 
Variations have even been reported within sub-cultures. For example, Farmer and 
Andrews (2009) found that while shame was related to anger in undergraduate 
students this was not the case in youth offenders. They explained this finding by 
suggesting that for the offending subculture anger was considered an adaptive tool 
that protected their social status and self-esteem, and thus did not lead to shame. 
Consequently, caution needs to be drawn when generalising the results of the current 
study across different cultures and ethnicities.
A further consideration regarding the sample was that people with a diagnosis 
of Major Depressive Disorder were excluded to limit confounding variables. As 
people with drug dependence have high rates of co-morbid mood disorders, the 
current findings may only be applicable to a subsample of the substance misuse 
population (i.e. those without co-morbid MDD). The current sample may actually 
exhibit lower levels of shame than would be expected for people with co-morbid 
difficulties. Additionally, as shame is related to avoidance and non-disclosure, it
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could be that participants who agreed to take part in the study may have been 
experiencing lower levels of shame than those who declined to take part.
Measurement.
Another limitation of the study was that the depression questionnaires used 
were not consistent between the groups. Due to unexpected difficulties in recruiting 
the comparison group and copyright issues restricting the use of the BDI-II online, an 
alternative measure had to be used with the comparison group. As a result, levels of 
depression could not be directly compared between the groups and so the possible 
effects of level of depression on findings could not be adequately assessed. In her 
study, Andersen (2002) controlled for levels of depression when comparing the 
groups due to the possible confounding effects of depression on shame. However, the 
current study did not find this appropriate, as there is great overlap between the 
indicators of depression and drug dependence as well as depression and shame. This 
issue is particularly relevant for depression measures such as the BDI-II that include 
several items regarding the physical health symptoms of depression (e.g. changes in 
sleeping, eating, irritability, concentration and interest in sex) because these physical 
symptoms can overlap with those of drug dependence and withdrawal. This suggests 
that substance use participants could score highly on the BDI-II independent of 
depression (Buckley et al., 2001). Thus controlling for depression could have 
adjusted away some of the real effects of substance use on shame.
Overall, selecting a different measure of depression that places less emphasis 
on physical symptoms (or that has population-specific norms and cut-offs for 
substance using populations) and that could have been used consistently across both 
groups would have strengthen the current study and enabled a more rigorous
205
examination of the possible confounding effects of depression. The current study 
was, however, able to somewhat limit the effects of depression on results by 
excluding people with a diagnosis of MDD and using the ESS as a measure of shame 
as it is less sensitive to mood effects (Andrews et ah, 2002).
A final consideration is that the study used self-report measures, which rely 
upon participants’ awareness and willingness to answer questions regarding their 
feelings accurately. Due to the implicit and painful nature of shame, people may 
often be unaware of it or may want to conceal its presence (Tangney & Tracy, 2012). 
This raises difficulties for studies wishing to accurately measure shame using self- 
report methods (Randles & Tracy, 2013; Scheff, 1998). Despite the avoidance 
aspects of shame, however, MacDonald (1998) reports that people are willing to 
discuss shame in research contexts. Additionally, a strength of the current study is 
that a high internal consistency was found within all ESS subscales, in line with 
Andrews and colleagues (2002), and in all other measures used.
Future Studies
Drawing on the findings and limitations of the current study, some suggestions 
can be made for future empirical work. Following the robust finding that shame 
related to one’s character is associated with substance use, longitudinal research 
would be useful in ascertaining the causal direction of this relationship. This could 
greatly expand our understanding of the role of shame in the development, 
maintenance and recovery from substance use, and vice versa. Additionally, the role 
of aggression in mediating this relationship needs to be understood further. It could 
also be important clinically for further research to be conducted on shame-based 
interventions for individuals with substance misuse difficulties who also present with
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aggression. Studies, for example, could investigate the effectiveness of 
Compassionate Mind Training (Gilbert & Proctor, 2006) in this population. The use 
of mixed-methods designs would be helpful in these studies to identify mechanisms 
for change pre and post treatment and to increase our understanding of the role of 
shame in the process of recovery from addiction.
In addition, the investigation of other possible mediators of the relationship 
between shame and substance use could further elucidate the mechanisms underlying 
this complex relationship. Of particular interest are constructs that might influence 
the dysfunctional perceptions of one’s character and contribute to both substance use 
and shame proneness. Following on from the findings of the current study, it may be 
useful for future studies to explore further the role of self-ambivalence, other 
attachment related constructs and trauma as mediators using larger sample sizes and 
different comparison groups. Other interesting directions for empirical research to 
examine are whether variables such as type of drug, duration of drug use and 
treatment stage or length moderate the substance use -  shame relationship.
Moreover, studies using a more diverse population would be valuable in 
providing information on how shame and substance use is experienced and perceived 
across different ethnicities. Mixed-method designs may be useful so as to include 
qualitative information of the different meanings attached to experiences that may be 
conceptualised as shaming in different cultures. The effects of other demographic 
differences, such as gender and education, in shame could also be investigated 
further in future work.
Finally, this study focused primarily on the dysfunctional effects of 
maladaptive shame. Shame, however, is considered to also have positive adaptive 
functions (Bennett, 2005). For example, shame has been positively linked to
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treatment motivation (Rosenkranz, Henderson, Muller & Goodman, 2012). 
Additionally, substance users have described the stigma and shame associated with 
certain drugs, such as crack cocaine, as motives for avoiding them (Furst, Johnson, 
Dunlap & Curtis, 1999). Thus, it could be interesting for future studies to further 
consider the protective properties of shame.
Conclusion
The current study aimed to contribute to current understandings of shame and 
relate these to individuals with substance use difficulties. The findings support an 
association between shame about one’s character and aggression within a substance 
use population. The current study provided recommendations of how the results can 
be applied when working clinically with this population. Additionally, although not 
all hypotheses were supported, findings provide evidence that self-related constructs 
are useful in understanding shame about one’s character. This suggests that 
addressing an individual’s fragmented self-states and negative self-evaluations might 
be important focus points when working through feelings of shame. Finally, 
considering the current study’s limitations, interesting avenues for future research 
have been suggested.
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Appendix A: Univeristy and NHS Ethics, and R&D approval letters
Dear Miss Trigeorgis
Study title: Investigating the relationships between shame,
disclosure and self-ambivalence in clients with drug- 
dependence.
REG reference: 12/LO/0699
The Research Ethics Committee reviewed the above application at the meeting held on 14 
May 2012. Thank you for attending to discuss the study.
Ethical opinion
When you joined the meeting, the Committee asked you to explain the IAPT (Improving 
Access to Psycho Therapies) system and you rational behind using this system to recruit 
the control group. You explained that this was a primary care service used for assessing 
patients of low to moderate depression and was chosen for control recruitment because it 
would allow a  similar demographic to the drug-users profile and therefore would allow for 
more comparable results. The Committee asked why alcohol-dependence had not been 
considered “substance abuse” and you assured the Committee that it had been accounted 
for and that any serious alcohol mis-users would be identified in screening or during their 
regular assessm ents and would not be included in the study.
The Committee then asked you to explain the rationale behind the TOPF-UK word list. You 
described it as a  “pre-morbid functioning IQ test” to give an estimate of a  person's cognitive 
level and was being used in this study as a  control test between the groups to assess any 
additional variables between the groups. The Committee was concerned that the test was 
perhaps narrow; using words typically recognizable by particular social groups or levels of 
education and therefore inappropriate, but you assured the Committee that this was a  UK 
validated test that is adapted from a  previous WTARUK scale, and was the best test 
available.
The Committee then asked you whether there could be an alternative member of the clinical 
team that could approach the patients with the introduction of the study. You kindly agreed 
to try and enlist another member of the care team who would introduce the study and give 
the information sheet and then review whether they wanted to take part the following week 
when they return for their weekly assessment. The Committee then asked you to confirm 
that none of the participants would be patients of the service whom you've already been in 
contact with, and you did.
The Committee then asked you if you were planning on informing the GP's but you 
explained that you didn’t feel it was necessary as the participation of the study would be 
input into the patient's service notes.
The m em bers of the Committee present gave a  favourable ethical opinion of the above 
research  on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below.
Conditions of the favourable opinion
The favourable opinion is subject to the following conditions being met prior to the start of 
the study.
1. The Patient information sh ee t is am ended in the following ways;
- Under the heading “W hat are the benefits of taking part in this research”, the first two
sen ten ces “While you may not s e e  Your input to this research is therefore vital.” must
be removed a s  the Committee felt this w as a  coercive use  of emotive language.
- Under the heading “Are there any downsides of taking part?” the sentence “I am not 
being intrusive by asking these  questions a s  they are needed for my research” m ust be 
removed a s  the Committee felt this w as applying unnecessary  pressure.
- Under the heading “What if there is a  problem” the paragraph which sta tes “The normal 
National Health Service complaints m echanism ...”, the Committee felt these  m echanism s 
should be outlined more explicitly for the patients information.
2. The Advert should be am ended in the following ways;
- The sen tences “Improved treatm ent options and services” and “Have your voice heard” 
m ust be removed a s  the Committee agreed these  were overly suggestive incentives to take 
part.
3. You must ensure that an alternative m em ber of the clinical team  will initially approach 
the participants with the Patient information sheet.
4. The Committee also advised that the description of controls is expanded upon.
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable).
You should notify the REC in writing once all conditions have been met (except for 
site approvals from host organisations) and provide copies of any revised 
documentation with updated version numbers. Confirmation should also be provided 
to host organisations together with relevant documentation
M anagem ent permission or approval must be obtained from each host organisation prior to 
the start of the study at the site concerned.
Management permission (“R&D approval”) should be sought from all NHS organisations 
involved in the study in accordance with NHS research governance arrangements.
Ethical review of research sites
NHS Sites
The favourable opinion applies to all NHS sites taking part in the study, subject to 
m anagem ent permission being obtained from the NHS/HSC R&D office prior to the start of 
the study (see “Conditions of the favourable opinion” below).
Guidance on applying for NHS permission for research  is available in the Integrated 
R esearch Application System  or at httoV/www.rdforum.nhs.uk.
The a ttached  docum ent “After ethical review -  guidance for re sea rch ers” gives detailed 
guidance on reporting requirem ents for stud ies with a  favourable opinion, including:
• Notifying substantial am endm ents
• Adding new sites and investigators
• Notification of serious b reach es of the protocol
• P rogress and safety  reports
• Notifying the end of the  study
The NRES w ebsite also provides guidance on th ese  topics, which is updated in the  light of 
ch an g es in reporting requirem ents or procedures.
You are  invited to give your view of the service that you have received from the National 
R esearch  Ethics Service and the  application procedure. If you wish to m ake your views 
known p lease  u se  the  feedback form available on the website.
Further information is available a t National R esearch  Ethics Service w ebsite > After Review
Feedback
12/LO/0699 Please quote this number on all correspondence
With the  Com m ittee’s  best w ishes for the su c c ess  of this project
Yours sincerely
Dr Shelley Dolan 
Chair
Email: lara.callaghan@ im perial.nhs.uk
Enclosures: List of names and professions o f members who were present at the 
meeting and those who submitted written comments 
“After ethical review  -  guidance for researchers” [SL-AR2]
Copy to: Mr Glenn Moulton
Ms Angela Williams, Camden And Islington NHS Foundation Trust
Dear Christina,
I am pleased to confirm that the following study has now received R&D approval, and you 
may now start your research in the trust(s) identified below:
Study Title: Investigating the relationship between sham e and substance misuse
R&D reference: 12MHS07 
REC reference: 12/LO/0699
Camden and Islington NHS Foundation Trust - -  ~~  ■ ■ : :
If  any information on this document is altered after the date of issue, this document will be deemed INVALID
Please ensure that all members of the research team are aware of their responsibilities as 
researchers which are stated in page 2. For more details on these responsibilities, please 
check the R&D handbook or NoCLoR website: http://www.noclor.nhs.uk
We would like to wish you every success with your project.
Yours sincerely,
Mabel Sail!
Senior Research Governance Officer
R&D approval 05/07/2012 REC reference 12/10/0699, R&D reference 12MHS07 Page 1 of 2
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Dr Adrian Coyle
Chair: Faculty of Arts and Human Sciences Ethics 
Committee
Faculty of 
Arts and Human Sciences 
University of Surrey
Guildford, Surrey GU2 7XH UK
T: +44 (0)1483 689445 
F: +44 (0)1483 689550
www.surrey.ac.uk
Christina Trigeorgis 
Trainee Clinical Psychologist 
School of Psychology 
University of Surrey
21st June 2012 
Dear Christina
Reference: 778-PSY-12 (FEO/NRES with conditions)
Title of Project: Investigating the relationships between shame, disclosure and self- 
ambivalence in clients with drug-dependence
Thank you for your submission of the above proposal.
The Faculty of Arts and Human Sciences Ethics Committee has now given a favourable 
ethical opinion.
If there are any significant changes to your proposal which require further scrutiny, please 
contact the Faculty Ethics Committee before proceeding with your Project.
Yours sincerely
Dr Adrian Coyle 
Chair
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Appendix B: Information Sheet and Consent Form
Participant Information Sheet SURREY
UNIVERSITY OF
What is the role of shame in drug use?
Introduction
My name is Christina Trigeorgis and I am a Trainee Clinical Psychologist based in 
the Psychology Department at the University of Surrey, Guildford. As part of my 
training to become a Clinical Psychologist, I have to conduct research with members 
of the public.
To help you decide if you would like to take part, please read this Information Sheet 
so that you know what you will be asked to do. I will go through this Information 
Sheet with you to answer any questions you have. This should take about 5-10 
minutes.
What is the study about?
I am interested in exploring feelings of shame in people who use drugs and I would 
be grateful if you would help me with this by taking part in my study. It is thought 
that shame plays a role in drug use but this has been an under-researched area and 
little is known about it.
Do I have to take part?
No, taking part in this study is entirely up to you. To help you decide whether or not 
to take part, you can talk it over with friends, family, colleagues, health professionals, 
etc. You can also contact me for further information and I will be happy to answer 
any queries or concerns. My contact details are at the end.
What will I have to do?
I will ask you to fill in some questionnaires about your mood and feelings, and to 
answer some questions about your current or past drug use. Completing these 
questionnaires should take approximately 20-30 minutes and you will only have to 
do them once. You can do this in a private room.
How do I agree to take part?
If you agree to take part, you will be asked to sign a consent form but you can still 
choose not to answer all of the questions. You can also withdraw from the research 
at any time without giving a reason. Whether you decide to take part in this research 
or not, your decision will have no effect on your standard of care or treatment in any 
way. The consent forms will be kept securely in your file at the service.
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Does what I sav get shared with anyone else?
What you answer will remain strictly confidential and will only be seen by myself. 
Your name and all personal details about you will be kept anonymous in the study. 
This includes any information about where you live, your real name, your age, 
gender, ethnicity, religion, etc. — or any other information that would identify you 
personally. The questionnaires will be coded and your name will not appear on any 
of the forms.
All information gathered during this research study will be anonymised and stored 
securely in accordance with the Data Protection Act 1998 and will be destroyed after 
five years.
However, if during our meeting should you disclose that you or someone else is at 
risk of harm then I may need to report this to someone else. If this should become 
necessary I will, however, usually discuss this with you before doing so.
What happens when the research study is completed?
The results of this research will be written up as part of a thesis due by September 
2013. Researchers usually like to have their research findings published in relevant 
academic journals so that others working in the same field can learn more. 
Sometimes we present our research findings at meetings or conferences. Again, all 
your personal details will be kept confidential at all times and you will not be 
identified in any report or publication.
I can send you a copy of the final research findings if you would like, plus copies of 
any articles in which the research is published. You can visit the University of Surrey 
library as a day visitor if you’d like to read any of the journals.
What are the benefits of taking part in this research?
We hope that the findings from this research will help to improve services offered by 
the NHS, and by the private and voluntary sectors, to benefit people with substance 
misuse problems in the future.
The research also provides an opportunity for you to think about and reflect on your 
experiences and feelings in relation to drug use. After participating in the study you 
will be able to enter a prize draw to win a voucher worth 5 GBP.
Are there any downsides of taking part?
You may find some of the questions quite personal. Many people find talking about 
their experiences helpful but others may find it brings up upsetting feelings or 
memories. If you find a question too personal or upsetting in any way, you don’t 
have to answer it. If this happens and you would like some support, then I can spend 
some time with you afterwards or you can contact your key worker. I will also 
provide you with a list of local services that you can contact for further support or in 
case of an emergency.
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What if there is a problem?
If you have any concerns about any aspect of the way you have been treated during 
the course of the research study, then you can contact my supervisor. His name and 
contact details are provided at the end of the sheet.
In the event that something does go wrong and you are harmed during the research 
and this is due to someone's negligence, then you may have grounds for a legal 
action for compensation against the University of Surrey but you may have to pay 
your legal costs. The normal National Health Service complaints mechanisms will 
still be available to you (if appropriate). More information can be found on:
http://www.nhs.uk/choiceintheNHS/Rightsandpledges/complaints/Pages/NHScompla
ints.aspx
Who is organising and funding the research?
This research is organised and funded by the University of Surrey.
Has the research been approved bv any committee?
All research in the NHS is looked at by an independent group of people called a 
Research Ethics Committee, to protect your interests. This study has been reviewed 
and given a favourably opinion by the London-Chelsea NHS Research Ethics 
Committee (Ref: 12/LO/0699). The study has also been approved by the Faculty of 
Arts & Human Sciences Ethics Committee at the University of Surrey.
I hope I have answered all of your questions about the research study, but please feel 
to ask me anything else that I have not covered. My contact details and those of my 
supervisor are below.
Thank you very much for taking the time to read this Information Sheet!
Research being conducted by:
Christina Trigeorgis 
Trainee Clinical Psychologist
Supervised bv:
Dr Paul Davis
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Consent Form (Confidential)
Title of project: What is the role of shame in drug use?
Name of Researcher: Christina Trigeorgis
• I have read and understood the Information Sheet. I have been given information by 
the researcher about what the project is about, where and why it is being done, and 
how long it is likely to take.
• I understand that my decision to take part in this project is entirely voluntary. I 
understand that I am free to withdraw at any time and this will have no effect on any 
care that I may be receiving.
• I have been given the opportunity to ask the researcher questions about the research 
and have understood the answers to the questions I have asked.
• I understand that all personal data are held and processed in the strictest confidence, 
and in accordance with the Data Protection Act (1998).
• I understand that sections of my case notes may be looked at by the researcher where 
it is relevant to my taking part in this study. I give permission for this individual to 
access my records.
• I have read and understood everything written above and have chosen to consent to 
participating in this study. I have been given enough time to think about this and 
agree to comply with the instructions and restrictions of the project.
» I agree to complete questionnaires for the above research project.
Name of participant:
Signed:
Date:
Name of researcher/person taking consent: 
Signed:
Date:
Participant Number:
#  UNIVERSITY OFmSURREY
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Appendix C: Questionnaire Measures
Cl: Demographic Questionnaire
1. What is your age?
2. What is your gender?
1. Male 2. Female
3. What is your ethnicity?
A White
1. British
2. Irish
3. Any other White background
D Black or Black British
10. Caribbean
11. African
12. Any other Black background
B Mixed
4. White and Black Caribbean
5. White and Black African
6. White and Asian
7. Any other Mixed background
C Other ethnic group
8. Chinese
9. Arab
E Asian or Asian British
13. Indian
14. Pakistani
15. Bangladeshi
16. Any other Asian background
F Any other ethnic group, please 
specify:___________________
4. Education
1. Number of years in education:________
2. Age when left school:_________
3. Qualifications (circle): O-levels, A-levels, Higher education:
4. Later qualifications or training:_______
5. Occupation:______
5. Have you seen anyone in the past 2 years about a mental health problem (e.g. 
psychologist or psychiatrist)?
1. Yes 2. No
6. Have you taken any medication for a mental health problem in the past 2 years?
1. Yes 2. No
7. Are you currently receiving treatment or have a diagnosis of Major Depressive 
Disorder?
1. Yes 2. No
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C2: Drug Abuse Screening Test-10 item (DAST-10; Skinner, 1982)
Instructions: The following questions concern information about your possible 
involvement with drugs not including alcoholic beverages during the past 12 months. 
Carefully read each statement and decide if your answer is “Yes or No . Then, 
circle the appropriate response beside the question.
In the statements “drug abuse” refers to (1) the use of prescribed or over the counter 
drugs may include: cannabis (e.g. marijuana, hash), solvents, tranquillizers (e.g. 
Valium), barbiturates, cocaine, stimulants (e.g. speed), hallucinogens (e.g. LSD) or 
narcotics (e.g. heroin). Remember that the questions do not include alcoholic
beverages.
These Questions refer to the past 12 months. Circle Your 
Response
1. Have you used drugs other than those required for medical 
reasons?
Yes No
2. Do you abuse more than one drug at a time? Yes No
3. Are you always able to stop using drugs when you want to? Yes No
4. Have you had “blackouts” or “flashbacks” as a result of 
drug use?
Yes No
5. Do you ever feel bad or guilty about your drug use? Yes No
6. Does your spouse (or parents) ever complain about your 
involvement with drugs?
Yes No
7. Have you neglected your family because of your use of 
drugs?
Yes No
8. Have you engaged in illegal activities in order to obtain 
drugs?
Yes No
9. Have you ever experienced withdrawal symptoms (felt sick) 
when you stopped taking drugs?
Yes No
10. Have you had medical problems as a result of your drug use 
(e.g. memory loss, hepatitis, convulsions, bleeding, etc.)?
Yes No
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C3: Patient Health Questionnaire-9 (PHQ-9: Spitzer, Kroenke & Williams, 1999)
Instructions: Over the last 2 weeks, how often have you been bothered by any of 
the following problems? Read each item carefully, and circle your response.
Not
at
all
Several
days
More than 
half the 
days
Nearly
every
day
0 1 2 3
1. Little interest or pleasure in doing things
2. Feeling down, depressed, or hopeless
3. Trouble falling asleep, staying asleep, or 
sleeping too much
4. Feeling tired or having little energy
5. Poor appetite or overeating
6. Feeling bad about yourself, feeling that you 
are a failure, or feeling that you have let 
yourself or your family down
7. Trouble concentrating on things such as 
reading the newspaper or watching 
television
8. Moving or speaking so slowly that other 
people could have noticed. Or being so 
fidgety or restless that you have been 
moving around a lot more than usual
9. Thinking that you would be better off dead 
or that you want to hurt yourself in some 
way
Totals
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C4: Experiences of Shame Scale (ESS; Andrews et al., 2002)
Instructions: These questions are about your feelings and if they have occurred at 
any time in the past year. There are no ‘right’ or ‘wrong’ answers. Please indicate 
the response that applies to you with a circle.
Not A Moderately Very
at all little much
1. Have you felt ashamed of any of your personal 1 2  3 4
habits?
2. Have you worried about what other people 1 2  3 4
think of any of your personal habits?
3. Have you tried to cover up or conceal any of 1 2 3 4
your personal habits?
4. Have you felt ashamed of your manner with 1 2  3 4
others?
5. Have you worried about what other people 1 2  3 4
think of your manner with others?
6. Have you avoided people because of your 1 2  3 4
manner?
7. Have you felt ashamed of the sort of person 1 2  3 4
you are?
8. Have you worried about what other people 1 2  3 4
think of the sort of person you are?
9. Have you tried to conceal from others the sort 1 2  3 4
of person you are?
10. Have you felt ashamed of your ability to do 1 2  3 4
things?
11. Have you worried about what other people 1 2  3 4
think of your ability to do things?
12. Have you avoided people because of your 1 2  3 4
inability to do things?
13. Do you feel ashamed when you do something 1 2  3 4
wrong?
14. Have you worried about what other people 1 2  3 4
think when you do something wrong?
15. Have y o u  tried to cover up or conceal things 1 2  3 4
you felt ashamed of having done?
16. Have you felt ashamed when you said 
something stupid?
17. Have you worried about what other people 
think of you when you said something stupid?
18. Have you avoided contact with anyone who 
knew you said something stupid?
19. Have you felt ashamed when you failed in a 
competitive situation?
20. Have you worried about what other people 
think of you when you failed in a competitive 
situation?
21. Have you avoided people who have seen you 
fail?
22. Have you felt ashamed of your body or any 
part of it?
23. Have you worried about what other people 
think of your appearance?
24. Have you avoided looking at yourself in the 
mirror?
25. Have you wanted to hide or conceal you body 
or any part of it?
Drug-related items
26. Have you felt ashamed of having a drug 
problem?
27. Have you worried about what other people 
think of you having a drug problem?
28. Other than for legal reasons, have you tried to 
cover up or conceal that you have a drug problem?
29. Have you felt ashamed of any of the things 
you have done in relation to taking drugs?
30. Have you worried about what other people 
think of any of the things you have done in relation 
to taking drugs?
31. Other than for legal reasons, have you tried to 
cover up or conceal any of the things you have done 
in relation to taking drugs?
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2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
2 3 4
1 2  3 4
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C5: Self-Ambivalence Measure (SAM; Bhar & Kyrios, 2007)
Instructions: Please rate the extent to which you agree with the following 
statements. Indicate your answer by circling the appropriate response on the scale 
beside each statement.
Not 
at all
1. I doubt whether others 0
really like me.
2. I am secure in my sense of 0
self-worth.
3. I feel tom between 0
different parts of my personality.
4. I fear I am capable of 0
doing something terrible.
5. I think about my worth as 0
a person.
6. I am constantly aware of 0
how others perceive me.
7. I feel I am lull of 0
contradictions.
8. I question the extent to 0
which others want to be close to
me.
9. I tend to think of myself in 0
terms of categories such as “good”
or “bad”.
10. I have mixed feelings 0
about my self-worth.
11. I question whether I am a 0
moral person.
12. I think about how I can 0
improve myself
13. If I inadvertently allow 0
harm to come to others, this proves
I am untrustworthy.
14. I tend to move from one 0
extreme to the other in how I think
Agree a Agree Agree Agree
little moderately a lot totally
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
about myself.
15. I am mindful about how I 0 
come across to others.
16. I am constantly concerned 0 
about whether I am a “decent”
human being.
17. I am constantly worried 0 
about whether I am a good or bad 
person.
18. I question whether I am 0 
morally a good or bad person.
19. I constantly worry about 0 
whether I will make anything of 
myself.
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1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
1 2 3 4
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C6: Rosenberg Self-Esteem Scale (RSES; Rosenberg, 1965)
Instructions: Below is a list of statements dealing with your general feelings about 
yourself. Please circle the box next to the statement that most closely represents 
your feelings.
1. On the whole, I am satisfied with 
myself.
2. At times, I think I am no good at all.
3. I feel that I have a number of good 
qualities.
4. I am able to do things as well as most 
other people.
5. I feel I do not have much to be proud of.
6. I certainly feel useless at times.
7. I feel that Fm a person of worth, at least 
on an equal plane with others.
8. I wish I could have more respect for 
myself.
9. All in all, I am inclined to feel that I am 
a failure.
10. I take a positive attitude toward myself.
Strongly Agree Disagree Strongly
Agree Disagree
0 1 2  3
0 1 2  3
0 1 2  3
0 1 2  3
0 1 2  3
0 1 2 3
0 1 2  3
0 1 2  3
0 1 2  3
0 1 2  3
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Cl: Distress Disclosure Index (DDI; Khan & Hessling, 2001)
Instructions: Please read the following statements and rate them from 1 (strongly 
disagree) to 5 (strongly agree) by circling the appropriate response.
Strongly Disagree Neutral Agree Strongly 
Disagree Agree
1. When I feel upset I usually 
confide in my friends.
2. I prefer not to talk about my 
problems.
3. When something unpleasant 
happens to me, I often look for 
someone to talk to.
4. I typically don’t discuss things 
that upset me.
5. When I feel depressed or sad, I 
tend to keep those feelings to 
myself.
6. I try to find people to talk with 
about my problems.
7. When I am in a bad mood, I talk 
about it to my friends.
8. If I have a bad day, the last 
thing I want to do is talk about 
it.
9. I rarely look for people to talk 
to when I am having problems.
10. When I am distressed I don’t 
tell anyone.
11. I usually seek out someone to 
talk to when I am in a bad 
mood.
12. I am willing to tell others my 
distressing thoughts.
244
C8: Buss-Perry Aggression Questionnaire (AQ; Buss & Perry, 1992)
Instructions: Using the 5-point scale shown below, indicate how uncharacteristic 
or characteristic each of the following statements is in describing you.
1 = extremely uncharacteristic of me
2 = somewhat uncharacteristic of me
3 = neither uncharacteristic nor characteristic of me
4 = somewhat characteristic of me
5 = extremely characteristic of me
1. Some of my friends think I am a hothead
2. When people annoy me, I may tell them what I think of them.
3. I know that “friends” talk about me behind my back
4. There are people who pushed me so far that we came to blows
5. When people are especially nice to me, I wonder what they want
6. Given enough provocation, I may hit another person
7. When frustrated, I let my irritation show
8. My friends say that I’m somewhat argumentative
9. I sometimes feel that people are laughing at me behind my back
10. I am sometimes eaten up with jealousy
11. I have threatened people I know
12. I can think of no good reason for ever hitting a person
13. At times I feel I have gotten a raw deal out of life
14. I sometimes feel like a powder keg ready to explode
15. I am an even-tempered person
16. I tell my friends openly when I disagree with them
17. Once in a while, I can’t control the urge to strike another person
18. I am suspicious of overly friendly strangers
19. Sometimes I fly off the handle for no good reason
20. I have become so mad that I have broken things
21. If somebody hits me, I hit back
22. Other people always seem to get the breaks
23. I have trouble controlling my temper
24. I often find myself disagreeing with people
25. I get into fights a little more than the average person
26. I wonder why sometimes I feel so bitter about things
27. I flare up quickly but get over it quickly
28. I can’t help getting into arguments when people disagree with me
29. If I have to resort to violence to protect my rights, I will
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Appendix E: Normality assumptions
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Residual for ESS Total
Figure E3. Histogram of ESS Total residuals to visually examine normality assumptions of 
analyses conducted for Hypothesis one.
- 20.00
Residual for ESS Chara
Figure E4. Histogram of ESS Character residuals to visually examine normality assumptions 
of analyses conducted for Hypothesis two.
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- 20.00 10.00 20.00
Residual for ESS Behav
Figure E5. Histogram of ESS Behaviour residuals to visually examine normality 
assumptions of analyses conducted for Hypothesis two.
Residual for E SS_B ody
Figure E6. Histogram of ESS Body residuals to visually examine normality assumptions o f
analyses conducted for Hypothesis two.
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Unstandardized Residual
Figure E7. Histogram of ESS Character residuals to visually examine normality assumptions 
of analyses (with self-ambivalence measure) conducted for Hypothesis four.
- 2 0 .0 0 0 0 0 - 10.00000 00000 2 0 .0 00 0 0
Un standardized Residual
Figure E8. Histogram of ESS Character residuals to visually examine normality assumptions
of analyses (with self-esteem measure) conducted for Hypothesis four.
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Unstandardized Residual
Figure E9. Histogram of ESS Character residuals to visually examine normality assumptions 
of analyses (with aggression measure) conducted for Hypothesis four.
-3 0 .0 0 - 2 0 .00 - 10 .00  .00  1 0 .0 0  2 0 .0 0  
Residual for DDI Total
3 0 .0 0
Figure E10. Histogram of DDI measure residuals to visually examine normality assumptions
of analyses conducted for Hypothesis five.
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Appendix F: Analysis of Variance tables
Table FI
Analysis o f  Variance Summary for ESS Total With and Without Demographic 
Covariates
Source Sum of Squares df Mean
Square
F Sig. Partial Eta 
Squared
Group 6099.61 1 6099.61 18.86 .000* .161
Error 31701.30 98 323.48
Group 569.75 1 569.75 1.90 .172 .021
Age 279.13 3 93.04 .31 .818 .010
Gender 1052.84 1 1052.84 3.51 .064 .038
Education level 2427.23 4 606.81 2.02 .098 .083
Employment 220.99 1 220.99 .74 .393 .008
Error 26715.91 89 300.18
*p< .001
Table F2
Analysis o f Variance Summary for ESS Character shame subscale With and Without 
Demographic Covariates
Source Sum of Squares df Mean
Square
F Sig. Partial Eta 
Squared
Group
Error
2361.96
8559.04
1
98
2361.96
87.337
27.04 .000** .216
Group 378.34 1 378.34 4.32 .040* .046
Age 51.92 3 17.31 .198 .898 .007
Gender 75.56 1 75.56 .86 .355 .010
Education level 458.81 4 114.70 1.31 222 .056
Employment 39.22 1 39.22 .45 .505 .005
Error 7786.92 89 87.49
*p< .05, **/?< .001
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Table F3
Analysis o f Variance Summary for ESS Behaviour shame subscale With and Without 
Demographic Covariates
Source Sum of Squares df Mean
Square
F Sig. Partial Eta 
Squared
Group 571.21 1 571.21 11.32 .001** .104
Error 4944.50 98 50.45
Group 43.19 1 43.19 .94 .334 .010
Age 58.10 3 19.37 .42 .737 .014
Gender 126.95 1 126.95 2.77 .100 .030
Education level 490.80 4 122.70 2.68 .037* .107
Employment 35.92 1 35.92 .784 .378 .009
Error 4078.95 89 45.83
*p< .05, **/?< .01
Table F4
Analysis o f  Variance Summary for ESS Body shame sub scale With and Without 
Demographic Covariates
Source Sum of Squares df Mean
Square
F Sig. Partial Eta 
Squared
Group 31.36 1 31.36 2.18 .143 .022
Error 1407.64 98 14.36
Group 4.64 1 4.64 .38 .538 .004
Age 24.83 3 8.28 .68 .565 .022
Gender 155.95 1 155.95 12.87 .001* .126
Education level 86.13 4 21.53 1.78 .141 .074
Employment 6.81 1 6.81 .562 .455 .006
Error 1078.75 89 12.12
*p< .01
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Research Log
1 Formulating and testing hypotheses and research questions Y
2 Carrying out a structured literature search using information technology 
and literature search tools
Y
3 Critically reviewing relevant literature and evaluating research methods Y
4 Formulating specific research questions Y
5 Writing brief research proposals Y
6 Writing detailed research proposals/protocols Y
7 Considering issues related to ethical practice in research, including issues 
of diversity, and structuring plans accordingly
Y
8 Obtaining approval from a research ethics committee Y
9 Obtaining appropriate supervision for research Y
10 Obtaining appropriate collaboration for research Y
11 Collecting data from research participants Y
12 Choosing appropriate design for research questions Y
13 Writing patient information and consent forms Y
14 Devising and administering questionnaires Y
15 Negotiating access to study participants in applied NHS settings Y
16 Setting up a data file Y
17 Conducting statistical data analysis using SPSS Y
18 Choosing appropriate statistical analyses Y
19 Preparing quantitative data for analysis Y
20 Choosing appropriate quantitative data analysis Y
21 Summarising results in figures and tables Y
22 Conducting semi-structured interviews Y
23 Transcribing and analysing interview data using qualitative methods Y
24 Choosing appropriate qualitative analyses Y
25 Interpreting results from quantitative and qualitative data analysis Y
26 Presenting research findings in a variety of contexts Y
27 Producing a written report on a research project Y
28 Defending own research decisions and analyses Y
29 Submitting research reports for publication in peer-reviewed journals or 
edited book
Y
30 Applying research findings to clinical practice Y
